See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for all members

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36958517	0	Pelland-Marcotte MC, Bouchard V, Begin E, et al. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023 Mar 21:S1538-7836(23)00242-8. doi: 10.1016/j.jtha.2023.03.012.
	36940444	0	Wang TY, Wahed AS, Morris A, et al. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Ann Intern Med. 2023 Mar 21. doi: 10.7326/M22-3350.
	36923708	0	Agbani EO, Skeith L, Lee A. Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers. Res Pract Thromb Haemost. 2023 Feb 8;7(2):100075. doi: 10.1016/j.rpth.2023.100075. eCollection 2023 Feb.
	36923287	0	Bunch CM, Chang E, Moore EE, et al. SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock. Front Physiol. 2023 Feb 27;14:1094845. doi: 10.3389/fphys.2023.1094845. eCollection 2023.
	36921919	0	Whitworth H, Amankwah EK, Betensky M, et al. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2023 Mar 13:S1538-7836(23)00230-1. doi: 10.1016/j.jtha.2023.03.004.
	36912116	0	Singh T, Lavikainen LI, Halme ALE, et al. Timing of symptomatic venous thromboembolism after surgery: meta-analysis. Br J Surg. 2023 Mar 13:znad035. doi: 10.1093/bjs/znad035.
	36907381	0	Candeloro M, Valeriani E, Monreal M, et al. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis. J Thromb Haemost. 2023 Mar 10:S1538-7836(23)00176-9. doi: 10.1016/j.jtha.2023.03.002.
	36905769	0	Spenard E, Geerts W, Lin Y, et al. Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol. 2023 Mar 9;172:9-14. doi: 10.1016/j.ygyno.2023.02.012.
	36896358	0	Srinivasan S, Kumar PG, Govil D, et al. Competencies for Point-of-care Ultrasonography in ICU: An ISCCM Expert Panel Practice Recommendation. Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S7-S12. doi: 10.5005/jp-journals-10071-24199.
	36895083	0	Shargall Y, Wiercioch W, Brunelli A, et al. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. J Thorac Cardiovasc Surg. 2023 Mar;165(3):794-824.e6. doi: 10.1016/j.jtcvs.2022.05.041. Epub 2022 Dec 15.
	36891522	0	Shapiro AD, Hardesty BM, Peyvandi F, et al. Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review. Res Pract Thromb Haemost. 2022 Dec 9;7(1):100007. doi: 10.1016/j.rpth.2022.100007. eCollection 2023 Jan.
	36863566	0	Davis S, Goodacre S, Horner D, et al. Decision-analysis modelling of effectiveness and cost-effectiveness of pharmacological thromboprophylaxis for surgical inpatients, using variable risk assessment models or other strategies. J Thromb Haemost. 2023 Feb 28:S1538-7836(23)00166-6. doi: 10.1016/j.jtha.2023.02.018.
	36858800	0	Humphries B, Leon-Garcia M, Bates SM, et al. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study. BMJ Evid Based Med. 2023 Mar 1:bmjebm-2022-112098. doi: 10.1136/bmjebm-2022-112098.
	36858345	0	Schenker C, Marx CE, Kraaijpoel N, et al. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. J Thromb Haemost. 2023 Feb 27:S1538-7836(23)00161-7. doi: 10.1016/j.jtha.2023.02.013.
	36852972	0	Medeiros SK, Sharma N, Dwivedi D, et al. The effects of DNase I and low-molecular-weight heparin in a murine model of polymicrobial abdominal sepsis. Shock. 2023 Mar 1. doi: 10.1097/SHK.0000000000002095.
	36852262	0	Bosch A, Uleryk E, Avila L. Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review. Res Pract Thromb Haemost. 2023 Feb 2;7(2):100064. doi: 10.1016/j.rpth.2023.100064. eCollection 2023 Feb.
	36841648	0	Mulder FI, Kraaijpoel N, Carrier M, et al. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study. J Thromb Haemost. 2023 Jan 11:S1538-7836(23)00031-4. doi: 10.1016/j.jtha.2023.01.003.
	36820873	0	Caiano LM, Riva N, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis. Expert Rev Hematol. 2023 Feb 23. doi: 10.1080/17474086.2023.2184340.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36798284	0	Yang Y, Du Y, Ivanov D, et al. Molecular architecture and platelet-activating properties of small immune complexes assembled on intact heparin and their possible involvement in heparin-induced thrombocytopenia. bioRxiv. 2023 Feb 11:2023.02.11.528150. doi: 10.1101/2023.02.11.528150. Preprint.
	36796485	0	Barnes GD, Ageno W, Castellucci LA, et al. Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation. J Thromb Haemost. 2023 Feb 14:S1538-7836(23)00149-6. doi: 10.1016/j.jtha.2023.02.008.
	36781052	0	Kahn SR, Matino D, Carrier M, et al. First-Person Call to Attend 2023 Congress. J Thromb Haemost. 2023 Feb 11:S1538-7836(23)00117-4. doi: 10.1016/j.jtha.2023.01.039.
	36777286	0	Li PY, Yu P, Li A, et al. Convalescent Plasma Therapy for COVID-19 in Ambulatory vs Hospitalized Patients: Efficacy and Risk of Thromboembolism. Res Pract Thromb Haemost. 2023 Feb 6:100068. doi: 10.1016/j.rpth.2023.100068.
	36775414	0	Alsehly AA, Wang TF, Carrier M. Time to rethink extended thromboprophylaxis after cancer surgery? J Thromb Haemost. 2023 Feb;21(2):198-199. doi: 10.1016/j.jtha.2022.11.015.
	36773014	0	Krzywicka K, Aguiar de Sousa D, Cordonnier C, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur J Neurol. 2023 Feb 11. doi: 10.1111/ene.15735.
	36764659	0	Kumar R, Bakeer N, Dawson J, et al. Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency - first analysis of the International Society on Thrombosis and Haemostasis (ISTH) Pediatric Antithrombin Deficiency Database and Biorepository. J Thromb Haemost. 2023 Feb 8:S1538-7836(23)00100-9. doi: 10.1016/j.jtha.2023.01.037.
	36763520	0	Avila L, Bentley RF, Bastas DM, et al. Unravelling the pathophysiology of lower limb post-thrombotic syndrome in adolescents: a proof-of-concept study. Blood Adv. 2023 Feb 10:bloodadvances.2022009599. doi: 10.1182/bloodadvances.2022009599.
	36759279	0	Zheng Z, Mukhametova L, Boffa MB, et al. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis. J Thromb Haemost. 2023 Jan 14:S1538-7836(23)00036-3. doi: 10.1016/j.jtha.2023.01.008.
	36746545	0	Horner D, Rex S, Reynard C, et al. Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals. BMJ Open. 2023 Feb 6;13(2):e069244. doi: 10.1136/bmjopen-2022-069244.
	36740040	0	Robin P, Le Pennec R, Eddy M, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data. J Thromb Haemost. 2023 Feb 3:S1538-7836(23)00084-3. doi: 10.1016/j.jtha.2023.01.030.
	36739234	0	Bastas D, Brandao LR, Allen DD, et al. Functional impact of pediatric postthrombotic syndrome. J Thromb Haemost. 2023 Jan 10:S1538-7836(23)00032-6. doi: 10.1016/j.jtha.2023.01.004.
	36737374	0	Megy K, Downes K, Morel-Kopp MC, et al. Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617]. J Thromb Haemost. 2023 Feb 1:S1538-7836(23)00064-8. doi: 10.1016/j.jtha.2023.01.021.
	36732162	0	Shen C, Mackeigan DT, Shoara AA, et al. Dual roles of fucoidan-GPIbalpha interaction in thrombosis and hemostasis: implications for drug development targeting GPIbalpha. J Thromb Haemost. 2023 Jan 9:S1538-7836(23)00026-0. doi: 10.1016/j.jtha.2022.12.030.
	36729882	0	Ratnasekera A, Geerts W, Haut ER, et al. Implementation Science Approaches to Optimizing Venous Thromboembolism Prevention in Patients with Traumatic Injuries: Findings from the 2022 Consensus Conference to Implement Optimal VTE Prophylaxis in Trauma. J Trauma Acute Care Surg. 2022 Dec 6. doi: 10.1097/TA.0000000000003850.
	36724651	0	Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study. Thromb Res. 2022 Dec 15;223:87-94. doi: 10.1016/j.thromres.2022.12.001.
	36710196	0	Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021.
	36709677	0	Roberge G, Carrier M. Long VITT: A case report. Thromb Res. 2023 Jan 24;223:78-79. doi: 10.1016/j.thromres.2023.01.017.
	36707719	0	Scherlinger M, Richez C, Tsokos GC, et al. The role of platelets in immune-mediated inflammatory diseases. Nat Rev Immunol. 2023 Jan 27. doi: 10.1038/s41577-023-00834-4.
	36700178	0	Chan N, Wheeler M, Bhagirath V, et al. Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers. CJC Open. 2022 Oct 12;5(1):1-7. doi: 10.1016/j.cjco.2022.09.006. eCollection 2023 Jan.
	36696220	0	Choi SJ, Dwyer CN, Rapkin L, et al. The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07636-X. doi: 10.1016/j.jtha.2022.11.022.
	36696208	0	de Winter MA, Uijl A, Buller HR, et al. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07627-9. doi: 10.1016/j.jtha.2022.11.013.
	36696204	0	Shaw JR, Castellucci LA, Siegal D, et al. DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature. J Thromb Haemost. 2023 Mar;21(3):433-452. doi: 10.1016/j.jtha.2022.11.029. Epub 2022 Dec 22.
	36696189	0	Stals MAM, Moumneh T, Ainle FN, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07639-5. doi: 10.1016/j.jtha.2022.11.025.
	36696186	0	Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
	36696183	0	Aziz J, Wang TF, Siegal D, et al. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2022 Dec 27:S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016.
	36695400	0	Yin R, Patel V, Malik RA, et al. Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin. J Thromb Haemost. 2023 Jan;21(1):83-93. doi: 10.1016/j.jtha.2022.10.001. Epub 2022 Dec 22.
	36695399	0	Guan Z, Wang R, Hussain RH, et al. Rivaroxaban and apixaban are less effective than enoxaparin for the prevention of catheter-induced clotting in vitro. J Thromb Haemost. 2023 Jan;21(1):76-82. doi: 10.1016/j.jtha.2022.10.020. Epub 2022 Dec 22.
	36695396	0	Bistervels IM, Wiegers HMG, Ainle FN, et al. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study. J Thromb Haemost. 2023 Jan;21(1):57-67. doi: 10.1016/j.jtha.2022.11.004. Epub 2022 Dec 22.
	36695378	0	Miljic P, Noureldin A, Lavin M, et al. Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians' survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023 Jan;21(1):154-163. doi: 10.1016/j.jtha.2022.10.019. Epub 2022 Dec 22.
	36685003	0	Saville O, Elbatarny M, Tera Y, et al. Sex Differences in D-Dimer and Critical Illness in COVID-19 Patients: A Systematic Review and Meta-analysis. Res Pract Thromb Haemost. 2023 Jan 14:100042. doi: 10.1016/j.rpth.2023.100042.
	36649737	0	Schenker C, Stalder O, Mean M, et al. Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials. Thromb Haemost. 2023 Jan 9. doi: 10.1055/s-0042-1760365.
	36648242	0	de Winter MA, Buller HR, Carrier M, et al. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score. Eur Heart J. 2023 Jan 17:ehac776. doi: 10.1093/eurheartj/ehac776.
	36626707	0	Li A, La J, May SB, et al. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 Jan 10:JCO2201542. doi: 10.1200/JCO.22.01542.
	36624252	0	Lin K, Xu K, Daoust R, et al. Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study. CJEM. 2023 Jan 10. doi: 10.1007/s43678-022-00440-8.
	36609323	0	Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927.
	36603593	0	Zidan A, Noureldin A, Kumar SA, et al. COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications. Semin Thromb Hemost. 2023 Feb;49(1):9-14. doi: 10.1055/s-0042-1759684. Epub 2023 Jan 5.
	36601884	0	Carlin S, de Vries TA, Budaj A, et al. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances. Kardiol Pol. 2022;80(12):1200-1210. doi: 10.33963/KP.a2022.0283.
	36594041	0	Fraser DD, Patel MA, Van Nynatten LR, et al. Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients. Heliyon. 2023 Jan;9(1):e12704. doi: 10.1016/j.heliyon.2022.e12704. Epub 2022 Dec 29.
	36574232	0	Agbani EO, Hers I, Poole AW. Platelet Procoagulant Membrane Dynamics: A Key Distinction Between Thrombosis and Hemostasis? Blood Adv. 2022 Dec 27:bloodadvances.2022008122. doi: 10.1182/bloodadvances.2022008122.
	36574172	0	Venier LM, Clerici B, Bissola AL, et al. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder. Int J Hematol. 2022 Dec 27:1-8. doi: 10.1007/s12185-022-03516-4.
	36565677	0	Turpie AGG, Farjat AE, Haas S, et al. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2022 Nov 25;222:31-39. doi: 10.1016/j.thromres.2022.11.016.
	36556013	0	Yamaura L, Young D, Skeith L, et al. Heightened Procoagulation after Post-Operative Thromboprophylaxis Completion in Patients with Metastatic Bone Disease from Primary Colorectal Cancer. J Clin Med. 2022 Dec 13;11(24):7397. doi: 10.3390/jcm11247397.
	36534732	0	Weitz JI, Eikelboom JW. What Is the Future of Factor XI Inhibitors? Circulation. 2022 Dec 20;146(25):1899-1902. doi: 10.1161/CIRCULATIONAHA.122.061132. Epub 2022 Dec 19.
	36522193	0	Porres-Aguilar M. Factor XI Inhibitors for the Prevention of Thrombosis: Towards Safer Anticoagulation Strategies. Arch Med Res. 2022 Dec 13:S0188-4409(22)00165-5. doi: 10.1016/j.arcmed.2022.11.018.
	36519935	0	Shargall Y, Wiercioch W, Brunelli A, et al. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac488. doi: 10.1093/ejcts/ezac488.
	36514740	0	Mavrakanas TA, Charytan DM. Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360. 2022 Aug 1;3(10):1769-1771. doi: 10.34067/KID.0003002022. eCollection 2022 Oct 27.
	36514164	0	Chornenki NLJ, Tritschler T, Stucki F, et al. All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Syst Rev. 2022 Dec 13;11(1):269. doi: 10.1186/s13643-022-02146-5.
	36506517	0	Yu YH, Oh IS, Jeong HE, et al. Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes. Front Pharmacol. 2022 Nov 24;13:1034636. doi: 10.3389/fphar.2022.1034636. eCollection 2022.
	36498688	0	Skeith L, Hurd K, Chaturvedi S, et al. Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise. J Clin Med. 2022 Nov 30;11(23):7115. doi: 10.3390/jcm11237115.
	36485150	0	Boonyawat K, Angchaisuksiri P. Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):474-480. doi: 10.1182/hematology.2022000383.
	36485108	0	Wang TF, Carrier M. The 5 most frequently asked questions about factor Xa inhibitors. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):515-521. doi: 10.1182/hematology.2022000385.
	36481128	0	Porres-Aguilar M, Ansell J, Mukherjee D, et al. Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs. Arch Med Res. 2022 Dec 5:S0188-4409(22)00163-1. doi: 10.1016/j.arcmed.2022.11.016.
	36469448	0	Iannattone PA, Yang SS, Koolian M, et al. Incidence of Venous Thromboembolism in Adults Receiving Extracorporeal Membrane Oxygenation: A Systematic Review. ASAIO J. 2022 Dec 1;68(12):1523-1528. doi: 10.1097/MAT.0000000000001694. Epub 2022 Mar 19.
	36462135	0	Siegal DM, Freedman D, Ansell J. Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review. J Thromb Thrombolysis. 2023 Feb;55(2):197-202. doi: 10.1007/s11239-022-02739-w. Epub 2022 Dec 3.
	36455606	0	Galanaud JP, Genty-Vermorel C, Barrellier MT, et al. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial. Lancet Haematol. 2022 Dec;9(12):e886-e896. doi: 10.1016/S2352-3026(22)00247-2.
	36452204	0	Haas S, Farjat AE, Pieper K, et al. On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. TH Open. 2022 Nov 3;6(4):e354-e364. doi: 10.1055/s-0042-1757744. eCollection 2022 Oct.
	36444228	0	Papadopoulos E, Abdulrehman J, Alibhai SMH. The Value of Performance Status in Predicting Clinical Outcomes in Patients With Cancer-Associated Pulmonary Embolism. JACC CardioOncol. 2022 Nov 15;4(4):519-521. doi: 10.1016/j.jaccao.2022.10.001. eCollection 2022 Nov.
	36434811	0	Hansen-Barkun C, Martel M, Douketis J, et al. Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002076.
	36428830	0	Wauthier L, Favresse J, Hardy M, et al. D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review. Diagnostics (Basel). 2022 Nov 12;12(11):2770. doi: 10.3390/diagnostics12112770.
	36427068	0	Pelland-Marcotte MC, Tole S, Bouhelier E, et al. Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature. Pediatr Hematol Oncol. 2022 Nov 25:1-8. doi: 10.1080/08880018.2022.2150797.
	36414382	0	Favaloro EJ, Mohammed S, Donikian D, et al. Corrigendum to "A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia" [Pathology (53) (2021) 247-256]. Pathology. 2022 Dec;54(7):972. doi: 10.1016/j.pathol.2022.11.002.
	36413608	0	Afonso E, Bayat F, Ladouceur L, et al. Highly Stable Hierarchically Structured All-Polymeric Lubricant-Infused Films Prevent Thrombosis and Repel Multidrug-Resistant Pathogens. ACS Appl Mater Interfaces. 2022 Nov 22. doi: 10.1021/acsami.2c17309.
	36413031	0	Tran A, Fernando SM, Gates RS, et al. Efficacy and Safety of Anti-Xa Guided versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients - A Systematic Review and Meta-Analysis. Ann Surg. 2022 Nov 22. doi: 10.1097/SLA.0000000000005754.
	36410399	0	Fainchtein K, Tera Y, Kearn N, et al. Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography. Semin Thromb Hemost. 2022 Nov 21. doi: 10.1055/s-0042-1758116.
	36409922	0	Ding Z, Sherlock M, Chan AKC, et al. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada. Blood Coagul Fibrinolysis. 2022 Dec 1;33(8):449-456. doi: 10.1097/MBC.0000000000001166. Epub 2022 Nov 7.
	36405542	0	Wright JM, Bottega N, Therrien J, et al. The multidisciplinary management of a mechanical mitral valve thrombosis in pregnancy: a case report and review of the literature. Eur Heart J Case Rep. 2022 Nov 1;6(11):ytac424. doi: 10.1093/ehjcr/ytac424. eCollection 2022 Nov.
	36399203	0	Bonsu KO, Young SW, Lee T, et al. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region. Eur J Clin Pharmacol. 2022 Nov 18. pii: 10.1007/s00228-022-03418-8. doi: 10.1007/s00228-022-03418-8.
	36397933	0	Ivankovic V, McAlpine K, Delic E, et al. Extended-duration thromboprophylaxis for abdominopelvic surgery: Development and evaluation of a risk-stratified patient decision aid to facilitate shared decision making. Res Pract Thromb Haemost. 2022 Nov 14;6(8):e12831. doi: 10.1002/rth2.12831. eCollection 2022 Nov.
	36382456	0	Tang Y, Xu Y, Zhang X, et al. [Low molecular weight heparin combined with aspirin to prevent perioperative venous thromboembolism in patients with splenic rupture and lower extremity fracture]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Nov 15;36(11):1381-1387. doi: 10.7507/1002-1892.202207096.
	36371248	0	de Wit K, Al-Haimus F, Hu Y, et al. Comparison of YEARS and Adjust-Unlikely D-dimer Testing for Pulmonary Embolism in the Emergency Department. Ann Emerg Med. 2022 Nov 10. pii: S0196-0644(22)01118-0. doi: 10.1016/j.annemergmed.2022.09.014.
	36368688	0	Grandone E, Barcellona D, Intrieri M, et al. The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism. Semin Thromb Hemost. 2022 Nov 11. doi: 10.1055/s-0042-1758062.
	36357215	0	Tritschler T, Sadeghipour P, Bikdeli B. Subgroup analysis in randomized controlled trials: Useful or misleading? Thromb Res. 2022 Oct 18. pii: S0049-3848(22)00426-1. doi: 10.1016/j.thromres.2022.10.009.
	36354038	0	Bistervels IM, Buchmuller A, Wiegers HMG, et al. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. Lancet. 2022 Oct 28. pii: S0140-6736(22)02128-6. doi: 10.1016/S0140-6736(22)02128-6.
	36352844	0	Jevtic SD, Arnold DM, Modi D, et al. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Front Cardiovasc Med. 2022 Oct 24;9:1040196. doi: 10.3389/fcvm.2022.1040196. eCollection 2022.
	36351906	0	Buoninfante A, Andeweg A, Baker AT, et al. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. NPJ Vaccines. 2022 Nov 9;7(1):141. doi: 10.1038/s41541-022-00569-8.
	36343959	0	Chornenki NLJ, Fralick M, Sholzberg M. Tests de depistage du rapport international normalise et du temps de cephaline activee. CMAJ. 2022 Nov 7;194(43):E1491-E1492. doi: 10.1503/cmaj.220629-f.
	36341698	0	Fu L, MacKeigan DT, Gong Q, et al. Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease. Br J Haematol. 2022 Nov 7. doi: 10.1111/bjh.18531.
	36337926	0	Jung RG, Duchez AC, Simard T, et al. Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype. JACC Basic Transl Sci. 2022 Sep 21;7(10):985-997. doi: 10.1016/j.jacbts.2022.05.002. eCollection 2022 Oct.
	36337058	0	Zhou LW, Yu AYX, Ngo L, et al. Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke. 2022 Nov 7. doi: 10.1161/STROKEAHA.122.039390.
	36326142	0	Zabeida A, Winikoff R, Pelland-Marcotte MC, et al. COVID-19-associated coagulopathy in children: A multicenter observational cohort study. Pediatr Blood Cancer. 2022 Nov 3:e30079. doi: 10.1002/pbc.30079.
	36325656	0	Massicotte-Azarniouch D, Sood MM, Fergusson DA, et al. The association of venous thromboembolism with blood transfusion in kidney transplant patients. Transfusion. 2022 Nov 3. doi: 10.1111/trf.17154.
	36323490	0	Weitz JI, Szekanecz Z, Charles-Schoeman C, et al. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 Nov;8(2). pii: rmdopen-2022-002571. doi: 10.1136/rmdopen-2022-002571.
	36315952	0	Shivakumar S. In acutely ill inpatients, benefits and harms of anticoagulants for VTE prophylaxis were assessed. Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0089.
	36302103	0	Chornenki NLJ, Fralick M, Sholzberg M. International normalized ratio and activated partial thromboplastin time testing. CMAJ. 2022 Aug 29;194(33):E1135. doi: 10.1503/cmaj.220629.
	36299837	0	Farrugia S, Cachia M, Degaetano J, et al. Palmar Digital Vein Thrombosis: A Case Report and Review of 36 Cases. Eur J Case Rep Intern Med. 2022 Sep 21;9(9):003552. doi: 10.12890/2022_003552. eCollection 2022.
	36299810	0	Mansory EM, Abu-Farhaneh M, Iansavitchene A, et al. Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2022 Sep 19;6(3):e276-e282. doi: 10.1055/a-1913-4377. eCollection 2022 Jul.
	36294316	0	Kyriakoulis KG, Dimakakos E, Kyriakoulis IG, et al. Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials. J Clin Med. 2022 Oct 11;11(20). pii: jcm11205997. doi: 10.3390/jcm11205997.
	36268462	0	Attard LM, Gatt A, Bertoletti L, et al. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. Vasc Health Risk Manag. 2022 Oct 13;18:793-807. doi: 10.2147/VHRM.S271411. eCollection 2022.
	36264575	0	Ngamvichchukorn T, Ruengorn C, Noppakun K, et al. Association Between Pretransplant Dialysis Modality and Kidney Transplant Outcomes: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Oct 3;5(10):e2237580. doi: 10.1001/jamanetworkopen.2022.37580.
	36242733	0	Liu S, McLeod SL, Atzema CL, et al. Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department. CJEM. 2022 Dec;24(8):853-861. doi: 10.1007/s43678-022-00392-z. Epub 2022 Oct 15.
	36225436	0	Ganta N, Prasad A, Kochhar S, et al. A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction. Cureus. 2022 Sep 7;14(9):e28883. doi: 10.7759/cureus.28883. eCollection 2022 Sep.
	36223804	0	Ortega-Paz L, Talasaz AH, Sadeghipour P, et al. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. Semin Thromb Hemost. 2022 Oct 12. doi: 10.1055/s-0042-1757634.
	36217296	0	Wang TF, Sanfilippo KM, Douketis J, et al. Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Sep 26. doi: 10.1111/jth.15896.
	36213364	0	Siegal DM, Leong DP. Evaluating Anticoagulant Strategies for Atrial Fibrillation in Patients With Cancer: Challenges and Opportunities. JACC CardioOncol. 2022 Sep 20;4(3):351-353. doi: 10.1016/j.jaccao.2022.08.005. eCollection 2022 Sep.
	36212651	0	Heldner MR, Aguiar de Sousa D, Field TS, et al. Editorial: Cerebral venous thrombosis. Front Neurol. 2022 Sep 23;13:1021547. doi: 10.3389/fneur.2022.1021547. eCollection 2022.
	36210563	0	Wang TF. Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer. Thromb Res. 2022 May;213 Suppl 1:S66-S71. doi: 10.1016/j.thromres.2021.11.026. Epub 2022 May 26.
	36210560	0	Delluc A, Robin P. (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know? Thromb Res. 2022 May;213 Suppl 1:S42-S45. doi: 10.1016/j.thromres.2022.01.018. Epub 2022 May 26.
	36206783	0	Aibar J, Schulman S. Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):e1-e2. doi: 10.1055/s-0042-1757330. Epub 2022 Oct 7.
	36205248	0	Raskob GE, Ageno W, Albers G, et al. Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness. J Am Heart Assoc. 2022 Oct 7:e026229. doi: 10.1161/JAHA.122.026229.
	36201366	0	Potere N, Barco S, Mahe I, et al. Awareness of Venous Thromboembolism among Patients with Cancer: Preliminary Findings from a Global Initiative for World Thrombosis Day. J Thromb Haemost. 2022 Oct 6. doi: 10.1111/jth.15902.
	36200348	0	Shaw JR, Li N, Nixon J, et al. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost. 2022 Dec;20(12):2953-2963. doi: 10.1111/jth.15901. Epub 2022 Oct 18.
	36199587	0	AlEidan FAS, AlManea RK, AlMoneef AT, et al. Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study. Int J Gen Med. 2022 Sep 28;15:7559-7568. doi: 10.2147/IJGM.S359893. eCollection 2022.
	36199014	0	Leon-Garcia M, Humphries B, Maraboto A, et al. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review. BMC Pregnancy Childbirth. 2022 Oct 5;22(1):747. doi: 10.1186/s12884-022-05042-x.
	36198021	0	Srikajornlarp S, Amnueypol M, Vathesatogkit P, et al. Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221130058. doi: 10.1177/10760296221130058.
	36186105	0	Koolian M, Wiseman D, Mantzanis H, et al. Anticoagulation stewardship: Descriptive analysis of a novel approach to appropriate anticoagulant prescription. Res Pract Thromb Haemost. 2022 Sep 25;6(6):e12758. doi: 10.1002/rth2.12758. eCollection 2022 Aug.
	36174599	0	Kwaan HC, Walsh M, Lindholm PF, et al. Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemostatic Function. Semin Thromb Hemost. 2022 Sep 29. doi: 10.1055/s-0042-1756700.
	36150513	0	Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multi-database cohort study. Am J Med. 2022 Sep 20. pii: S0002-9343(22)00666-0. doi: 10.1016/j.amjmed.2022.08.033.
	36135074	0	Harrigan AM, Rioux J, Shivakumar S. Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner. Curr Oncol. 2022 Sep 8;29(9):6419-6432. doi: 10.3390/curroncol29090505.
	36122922	0	Barber MRW, Clarke AE, Adams CD, et al. Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus. CMAJ. 2022 Sep 19;194(36):E1243-E1247. doi: 10.1503/cmaj.220491.
	36122573	0	Ziemba YC, Abdulrehman J, Hollestelle MJ, et al. Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade. Semin Thromb Hemost. 2022 Sep 19. doi: 10.1055/s-0042-1754332.
	36121587	0	Eikelboom R, Whitlock RP, Sibilio S, et al. Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study. Cardiovasc Drugs Ther. 2022 Sep 19. pii: 10.1007/s10557-022-07381-5. doi: 10.1007/s10557-022-07381-5.
	36100263	0	Auer RC, Ott M, Karanicolas P, et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
	36095313	0	Duffett L. Deep Venous Thrombosis. Ann Intern Med. 2022 Sep 13. doi: 10.7326/AITC202209200.
	36082668	0	van de Munckhof A, Lindgren E, Kleinig TJ, et al. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase. Stroke. 2022 Sep 9:101161STROKEAHA122039575. doi: 10.1161/STROKEAHA.122.039575.
	36076354	0	Porres-Aguilar M, Mukherjee D, Didia SC, et al. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies. Vascular. 2022 Sep 8:17085381221126235. doi: 10.1177/17085381221126235.
	36074019	0	DeYoung V, Singh K, Kretz CA. Mechanisms of ADAMTS13 Regulation. J Thromb Haemost. 2022 Sep 8. doi: 10.1111/jth.15873.
	36055334	0	Gwozdz AM, de Jong CMM, Fialho LS, et al. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. Lancet Haematol. 2022 Sep;9(9):e698-e706. doi: 10.1016/S2352-3026(22)00215-0.
	36051542	0	Simard C, Gerstein L, Cafaro T, et al. Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12801. doi: 10.1002/rth2.12801. eCollection 2022 Aug.
	36051541	0	Rinfret F, Gu CS, Vedantham S, et al. New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12796. doi: 10.1002/rth2.12796. eCollection 2022 Aug.
	36046208	0	Spyropoulos AC, Goldin M, Ageno W, et al. Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial. TH Open. 2022 Jul 11;6(3):e177-e183. doi: 10.1055/s-0042-1750379. eCollection 2022 Jul.
	36033945	0	Jin FM, Wang M, Wu XM, et al. Effects of wasp venom on venous thrombosis in rats. Iran J Basic Med Sci. 2022 Jul;25(7):822-826. doi: 10.22038/IJBMS.2022.63219.13962.
	36032214	0	Woller SC, de Wit K, Robert-Ebadi H, et al. A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH. Res Pract Thromb Haemost. 2022 Aug 26;6(6):e12786. doi: 10.1002/rth2.12786. eCollection 2022 Aug.
	36032177	0	Mah J, Lee A, Scott JN, et al. Pneumococcal otogenic meningitis complicated by pneumocephalus, seizures, right-sided hemiplegia and cortical venous thrombosis. IDCases. 2022 Aug 17;29:e01601. doi: 10.1016/j.idcr.2022.e01601. eCollection 2022.
	36030069	0	Ciuffini LA, Wang TF, Lodigiani C, et al. Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting. Best Pract Res Clin Haematol. 2022 Mar;35(1):101351. doi: 10.1016/j.beha.2022.101351. Epub 2022 Jun 6.
	36030068	0	Wang TF, Leader A, Sanfilippo KM. Thrombosis and bleeding in hematological malignancy. Best Pract Res Clin Haematol. 2022 Mar;35(1):101353. doi: 10.1016/j.beha.2022.101353. Epub 2022 Jun 16.
	36028857	0	Antic D, Milic N, Chatzikonstantinou T, et al. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.
	36016942	0	Pryzdial ELG, Leatherdale A, Conway EM. Coagulation and complement: Key innate defense participants in a seamless web. Front Immunol. 2022 Aug 9;13:918775. doi: 10.3389/fimmu.2022.918775. eCollection 2022.
	36010225	0	Robert-Ebadi H, Moumneh T, Le Gal G, et al. Diagnosis of Pulmonary Embolism during Pregnancy. Diagnostics (Basel). 2022 Aug 3;12(8). pii: diagnostics12081875. doi: 10.3390/diagnostics12081875.
	36002241	0	Kirwan C, Ramsden S, Carter J, et al. Starting anticoagulation for atrial fibrillation in the emergency department safely. Emerg Med J. 2022 Aug 24. pii: emermed-2022-212487. doi: 10.1136/emermed-2022-212487.
	35992565	0	Bistervels IM, Bavalia R, Beyer-Westendorf J, et al. Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2022 Jul 1;6(5):e12748. doi: 10.1002/rth2.12748. eCollection 2022 Jul.
	35974661	0	Candeloro M, Di Nisio M, Potere N, et al. Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants. J Am Geriatr Soc. 2022 Aug 16. doi: 10.1111/jgs.18001.
	35967591	0	Briller JE, Aggarwal NR, Davis MB, et al. Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections. JACC Adv. 2022 Aug 10:100057. doi: 10.1016/j.jacadv.2022.100057.
	35960423	0	Ikesaka R, Kaur B, Crowther M, et al. Efficacy and safety of pre-operative insertion of inferior vena cava filter in patients undergoing bariatric surgery: a systematic review. J Thromb Thrombolysis. 2022 Aug 12. pii: 10.1007/s11239-022-02689-3. doi: 10.1007/s11239-022-02689-3.
	35938419	0	Yaghi S, Saldanha IJ, Misquith C, et al. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis. Stroke. 2022 Aug 8:101161STROKEAHA122039579. doi: 10.1161/STROKEAHA.122.039579.
	35931818	0	Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022 Aug 5. pii: 10.1038/s41577-022-00762-9. doi: 10.1038/s41577-022-00762-9.
	35923661	0	Bonsu KO, Young S, Lee T, et al. Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey. Patient Prefer Adherence. 2022 Jul 26;16:1771-1780. doi: 10.2147/PPA.S367105. eCollection 2022.
	35920155	0	McCullough-Hicks ME, Halterman DJ, Anderson D, et al. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection. Stroke. 2022 Aug 3:101161STROKEAHA122038955. doi: 10.1161/STROKEAHA.122.038955.
	35919877	0	Tanguay M, Seguin C. Recurrent thrombosis rescued by fondaparinux in high-risk patients: A case series. Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12773. doi: 10.1002/rth2.12773. eCollection 2022 Jul.
	35919876	0	Bastas D, Vincelli J, De R, et al. Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability. Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12779. doi: 10.1002/rth2.12779. eCollection 2022 Jul.
	35918731	0	Holbrook AM, Vidug K, Yoo L, et al. Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2022 Aug 2;8(1):166. doi: 10.1186/s40814-022-01130-z.
	35914222	0	Palareti G, Poli D, Ageno W, et al. D-dimer and reduced dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood Adv. 2022 Aug 1. pii: 486077. doi: 10.1182/bloodadvances.2022007973.
	35906715	0	Spyropoulos AC, Connors JM, Douketis JD, et al. Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. J Thromb Haemost. 2022 Jul 7. doi: 10.1111/jth.15809.
	35895858	0	Porres-Aguilar M, Rosovsky RP, Rivera-Lebron BN, et al. Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism. J Thromb Haemost. 2022 Jul 27. doi: 10.1111/jth.15832.
	35887951	0	Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. J Clin Med. 2022 Jul 19;11(14). pii: jcm11144188. doi: 10.3390/jcm11144188.
	35877546	0	Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022 Jul 25. doi: 10.1111/bjh.18331.
	35867883	0	Back V, Asgari A, Franczak A, et al. Inhibition of Platelet Aggregation by Activation of Platelet Intermediate Conductance Ca(2+) -Activated Potassium Channels. J Thromb Haemost. 2022 Jul 22. doi: 10.1111/jth.15827.
	35852851	0	Conway EM, Pryzdial ELG. Complement contributions to COVID-19. Curr Opin Hematol. 2022 Sep 1;29(5):259-265. doi: 10.1097/MOH.0000000000000724. Epub 2022 Jul 11.
	35844166	0	Leong R, Chu DK, Crowther MA, et al. Direct oral anticoagulants after bariatric surgery - what is the evidence? J Thromb Haemost. 2022 Jul 18. doi: 10.1111/jth.15823.
	35830171	0	Bikdeli B, Caraballo C, Trujillo-Santos J, et al. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. JAMA Cardiol. 2022 Jul 13. pii: 2793876. doi: 10.1001/jamacardio.2022.1988.
	35814801	0	Ariens RA, Hunt BJ, Agbani EO, et al. Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress. Res Pract Thromb Haemost. 2022 Jul 6;6(5):e12747. doi: 10.1002/rth2.12747. eCollection 2022 Jul.
	35809961	0	Porres-Aguilar M, Mukherjee D, Lazo-Langner A. Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19. Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038.
	35803552	0	Thukral S, Salter A, Lancia S, et al. Predictors of Clinical Outcomes of Pharmacomechanical Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis - Analysis of a Multicenter Randomized Trial. J Vasc Interv Radiol. 2022 Jul 5. pii: S1051-0443(22)01050-8. doi: 10.1016/j.jvir.2022.05.030.
	35793687	0	Candeloro M, Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin Thromb Hemost. 2022 Jul 6. doi: 10.1055/s-0042-1749661.
	35790272	0	Dimakakos E, Gomatou G, Catalano M, et al. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. Anticancer Res. 2022 Jul;42(7):3261-3274. doi: 10.21873/anticanres.15815.
	35787808	0	Roberge G, Cote B, Calabrino A, et al. Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases. Thromb J. 2022 Jul 4;20(1):38. doi: 10.1186/s12959-022-00398-8.
	35780487	0	Lavin M, Christopherson P, Grabell J, et al. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost. 2022 Jul 3. doi: 10.1111/jth.15807.
	35779962	0	Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, et al. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil. Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761-7. doi: 10.1016/j.vaccine.2022.06.014.
	35772400	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VIII. Semin Thromb Hemost. 2022 Jun;48(4):405-406. doi: 10.1055/s-0042-1748886. Epub 2022 Jun 30.
	35759737	0	Porres-Aguilar M, Anaya-Ayala JE. [Comment on article "Enoxaparin dose associated with decreased risk of death in COVID-19"]. Rev Med Inst Mex Seguro Soc. 2022 May 2;60(3):247-248.
	35753074	0	Chelle P, Iorio A, Edginton AN. A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates. J Thromb Haemost. 2022 Sep;20(9):2012-2021. doi: 10.1111/jth.15803. Epub 2022 Jul 7.
	35748885	0	Cuker A, Tseng EK, Schunemann HJ, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients Blood Adv. 2022 Jun 24. pii: 485690. doi: 10.1182/bloodadvances.2022007940.
	35735219	0	den Exter PL, Woller SC, Robert-Ebadi H, et al. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. 2022 Jun 4. doi: 10.1111/jth.15776.
	35730241	0	Genge L, Krala A, Tritschler T, et al. Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review. J Thromb Haemost. 2022 Jun 22. doi: 10.1111/jth.15788.
	35717670	0	Tritschler T, Cusano E, Langlois N, et al. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review. J Thromb Haemost. 2022 Jun 19. doi: 10.1111/jth.15787.
	35716055	0	Thachil J, Carrier M, Lisman T. Anticoagulation in thrombocytopenic patients - time to rethink? J Thromb Haemost. 2022 Jun 18. doi: 10.1111/jth.15789.
	35707621	0	Eagle GE, Schulman S. High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study. TH Open. 2022 Jun 13;6(2):e147-e153. doi: 10.1055/a-1827-7464. eCollection 2022 Apr.
	35697453	0	Wang M, Paterson M, Thabane L, et al. Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 2022 Jun 13;12(6):e057991. doi: 10.1136/bmjopen-2021-057991.
	35689346	0	Scutelnic A, Krzywicka K, Mbroh J, et al. Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination. Ann Neurol. 2022 Jun 10. doi: 10.1002/ana.26431.
	35679460	0	Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027.
	35677980	0	Nguyen TN, Qureshi MM, Klein P, et al. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31.
	35677520	0	Agrawal D, Gupta D, Nathani R, et al. Presence of Ascites at Presentation is Associated With Absence of Long-Term Response Amongst Patients With Budd-Chiari Syndrome When Treated With Medical Therapy Alone: A Single Centre Real-Life Experience. J Clin Exp Hepatol. 2022 May-Jun;12(3):861-870. doi: 10.1016/j.jceh.2021.10.148. Epub 2021 Nov 3.
	35667069	0	Mithoowani S, Lim W. Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis. Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0039.
	35660801	0	Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014.
	35653590	0	Baumann Kreuziger L, Sholzberg M, Cushman M. Anticoagulation in Hospitalized Patients with COVID-19. Blood. 2022 Jun 2. pii: 485455. doi: 10.1182/blood.2021014527.
	35648414	0	Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, et al. Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA Cardiol. 2022 Jun 1. pii: 2793119. doi: 10.1001/jamacardio.2022.1292.
	35638475	0	da Costa WL Jr, Guffey D, Oluyomi A, et al. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022 May 31. doi: 10.1002/ajh.26623.
	35635332	0	Sanfilippo KM, Wang TF, Carrier M, et al. Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. J Thromb Haemost. 2022 May 18. doi: 10.1111/jth.15759.
	35621286	0	Amenyogbe A, Lemire F, Yachnin D, et al. A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer. Can Urol Assoc J. 2022 May 20. pii: cuaj.7865. doi: 10.5489/cuaj.7865.
	35613465	0	Candeloro M, Valeriani E, Monreal M, et al. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis. Blood Adv. 2022 May 25. pii: 485361. doi: 10.1182/bloodadvances.2022007961.
	35611985	0	Sanfilippo KM, Moik F, Candeloro M, et al. Unanswered questions in cancer-associated thrombosis. Br J Haematol. 2022 May 25. doi: 10.1111/bjh.18276.
	35611694	0	Chang SJ, Rebchuk AD, Teal P, et al. COVID-19-Associated Cerebral Developmental Venous Anomaly Thrombosis With Hemorrhagic Transformation. Stroke. 2022 May 25:101161STROKEAHA122039534. doi: 10.1161/STROKEAHA.122.039534.
	35609563	0	Bissola AL, Daka M, Arnold DM, et al. The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Adv. 2022 Jul 26;6(14):4228-4235. doi: 10.1182/bloodadvances.2022007766.
	35606788	0	Young SW, Bonsu KO, Lee T, et al. Patient satisfaction with quality of care of a multidisciplinary thrombosis service - a cross sectional survey. BMC Health Serv Res. 2022 May 23;22(1):685. doi: 10.1186/s12913-022-08089-w.
	35606079	0	Boffa MB. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis. Atherosclerosis. 2022 May;349:72-81. doi: 10.1016/j.atherosclerosis.2022.04.009.
	35599706	0	Lai CMB, Lee AYY, Parkin SBI. Vaccine-induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report. Res Pract Thromb Haemost. 2022 May 18;6(4):e12716. doi: 10.1002/rth2.12716. eCollection 2022 May.
	35599704	0	Nersesian S, Sholzberg M, Cushman M, et al. The Journey to a Successful Illustrated Review. Res Pract Thromb Haemost. 2022 May 18;6(4):e12721. doi: 10.1002/rth2.12721. eCollection 2022 May.
	35587536	0	Popov J, Coelho S, Carrier M, et al. Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study. J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
	35582246	0	Bayadinova JA, Sardo LA, Penton L, et al. 'Spot the CLOT': Awareness of cancer-associated thrombosis in healthcare providers. Can Oncol Nurs J. 2022 Apr 1;32(2):325-330. eCollection 2022 Spring.
	35581123	0	Garas SN, McAlpine K, Ross J, et al. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer. Urol Oncol. 2022 May 14. pii: S1078-1439(22)00116-8. doi: 10.1016/j.urolonc.2022.04.006.
	35580465	0	Mithoowani S, Moffat KA, Gupta A, et al. Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels. Thromb Res. 2022 Jul;215:1-4. doi: 10.1016/j.thromres.2022.05.005. Epub 2022 May 13.
	35577738	0	Yeap I, Karagiannis P, Ng SS, et al. A proven perioperative protocol for free flap surgery in a patient with heparin-induced thrombocytopenia. J Plast Reconstr Aesthet Surg. 2022 May 6. pii: S1748-6815(22)00282-0. doi: 10.1016/j.bjps.2022.04.090.
	35577626	0	Nicholson M, Goubran H, Chan N, et al. No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Rev. 2022 May 11:100970. doi: 10.1016/j.blre.2022.100970.
	35570324	0	Minford A, Brandao LR, Othman M, et al. Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thromb Haemost. 2022 Apr 17. doi: 10.1111/jth.15732.
	35537232	0	Bikdeli B, Piazza G, Jimenez D, et al. Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. Thromb Res. 2022 May 4;214:122-131. doi: 10.1016/j.thromres.2022.04.019.
	35520371	0	Farrugia S, Micallef D, Pisani D, et al. Retiform Purpura of the Lower Limbs Associated with Levamisole-Adulterated Cocaine. Eur J Case Rep Intern Med. 2022 Apr 28;9(4):003353. doi: 10.12890/2022_003353. eCollection 2022.
	35512906	0	Gabarin N, Arnold DM, Nazy I, et al. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). Semin Hematol. 2022 Apr;59(2):89-96. doi: 10.1053/j.seminhematol.2022.03.002. Epub 2022 Mar 7.
	35512903	0	Pai M. Epidemiology of VITT. Semin Hematol. 2022 Apr;59(2):72-75. doi: 10.1053/j.seminhematol.2022.02.002. Epub 2022 Feb 8.
	35506944	0	Gupta D, Kedia S, Rath GP, et al. A Century With Craniopagus Twin Separation Surgeries: Nihilism to Optimism. Neurosurgery. 2022 May 6. pii: 00006123-990000000-00256. doi: 10.1227/neu.0000000000001962.
	35503027	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. Blood Adv. 2022 May 3. pii: 485124. doi: 10.1182/bloodadvances.2022007561.
	35498021	0	Blondon M, Skeith L. Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review. Front Cardiovasc Med. 2022 Apr 12;9:886416. doi: 10.3389/fcvm.2022.886416. eCollection 2022.
	35491501	0	Sposato LA, Field TS. Atrial fibrillation detection after stroke: Is all created equal? Eur J Neurol. 2022 Jul;29(7):1869-1870. doi: 10.1111/ene.15375. Epub 2022 May 8.
	35487054	0	Grewal K, Atzema CL, Austin PC, et al. Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study. Thromb Res. 2022 Jun;214:47-52. doi: 10.1016/j.thromres.2022.04.007. Epub 2022 Apr 14.
	35470213	0	Mavrakanas TA. Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2022 Apr 25. pii: CJN.03410322. doi: 10.2215/CJN.03410322.
	35468835	0	Lamb T, Lenet T, Zahrai A, et al. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis. World J Emerg Surg. 2022 Apr 25;17(1):19. doi: 10.1186/s13017-022-00423-1.
	35462127	0	Falanga A, Girvalaki C, Monreal M, et al. How well do European patients understand cancer-associated thrombosis? A patient survey. Cancer Treat Res Commun. 2022 Apr 10;31:100557. doi: 10.1016/j.ctarc.2022.100557.
	35455936	0	de Almeida LGN, Young D, Chow L, et al. Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia. Cells. 2022 Apr 7;11(8). pii: cells11081256. doi: 10.3390/cells11081256.
	35452514	0	Laroche A, Soulet D, Bazin M, et al. Live imaging of platelets and neutrophils during antibody-mediated neurovascular thrombosis. Blood Adv. 2022 Apr 22. pii: 485043. doi: 10.1182/bloodadvances.2021006728.
	35445575	0	Lillicrap D, Morrissey JH. Investment in the future of thrombosis and hemostasis science. J Thromb Haemost. 2022 May;20(5):1033. doi: 10.1111/jth.15710.
	35439303	0	Ageno W, Beyer-Westendorf J, Contino L, et al. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Apr 19. pii: 484971. doi: 10.1182/bloodadvances.2022007397.
	35436439	0	Carrier M, Le Gal G. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation. Ann Intern Med. 2022 Apr;175(4):W43-W44. doi: 10.7326/L22-0038.
	35429163	0	Thomas CD, Franchi F, Keeley EC, et al. Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-site, Real-world Investigation. Clin Pharmacol Ther. 2022 Apr 16. doi: 10.1002/cpt.2612.
	35399410	0	Alnabwani D, Ganta N, Kochhar S, et al. Combined Oral Contraceptives Bringing to Light May-Thurner Syndrome. Cureus. 2022 Mar 4;14(3):e22839. doi: 10.7759/cureus.22839. eCollection 2022 Mar.
	35398856	0	Samji N, Twiss J, Chan AKC, et al. Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis. J Pediatr Hematol Oncol. 2022 Apr 8. pii: 00043426-990000000-00014. doi: 10.1097/MPH.0000000000002455.
	35389229	0	Spyropoulos AC, Raskob GE, Cohen AT, et al. Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847.
	35386738	0	Furtado S, Dunogue B, Jourdi G, et al. High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications. J Scleroderma Relat Disord. 2021 Jun;6(2):178-186. doi: 10.1177/2397198320957558. Epub 2020 Sep 24.
	35378030	0	Mavrakanas TA. Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARY. Kidney360. 2021 Apr 9;2(9):1412-1414. doi: 10.34067/KID.0001372021. eCollection 2021 Sep 30.
	35372933	0	Ouellette AC, Darling EK, Sivapathasundaram B, et al. Incidence, Risk Factors, and Outcomes of Neonatal Renal Vein Thrombosis in Ontario: Population-Based Cohort Study. Kidney360. 2020 May 27;1(7):640-647. doi: 10.34067/KID.0000912019. eCollection 2020 Jul 30.
	35371058	0	Jevtic SD, Nazy I. The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19. Front Immunol. 2022 Mar 14;13:807934. doi: 10.3389/fimmu.2022.807934. eCollection 2022.
	35363452	0	Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201171.
	35362102	0	Schulman S, Carlson V, Serrano PE, et al. Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. J Surg Oncol. 2022 Apr 1. doi: 10.1002/jso.26876.
	35360964	0	Wei M, Xu Y, Xia D, et al. Care and Treatment for an Antiphospholipid Syndrome-Related Lower Limb Skin Ulcer Unhealed for 7 Years: A Case Report. Int J Low Extrem Wounds. 2022 Mar 31:15347346221090079. doi: 10.1177/15347346221090079.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35315874	0	Bradbury CA, Lawler PR, Stanworth SJ, et al. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910.
	35309792	0	Shivji S, Carrier M. Screening for cancer in unprovoked venous thromboembolism. Hemasphere. 2019 Jun 30;3(Suppl). pii: HemaSphere-2019-0011. doi: 10.1097/HS9.0000000000000205. eCollection 2019 Jun.
	35298939	0	Xu Y, Gomes T, Wells PS, et al. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study. Thromb Res. 2022 Feb 24;213:57-64. doi: 10.1016/j.thromres.2022.02.018.
	35290837	0	Abufarhaneh M, Pandya RK, Alkhaja A, et al. Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis. Thromb Res. 2022 Mar 4;213:47-56. doi: 10.1016/j.thromres.2022.02.022.
	35289485	0	Bhatia K, Solanki S, Paes B, et al. Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit. Pediatr Blood Cancer. 2022 Mar 15:e29668. doi: 10.1002/pbc.29668.
	35285449	0	Leong R, Patel J, Samji N, et al. Use of thrombolytic agents to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2022 Mar 11. pii: 00001721-900000000-98300. doi: 10.1097/MBC.0000000000001134.
	35283031	0	Ask A, Eltringham-Smith L, Bhakta V, et al. Spotlight on animal models of acute traumatic coagulopathy: an update. Transfus Apher Sci. 2022 Apr;61(2):103412. doi: 10.1016/j.transci.2022.103412. Epub 2022 Mar 10.
	35282394	0	You D, Maarouf N, Hildebrand K, et al. An in vivo rabbit joint injury model to measure trauma-induced coagulopathy and the effect of timing of administration of ketotifen fumarate on posttraumatic joint contracture. OTA Int. 2022 Mar 10;5(1 Suppl):e177. doi: 10.1097/OI9.0000000000000177. eCollection 2022 Mar.
	35281583	0	Tawhari M, Al Oudah N, Al Zahrani Y, et al. IgG4-Related Kidney Disease Associated With End-Stage Kidney Disease, Renal Pseudotumor, and Renal Vein Thrombosis. Cureus. 2022 Mar 4;14(3):e22837. doi: 10.7759/cureus.22837. eCollection 2022 Mar.
	35275495	0	Roberge G, Carrier M. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221086283. doi: 10.1177/10760296221086283.
	35268283	0	Forte S, De Luna G, Abdulrehman J, et al. Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study. J Clin Med. 2022 Feb 23;11(5). pii: jcm11051193. doi: 10.3390/jcm11051193.
	35264372	0	Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, et al. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials. BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785.
	35263789	0	Roy DC, Wang TF, Mallick R, et al. GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy. Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720.
	35260475	0	Hasse S, Julien AS, Duchez AC, et al. Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. Lupus Sci Med. 2022 Mar;9(1). pii: 9/1/e000605. doi: 10.1136/lupus-2021-000605.
	35226556	0	Lawler PR, Hochman JS, Zarychanski R. What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine? Circulation. 2022 Mar;145(9):629-632. doi: 10.1161/CIRCULATIONAHA.121.058113. Epub 2022 Feb 28.
	35224860	0	Khan S, Jarad NA, Ladouceur L, et al. Transparent and Highly Flexible Hierarchically Structured Polydimethylsiloxane Surfaces Suppress Bacterial Attachment and Thrombosis Under Static and Dynamic Conditions. Small. 2022 Feb 28:e2108112. doi: 10.1002/smll.202108112.
	35224414	0	Candeloro M, Eikelboom JW, Chan N, et al. Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort. Res Pract Thromb Haemost. 2022 Feb 17;6(2):e12650. doi: 10.1002/rth2.12650. eCollection 2022 Feb.
	35217534	0	Cohen KR, Anderson D, Ren S, et al. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study. BMJ Open. 2022 Feb 25;12(2):e051624. doi: 10.1136/bmjopen-2021-051624.
	35217330	0	Beaudoin E, Kaka S, Gagnon E, et al. Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study. Thromb Res. 2022 Feb 12;212:19-21. doi: 10.1016/j.thromres.2022.02.001.
	35202841	0	Bikdeli B, Khairani CD, Barns BM, et al. Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. Contemp Clin Trials. 2022 Feb 21:106714. doi: 10.1016/j.cct.2022.106714.
	35201292	0	Lee AY, Al Moosawi M, Peterson EA, et al. Clinical Care Pathway for Suspected Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 vaccination. Blood Adv. 2022 Feb 24. pii: 484151. doi: 10.1182/bloodadvances.2021006862.
	35189662	0	Goldin M, Koulas I, Weitz JI, et al. State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism. Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1778-1083.
	35177631	0	Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers. 2022 Feb 17;8(1):11. doi: 10.1038/s41572-022-00336-y.
	35174235	0	Jurasz P, Ignjatovic V, Lordkipanidze M. Editorial: Established and Novel Roles of Platelets in Health and Disease. Front Cardiovasc Med. 2022 Jan 31;9:835615. doi: 10.3389/fcvm.2022.835615. eCollection 2022.
	35167861	0	Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12.
	35157815	0	Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731.
	35150946	0	Cook-Richardson S, Addo A, Kim P, et al. Show Me the Money, I'll Show You My Complications: Impacts of Incentivized Incident Self-Reporting Among Surgeons. J Surg Res. 2022 Feb 9;274:136-144. doi: 10.1016/j.jss.2021.12.012.
	35143324	0	Gorman JB, Field TS. ACTION-CVT: Are the Findings ACTIONable? Stroke. 2022 Feb 10:STROKEAHA122038564. doi: 10.1161/STROKEAHA.122.038564.
	35142014	0	Wang M, Swinton M, Troyan S, et al. Perceptions of patients and healthcare providers on patient education to improve oral anticoagulant management. J Eval Clin Pract. 2022 Feb 9. doi: 10.1111/jep.13665.
	35124234	0	Wang TF, Mallick R, Carrier M, et al. Safety and efficacy of apixaban thromboprophylaxis in ambulatory cancer patients according to renal function: A subgroup analysis of the AVERT trial. Thromb Res. 2022 Jan 31;211:85-87. doi: 10.1016/j.thromres.2022.01.022.
	35120747	0	Bates SM. Pregnancy-related venous thromboembolism: Progress but questions remain. Eur J Intern Med. 2022 Feb 1. pii: S0953-6205(22)00050-4. doi: 10.1016/j.ejim.2022.01.034.
	35106433	0	de Wit K. Do physicians contribute to psychological distress after venous thrombosis? Res Pract Thromb Haemost. 2022 Jan 23;6(1):e12651. doi: 10.1002/rth2.12651. eCollection 2022 Jan.
	35101871	0	Lu C, Crowther MA, Mithoowani S. Management of intentional overdose of low-molecular-weight heparin. CMAJ. 2022 Jan 31;194(4):E122-E125. doi: 10.1503/cmaj.211083.
	35100023	0	Rivard L, Friberg L, Conen D, et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31.
	35060304	0	Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources: Response to Comment from Yamada et al. J Thromb Haemost. 2022 Feb;20(2):542-543. doi: 10.1111/jth.15619.
	35040805	0	Grewal K, Atzema CL, Austin PC, et al. Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study. CMAJ. 2021 Oct 12;193(40):E1561-E1567. doi: 10.1503/cmaj.210811.
	35040802	0	Kimpton M, Kumar S, Wells PS, et al. Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer. CMAJ. 2021 Oct 12;193(40):E1551-E1560. doi: 10.1503/cmaj.210523.
	35038272	0	Warkentin TE, Pai M. The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia. Ann Intern Med. 2022 Jan 18. doi: 10.7326/M22-0118.
	35036824	0	Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi-database cohort study. Res Pract Thromb Haemost. 2022 Jan 10;6(1):e12643. doi: 10.1002/rth2.12643. eCollection 2022 Jan.
	35028817	0	Alimohammadi A, Kim DJ, Field TS. Updates in Cerebral Venous Thrombosis. Curr Cardiol Rep. 2022 Jan 13. pii: 10.1007/s11886-021-01622-z. doi: 10.1007/s11886-021-01622-z.
	35028601	0	Michels A, Lillicrap D, Yacob M. Role of von Willebrand factor in venous thromboembolic disease. JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022.
	35028491	0	Sanfilippo KM, Carson KR, Wang TF, et al. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma. Res Pract Thromb Haemost. 2022 Jan 9;6(1):e12634. doi: 10.1002/rth2.12634. eCollection 2022 Jan.
	35023983	0	Erez O, Othman M, Rabinovich A, et al. DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments. J Blood Med. 2022 Jan 6;13:21-44. doi: 10.2147/JBM.S273047. eCollection 2022.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	35015038	0	Goldenberg NA, Kittelson JM, Abshire TC, et al. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
	35008518	0	Carre J, Jourdi G, Gendron N, et al. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci. 2021 Dec 22;23(1). pii: ijms23010093. doi: 10.3390/ijms23010093.
	35001043	0	Paes B, Chan AKC, Shaik M, et al. Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study. Blood Coagul Fibrinolysis. 2022 Jan 6. pii: 00001721-900000000-98313. doi: 10.1097/MBC.0000000000001110.
	34996086	0	Selby R, Abdulrehman J. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic. J Appl Lab Med. 2022 Jan 5;7(1):373-378. doi: 10.1093/jalm/jfab134.
	34992986	0	Moores G, Warkentin TE, Farooqi MAM, et al. Spontaneous Heparin-Induced Thrombocytopenia Presenting as Cerebral Venous Sinus Thrombosis. Neurol Clin Pract. 2021 Dec;11(6):e929-e931. doi: 10.1212/CPJ.0000000000000805.
	34980834	0	Baumann Kreuziger L, Feng M, Bartosic A, et al. A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal. Blood Coagul Fibrinolysis. 2022 Jan 3. pii: 00001721-900000000-98316. doi: 10.1097/MBC.0000000000001122.
	34967109	0	Truong TK, Malik RA, Yao X, et al. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition. J Thromb Haemost. 2021 Dec 30. doi: 10.1111/jth.15631.
	34963615	0	Cook O, Cervi A, Laureano M, et al. Combined preoperative plasma exchange and red blood cell exchange transfusion in a renal transplant patient with protein S deficiency and hemoglobin SC disease. Transfus Apher Sci. 2021 Dec 16:103345. doi: 10.1016/j.transci.2021.103345.
	34962979	0	Bonaca MP, Antman EM, Cunningham JW, et al. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):695-706. doi: 10.1093/ehjcvp/pvab089.
	34958662	0	Juang LJ, Hur WS, Silva LM, et al. Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood. 2021 Dec 27. pii: 483255. doi: 10.1182/blood.2021014559.
	34955074	0	Nochaiwong S, Ruengorn C, Awiphan R, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022 Dec;54(1):80-97. doi: 10.1080/07853890.2021.2017474.
	34948552	0	Lobbes H, Mainbourg S, Mai V, et al. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies. Int J Environ Res Public Health. 2021 Dec 8;18(24). pii: ijerph182412944. doi: 10.3390/ijerph182412944.
	34941394	0	Silva LM, Doyle AD, Greenwell-Wild T, et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 2021 Dec 24;374(6575):eabl5450. doi: 10.1126/science.abl5450. Epub 2021 Dec 24.
	34940092	0	Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453.
	34939141	0	Bartoszko J, Li H, Fitzgerald J, et al. The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study. Can J Anaesth. 2022 Mar;69(3):311-322. doi: 10.1007/s12630-021-02165-1. Epub 2021 Dec 22.
	34934895	0	Kamin Mukaz D, Gergi M, Koh I, et al. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12632. doi: 10.1002/rth2.12632. eCollection 2021 Dec.
	34921078	0	Nasreen S, Calzavara AJ, Sundaram ME, et al. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 2021 Dec 17;11(12):e052019. doi: 10.1136/bmjopen-2021-052019.
	34920389	0	Angchaisuksiri P, Goto S, Farjat AE, et al. Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72]. Thromb Res. 2021 Dec 15;209:105. doi: 10.1016/j.thromres.2021.11.022.
	34905618	0	Hur WS, Paul DS, Bouck EG, et al. Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with a Fga truncation mutation. Blood. 2021 Dec 14. pii: 483059. doi: 10.1182/blood.2021012537.
	34904857	0	Stals MAM, Takada T, Kraaijpoel N, et al. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysis. Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-2625.
	34897975	0	Collins A, Memtsa M, Kirk E, et al. The risk of Venous ThromboEmbolism (VTE) in Early Pregnancy Loss: Review of the Literature and Current Guidelines and the Need for Guidance Communication from the SSC on Women's Health Issues for Thrombosis and Haemostasis. J Thromb Haemost. 2021 Dec 12. doi: 10.1111/jth.15621.
	34889418	0	Skeith L. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):559-569. doi: 10.1182/hematology.2021000291.
	34884884	0	Jourdi G, Lordkipanidze M, Philippe A, et al. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases. Int J Mol Sci. 2021 Dec 3;22(23). pii: ijms222313079. doi: 10.3390/ijms222313079.
	34878676	0	Olasupo OO, Haddix C, Nakar C, et al. Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders. Eur J Haematol. 2021 Dec 8. doi: 10.1111/ejh.13731.
	34877446	0	Maraveyas A, Beyer-Westendorf J, Lee AY, et al. Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomes. Res Pract Thromb Haemost. 2021 Nov 30;5(8):e12604. doi: 10.1002/rth2.12604. eCollection 2021 Dec.
	34863582	0	Bounameaux H, Haas S, Farjat AE, et al. Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545-4. doi: 10.1016/j.thromres.2021.11.023.
	34861200	0	Edupuganti S, Li M, Wu Z, et al. Factors associated with inferior vena cava filter placement and retrieval for patients with cancer-associated thrombosis. Am J Med. 2021 Nov 30. pii: S0002-9343(21)00791-9. doi: 10.1016/j.amjmed.2021.11.006.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34847829	0	Tafazoli A, Anil Kumar S, Othman M. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications. Platelets. 2021 Nov 30:1-6. doi: 10.1080/09537104.2021.1961718.
	34845714	0	Delluc A, Wang TF. How to treat incidental pulmonary embolism in cancer patients? Recent advances. Kardiol Pol. 2021 Nov 30. pii: VM/OJS/J/87173. doi: 10.33963/KP.a2021.0164.
	34843861	0	Wiercioch W, Nieuwlaat R, Zhang Y, et al. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2021 Nov 26. pii: S0895-4356(21)00389-9. doi: 10.1016/j.jclinepi.2021.11.031.
	34826190	0	Wendelboe AM, Langenfeld H, Ageno W, et al. Current practices of standardized risk assessment for venous thromboembolism: results from a global survey from the World Thrombosis Day steering committee. J Thromb Haemost. 2021 Nov 26. doi: 10.1111/jth.15608.
	34822215	0	Forgo G, Micieli E, Ageno W, et al. An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: systematic review and meta-analysis. J Thromb Haemost. 2021 Nov 25. doi: 10.1111/jth.15607.
	34807722	0	Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
	34798446	0	Lee A, Oley F Jr, Lo M, et al. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thromb Res. 2021 Oct 29;208:148-155. doi: 10.1016/j.thromres.2021.10.023.
	34795036	0	Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021.
	34788517	0	Zarychanski R, Lawler PR, Goligher E. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply. N Engl J Med. 2021 Nov 18;385(21):2014. doi: 10.1056/NEJMc2115560.
	34786471	0	Sardo LA, Bayadinova JA, Jenkins S, et al. The significance of VTE in cancer: Introduction of the 'Spot the CLOT' series. Can Oncol Nurs J. 2021 Nov 1;31(4):500-503. eCollection 2021 Fall.
	34780683	0	Weitz JI, Strony J, Ageno W, et al. Milvexian for the Prevention of Venous Thromboembolism. N Engl J Med. 2021 Nov 15. doi: 10.1056/NEJMoa2113194.
	34774202	0	Klok FA, Pai M, Huisman MV, et al. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol. 2021 Nov 11. pii: S2352-3026(21)00306-9. doi: 10.1016/S2352-3026(21)00306-9.
	34753191	0	Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
	34747320	0	Pavenski K, Huang SS, Patriquin CJ. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2021 Nov 8. doi: 10.1080/17474086.2021.2003703.
	34742140	0	Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018.
	34739003	0	Esposito EC, Kufera JA, Wolff TW, et al. Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter study. J Trauma Acute Care Surg. 2022 Feb 1;92(2):347-354. doi: 10.1097/TA.0000000000003455.
	34731547	0	Weitz JI, Raskob GE, Yi BA. Abelacimab for Prevention of Venous Thromboembolism. Reply. N Engl J Med. 2021 Nov 4;385(19):1822-1823. doi: 10.1056/NEJMc2114895.
	34730839	0	Puhm F, Flamand L, Boilard E. Platelet extracellular vesicles in COVID-19: Potential markers and makers. J Leukoc Biol. 2021 Nov 3. doi: 10.1002/JLB.3MIR0221-100R.
	34729724	0	Agbani EO, Schneider P, McDonald B, et al. Activated Platelets Harbour SARS-CoV-2 During Severe COVID-19. Thromb Haemost. 2021 Nov 2. doi: 10.1055/a-1683-8455.
	34729195	0	Porres-Aguilar M, Auron M, de Leon MCG. Klippel-Trenaunay and pregnancy. Oxf Med Case Reports. 2021 Oct 26;2021(10):omab096. doi: 10.1093/omcr/omab096. eCollection 2021 Oct.
	34727173	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis. Blood Adv. 2021 Nov 2. pii: 477753. doi: 10.1182/bloodadvances.2021005945.
	34724403	0	Chan NC, Weitz JI. In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 mo. Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160-130.
	34715510	0	Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012.
	34714962	0	Cohen O, Ageno W, Farjat AE, et al. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE. J Thromb Haemost. 2021 Oct 29. doi: 10.1111/jth.15574.
	34693641	0	Greinacher A, Langer F, Makris M, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources. J Thromb Haemost. 2021 Oct 25. doi: 10.1111/jth.15572.
	34677828	0	McGinnis JM, Helpman L, Gundayao M, et al. Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project. J Surg Oncol. 2021 Oct 22. doi: 10.1002/jso.26728.
	34671466	0	Akbari A, Kunkel E, Bota SE, et al. Proteinuria and venous thromboembolism in pregnancy: a population-based cohort study. Clin Kidney J. 2021 Jan 11;14(9):2101-2107. doi: 10.1093/ckj/sfaa278. eCollection 2021 Sep.
	34668299	0	Wang TF. Survival in patients with cancer-associated thrombosis in relation to anticoagulants: Re-vitalization of warfarin? J Thromb Haemost. 2021 Nov;19(11):2677-2679. doi: 10.1111/jth.15527.
	34663971	0	Kelton JG, Arnold DM, Nazy I. Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nat Rev Immunol. 2021 Dec;21(12):753-755. doi: 10.1038/s41577-021-00642-8.
	34662892	0	Carney BJ, Wang TF, Ren S, et al. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multi-center cohort study. Blood Adv. 2021 Oct 18. pii: 477385. doi: 10.1182/bloodadvances.2021005966.
	34662890	0	Woller SC, Stevens SM, Kaplan D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv. 2021 Oct 18. pii: 477384. doi: 10.1182/bloodadvances.2021005808.
	34662498	0	Mulder FI, Bosch FTM, Carrier M, et al. Growth differentiation factor-15 for prediction of bleeding in cancer patients. J Thromb Haemost. 2021 Oct 18. doi: 10.1111/jth.15559.
	34661341	0	Lavin M, Sanchez Luceros A, Kouides P, et al. Examining international practices in the management of pregnant women with von Willebrand disease. J Thromb Haemost. 2021 Oct 18. doi: 10.1111/jth.15561.
	34649864	0	Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.
	34645539	0	Zhou LW, Yu AYX, Hall W, et al. Validity of ICD 10 Codes for Cerebral Venous Thrombosis Depends on Clinical Context. Can J Neurol Sci. 2021 Oct 14:1-10. doi: 10.1017/cjn.2021.235.
	34638997	0	Moore SF, Agbani EO, Wersall A, et al. Opposing Roles of GSK3alpha and GSK3beta Phosphorylation in Platelet Function and Thrombosis. Int J Mol Sci. 2021 Sep 30;22(19). pii: ijms221910656. doi: 10.3390/ijms221910656.
	34636806	0	Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis. Crit Care Med. 2021 Oct 12. pii: 00003246-900000000-95047. doi: 10.1097/CCM.0000000000005382.
	34629257	0	Caiano LM, Costanzo S, Panzera T, et al. Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. Nutr Metab Cardiovasc Dis. 2021 Jul 30. pii: S0939-4753(21)00339-2. doi: 10.1016/j.numecd.2021.07.018.
	34625202	0	Violette PD. When to Start Pharmacologic Thromboprophylaxis. J Am Coll Surg. 2021 Nov;233(5):631-632. doi: 10.1016/j.jamcollsurg.2021.07.682.
	34617959	0	Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021 Oct 7. pii: 2785004. doi: 10.1001/jamainternmed.2021.6203.
	34613576	0	Kwan V, Kaplovitch E, Selby R, et al. Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism. J Thromb Thrombolysis. 2021 Oct 6. pii: 10.1007/s11239-021-02578-1. doi: 10.1007/s11239-021-02578-1.
	34607343	0	Zhang Y, Begum HA, Grewal H, et al. Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review. Blood Adv. 2021 Oct 4. pii: 477147. doi: 10.1182/bloodadvances.2020003576.
	34604803	0	Davis MK, Lim H, Lee AYY. Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation. JACC CardioOncol. 2021 Sep 21;3(3):425-427. doi: 10.1016/j.jaccao.2021.07.003. eCollection 2021 Sep.
	34604695	0	Lee S, Shenoy A, Shi D, et al. Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review. TH Open. 2021 Sep 30;5(3):e461-e469. doi: 10.1055/s-0041-1736310. eCollection 2021 Jul.
	34600964	0	Eikelboom J, Floege J, Thadhani R, et al. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int. 2021 Sep 30. pii: S0085-2538(21)00870-X. doi: 10.1016/j.kint.2021.08.028.
	34587197	0	Holbrook A, Wang M, Swinton M, et al. Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers. PLoS One. 2021 Sep 29;16(9):e0257798. doi: 10.1371/journal.pone.0257798. eCollection 2021.
	34581763	0	Sanchez van Kammen M, Aguiar de Sousa D, Poli S, et al. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurol. 2021 Sep 28. pii: 2784622. doi: 10.1001/jamaneurol.2021.3619.
	34572833	0	Wang TF, Khorana AA, Carrier M. Thrombotic Complications Associated with Immune Checkpoint Inhibitors. Cancers (Basel). 2021 Sep 14;13(18). pii: cancers13184606. doi: 10.3390/cancers13184606.
	34571100	0	Aguilar-Piedras MF, Porres-Aguilar M, Mukherjee D, et al. High Flow Nasal Cannula Oxygenation Successfully Used as Bridge Therapy for Systemic Thrombolysis in COVID-19 Associated Intermediate-high Risk Pulmonary Embolism. Curr Probl Cardiol. 2021 Sep 24:101000. doi: 10.1016/j.cpcardiol.2021.101000.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34558172	0	Carlin S, Eikelboom JW. Direct oral anticoagulant dose selection: Challenging cases. J Thromb Haemost. 2021 Nov;19(11):2680-2686. doi: 10.1111/jth.15536. Epub 2021 Sep 28.
	34556452	0	Violette PD, Cartwright R, Devereaux PJ, et al. ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery. Eur Urol Focus. 2021 Sep 21. pii: S2405-4569(21)00225-X. doi: 10.1016/j.euf.2021.08.010.
	34556430	0	Shiff B, Breau RH, Mallick R, et al. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urol Oncol. 2021 Dec;39(12):836.e19-836.e27. doi: 10.1016/j.urolonc.2021.08.016. Epub 2021 Oct 20.
	34555698	0	Ray JG, Warkentin TE, Park AL. Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group. Thromb Res. 2021 Sep 17;207:62-65. doi: 10.1016/j.thromres.2021.09.008.
	34547773	0	Jiang D, Lim W, Crowther M, et al. A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations. Blood Adv. 2021 Oct 26;5(20):3931-3936. doi: 10.1182/bloodadvances.2021005205.
	34535301	0	Grewal K, Atzema CL, Sutradhar R, et al. Venous Thromboembolism in Patients Discharged From the Emergency Department With Ankle Fractures: A Population-Based Cohort Study. Ann Emerg Med. 2021 Sep 14. pii: S0196-0644(21)00517-5. doi: 10.1016/j.annemergmed.2021.06.017.
	34535289	0	Pai M. Acquired Hemophilia A. Hematol Oncol Clin North Am. 2021 Dec;35(6):1131-1142. doi: 10.1016/j.hoc.2021.07.007. Epub 2021 Sep 15.
	34535037	0	Mahe I, Agnelli G, Ay C, et al. Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study. Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
	34532632	0	Page D, Zhu N, Sawler D, et al. Vaccine-induced immune thrombotic thrombocytopenia presenting with normal platelet count. Res Pract Thromb Haemost. 2021 Sep 14;5(6):e12596. doi: 10.1002/rth2.12596. eCollection 2021 Aug.
	34521104	0	Nieuwlaat R, Wiercioch W, Brozek JL, et al. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021 Sep 14. pii: S2473-9529(21)00555-3. doi: 10.1182/bloodadvances.2020003577.
	34518263	0	Galanaud JP, Abdulrehman J, Lazo-Langner A, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e049557. doi: 10.1136/bmjopen-2021-049557.
	34516270	0	Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14.
	34510039	0	Plecash AR, Byrne D, Flexman A, et al. Stroke in Patients with Left Ventricular Assist Devices. Cerebrovasc Dis. 2021 Sep 10:1-11. doi: 10.1159/000517454.
	34496121	0	Robert-Ebadi H, Elias A, Sanchez O, et al. Assessing the clinical probability of pulmonary embolism during pregnancy: The Pregnancy-Adapted Geneva (PAG) score. J Thromb Haemost. 2021 Sep 8. doi: 10.1111/jth.15521.
	34487616	0	Weitz JI, Farjat AE, Ageno W, et al. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J Thromb Haemost. 2021 Sep 6. doi: 10.1111/jth.15520.
	34485812	0	Falanga A, Gal GL, Carrier M, et al. Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives. TH Open. 2021 Aug 31;5(3):e376-e386. doi: 10.1055/s-0041-1736037. eCollection 2021 Jul.
	34479364	0	Schmidt RA, Lee AY. How I treat and prevent venous thrombotic complications in patients with lymphoma. Blood. 2021 Sep 3. pii: S0006-4971(21)01557-3. doi: 10.1182/blood.2019003689.
	34474482	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021 Oct 26;5(20):3951-3959. doi: 10.1182/bloodadvances.2021005493.
	34474480	0	Avila L, Amiri N, De R, et al. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. Blood Adv. 2021 Oct 12;5(19):3737-3747. doi: 10.1182/bloodadvances.2021004727.
	34474475	0	Malik RA, Zhou J, Fredenburgh JC, et al. Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein. Blood Adv. 2021 Sep 28;5(18):3540-3551. doi: 10.1182/bloodadvances.2021004567.
	34470058	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part VII. Semin Thromb Hemost. 2021 Sep;47(6):621-622. doi: 10.1055/s-0041-1725945. Epub 2021 Sep 1.
	34464871	0	Benmassaoud A, Rodger M. Challenging anticoagulation cases: Acute extensive portal vein thrombosis in a patient without cirrhosis - Evidence-based management of a rare clinical entity. Thromb Res. 2021 Oct;206:133-136. doi: 10.1016/j.thromres.2021.08.013. Epub 2021 Aug 18.
	34456159	0	LeBlanc R, Bergstrom DJ, Cote J, et al. Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium. Clin Lymphoma Myeloma Leuk. 2021 Aug 1. pii: S2152-2650(21)00311-6. doi: 10.1016/j.clml.2021.07.028.
	34455706	0	Bosch FTM, Mulder FI, Huisman MV, et al. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. J Thromb Haemost. 2021 Aug 29. doi: 10.1111/jth.15516.
	34455654	0	Abdulrehman J, Ziemba YC, Hsu P, et al. Diagnosis of von Willebrand disease: An assessment of the quality of testing in North American laboratories. Haemophilia. 2021 Nov;27(6):e713-e720. doi: 10.1111/hae.14397. Epub 2021 Aug 28.
	34453675	0	Goldhaber SZ, Ageno W, Casella IB, et al. Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Aug 28. pii: 10.1007/s11239-021-02463-x. doi: 10.1007/s11239-021-02463-x.
	34438079	0	McAlpine K, Breau RH, Werlang P, et al. Timing of Perioperative Pharmacologic Thromboprophylaxis Initiation and its Effect on Venous Thromboembolism and Bleeding Outcomes: A Systematic Review and Meta-Analysis. J Am Coll Surg. 2021 Nov;233(5):619-631.e14. doi: 10.1016/j.jamcollsurg.2021.07.687. Epub 2021 Aug 24.
	34435431	0	Vasanthamohan L, Boonyawat K, Chai-Adisaksopha C, et al. Reduced-dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta-analysis-Response to Commentary. J Thromb Haemost. 2021 Sep;19(9):2359-2360. doi: 10.1111/jth.15427.
	34427894	0	Hendin A, Castellucci L, Rosenberg H. Just the facts: how to assess for cerebral venous thrombosis. CJEM. 2021 Aug 24. pii: 10.1007/s43678-021-00194-9. doi: 10.1007/s43678-021-00194-9.
	34419428	0	Fernando SM, Tran A, Cheng W, et al. Venous Thromboembolism Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis. Chest. 2021 Aug 19. pii: S0012-3692(21)03688-6. doi: 10.1016/j.chest.2021.08.050.
	34418289	0	Avila L, Amiri N, De R, et al. Compression garments for the management of pediatric post-thrombotic syndrome: A prospective longitudinal study. J Thromb Haemost. 2021 Dec;19(12):3073-3079. doi: 10.1111/jth.15507. Epub 2021 Aug 30.
	34415324	0	Kizhakkedathu JN, Conway EM. Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet. Blood. 2022 Mar 31;139(13):1987-1998. doi: 10.1182/blood.2020007209.
	34409636	0	Douros A, Cui Y, Platt RW, et al. Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease. Br J Clin Pharmacol. 2021 Aug 19. doi: 10.1111/bcp.15046.
	34403852	0	Fernando SM, Mathew R, Munshi L, et al. Media portrayals of pulmonary embolism. Thromb Res. 2021 Oct;206:52-54. doi: 10.1016/j.thromres.2021.08.006. Epub 2021 Aug 11.
	34401639	0	Abdulrehman J, Zarabi S, Elbaz C, et al. Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Res Pract Thromb Haemost. 2021 Aug 7;5(5):e12535. doi: 10.1002/rth2.12535. eCollection 2021 Jul.
	34399433	0	Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155.
	34391064	0	Benipal H, Holbrook A, Paterson JM, et al. Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home. Thromb Res. 2021 Oct;206:18-28. doi: 10.1016/j.thromres.2021.07.016. Epub 2021 Aug 2.
	34387202	0	Tran A, Fernando SM, Carrier M, et al. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-Analysis. Ann Surg. 2021 Aug 13. pii: 00000658-900000000-93329. doi: 10.1097/SLA.0000000000005157.
	34384129	0	Gabarin N, Patterson S, Pai M, et al. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182.
	34379859	0	Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22.
	34355501	0	Megy K, Downes K, Morel-Kopp MC, et al. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis. J Thromb Haemost. 2021 Oct;19(10):2612-2617. doi: 10.1111/jth.15459. Epub 2021 Aug 5.
	34353538	0	Hsu C, Hutt E, Bloomfield DM, et al. Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Aug 10;78(6):625-631. doi: 10.1016/j.jacc.2021.06.010.
	34351722	0	Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
	34351721	0	Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
	34351057	0	Othman M, Baker AT, Gupalo E, et al. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23.
	34345092	0	Gabara C, Solarat B, Castro P, et al. Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Med Intensiva (Engl Ed). 2021 Jul 30. pii: S0210-5691(21)00178-9. doi: 10.1016/j.medin.2021.07.004.
	34342490	0	Abdel-Rahman O, Wu C, Easaw J. Risk of arterial and venous thromboembolic events among patients with colorectal carcinoma: a real-world, population-based study. Future Oncol. 2021 Oct;17(30):3977-3986. doi: 10.2217/fon-2021-0252. Epub 2021 Aug 3.
	34334192	0	Ho LTS, McVey MJ, Kuiper GJAJM, et al. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro. Br J Anaesth. 2021 Oct;127(4):e128-e130. doi: 10.1016/j.bja.2021.06.037. Epub 2021 Jul 30.
	34332213	0	Cohen AT, Maraveyas A, Beyer-Westendorf J, et al. Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study. Thromb Res. 2021 Oct;206:1-4. doi: 10.1016/j.thromres.2021.06.021. Epub 2021 Jul 2.
	34327829	0	Roberge G. May-Thurner syndrome prevalence as a risk factor for acute deep vein thrombosis is unknown. J Thromb Haemost. 2021 Aug;19(8):2093. doi: 10.1111/jth.15398.
	34327828	0	van Galen KPM, d'Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Aug;19(8):1883-1887. doi: 10.1111/jth.15397.
	34327827	0	Roberge G, D'Astous J, Rodger M. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al. J Thromb Haemost. 2021 Aug;19(8):2091-2092. doi: 10.1111/jth.15369.
	34327825	0	Wang TF, Baumann Kreuziger L, Leader A, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2021 Aug;19(8):2068-2081. doi: 10.1111/jth.15367.
	34327824	0	Sirotich E, Guyatt G, Gabe C, et al. Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021 Aug;19(8):2082-2088. doi: 10.1111/jth.15368.
	34327823	0	Lillicrap D, Morrissey JH. Evidence-based medicine in thrombosis and hemostasis: ISTH to the fore. J Thromb Haemost. 2021 Aug;19(8):1845-1846. doi: 10.1111/jth.15436.
	34327817	0	El-Khoury H, Saifi O, Haddad S, et al. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 Nov;68(11):e29210. doi: 10.1002/pbc.29210. Epub 2021 Jul 29.
	34326045	0	Pandor A, Tonkins M, Goodacre S, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672.
	34318606	0	Candeloro M, van Es N, Cantor N, et al. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Oct;19(10):2618-2628. doi: 10.1111/jth.15476. Epub 2021 Aug 8.
	34314574	0	Ageno W, Lopes RD, Goldin M, et al. Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. J Thromb Haemost. 2021 Nov;19(11):2772-2780. doi: 10.1111/jth.15477. Epub 2021 Aug 17.
	34297496	0	Verhamme P, Yi BA, Segers A, et al. Abelacimab for Prevention of Venous Thromboembolism. N Engl J Med. 2021 Aug 12;385(7):609-617. doi: 10.1056/NEJMoa2105872. Epub 2021 Jul 19.
	34296056	0	Krishnaswamy S, Ageno W, Arabi Y, et al. Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress. Res Pract Thromb Haemost. 2021 Jul 16;5(5):e12532. doi: 10.1002/rth2.12532. eCollection 2021 Jul.
	34289981	0	Weatherald J, Philipenko B, Montani D, et al. Ventilatory efficiency in pulmonary vascular diseases. Eur Respir Rev. 2021 Jul 20;30(161). pii: 30/161/200214. doi: 10.1183/16000617.0214-2020. Print 2021 Sep 30.
	34288447	0	Batty P, Lillicrap D. Gene therapy for hemophilia: Current status and laboratory consequences. Int J Lab Hematol. 2021 Jul;43 Suppl 1:117-123. doi: 10.1111/ijlh.13605.
	34284102	0	Morgano GP, Wiercioch W, Anderson DR, et al. A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. J Clin Epidemiol. 2021 Jul 18;140:69-78. doi: 10.1016/j.jclinepi.2021.07.010.
	34278193	0	Bavalia R, Bistervels IM, Boersma WG, et al. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12566. doi: 10.1002/rth2.12566. eCollection 2021 Jul.
	34278190	0	Asady E, Ghanima W, Jelsness-Jorgensen LP, et al. Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12556. doi: 10.1002/rth2.12556. eCollection 2021 Jul.
	34278187	0	Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: An illustrated review. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. eCollection 2021 Jul.
	34274156	0	Porres-Aguilar M, Perez-Nieto OR, Zamarron-Lopez EI, et al. Thromboprophylaxis strategies for COVID-19 patients. Arch Med Res. 2022 Jan;53(1):109-110. doi: 10.1016/j.arcmed.2021.06.011. Epub 2021 Jul 5.
	34273241	0	Xu Y, Siegal DM. Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants. J Thromb Haemost. 2021 Oct;19(10):2383-2393. doi: 10.1111/jth.15466. Epub 2021 Jul 29.
	34272818	0	Swan D, Carrier M, Lisman T, et al. Heparin - Messias or Verschlimmbesserung? J Thromb Haemost. 2021 Oct;19(10):2373-2382. doi: 10.1111/jth.15464. Epub 2021 Jul 29.
	34270093	0	You DZ, Krzyzaniak H, Viner B, et al. Thromboembolic complications after surgical fixation of bone metastases: A systematic review. J Surg Oncol. 2021 Dec;124(7):1182-1191. doi: 10.1002/jso.26601. Epub 2021 Jul 16.
	34267078	0	Makedonov I, Galanaud JP, Kahn SR. Significance and management of isolated distal deep vein thrombosis. Curr Opin Hematol. 2021 Sep 1;28(5):331-338. doi: 10.1097/MOH.0000000000000670.
	34264267	0	Houghton DE, Billett HH, Gaddh M, et al. Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis. Blood Adv. 2021 Jul 27;5(14):2807-2812. doi: 10.1182/bloodadvances.2021004698.
	34263098	0	Barco S, Valerio L, Gallo A, et al. Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost. 2021 Jun 15;5(5):e12520. doi: 10.1002/rth2.12520. eCollection 2021 Jul.
	34260818	0	Jevtic SD, Malinowski AK, Othman M, et al. Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis. J Thromb Haemost. 2021 Oct;19(10):2539-2545. doi: 10.1111/jth.15462. Epub 2021 Aug 5.
	34255928	0	Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1.
	34255420	0	Wik HS, Kahn SR, Eriksson H, et al. Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients. J Thromb Haemost. 2021 Oct;19(10):2495-2503. doi: 10.1111/jth.15449. Epub 2021 Jul 28.
	34253554	0	Jevtic SD, Morris AM, Warkentin TE, et al. Thrombocytopenie induite par l'heparine. CMAJ. 2021 Jul 12;193(27):E1067-E1068. doi: 10.1503/cmaj.210637-f.
	34246011	0	Deschenes-Simard X, Richard C, Galland L, et al. Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study. Thromb Res. 2021 Sep;205:29-39. doi: 10.1016/j.thromres.2021.06.018. Epub 2021 Jun 29.
	34240001	0	Mansory EM, Srigunapalan S, Lazo-Langner A. Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2021 Jul 6;5(3):e286-e294. doi: 10.1055/s-0041-1730967. eCollection 2021 Jul.
	34235393	0	Porres-Aguilar M, Mukherjee D. May-Thurner Syndrome in Pregnancy-Associated Venous Thromboembolism. TH Open. 2021 Jul 4;5(3):e251-e252. doi: 10.1055/s-0041-1731710. eCollection 2021 Jul.
	34233346	0	Huynh A, Kelton JG, Arnold DM, et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 2021 Aug;596(7873):565-569. doi: 10.1038/s41586-021-03744-4. Epub 2021 Jul 7.
	34233107	0	Patriquin CJ, Laroche V, Selby R, et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7.
	34232455	0	Carlin S, Geerts W, Khosravani H. The clot thickens-enhanced integration of stroke and thrombosis training. J Thromb Thrombolysis. 2021 Jul 7. pii: 10.1007/s11239-021-02502-7. doi: 10.1007/s11239-021-02502-7.
	34231501	0	Chung J, Stevic I, Gantioqui J, et al. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography. Blood Coagul Fibrinolysis. 2021 Jul 1;32(5):305-311. doi: 10.1097/MBC.0000000000001023.
	34226274	0	Sholzberg M, Arnold DM, Laupacis A. Reconnaitre, traiter et signaler les cas de thrombocytopenie immunitaire thrombotique induite par un vaccin. CMAJ. 2021 Jul 5;193(26):E1031-E1033. doi: 10.1503/cmaj.210882-f.
	34213527	0	Sanchez van Kammen M, Heldner MR, Brodard J, et al. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic. JAMA. 2021 Jul 27;326(4):332-338. doi: 10.1001/jama.2021.9889.
	34176221	0	Weitz JI, Peyvandi F. International Society on Thrombosis and Haemostasis: Present and future. J Thromb Haemost. 2021 Jul;19(7):1599-1601. doi: 10.1111/jth.15325.
	34175749	0	Knoll W, Fergusson N, Ivankovic V, et al. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature. Thromb Res. 2021 Aug;204:114-122. doi: 10.1016/j.thromres.2021.06.010. Epub 2021 Jun 19.
	34161671	0	Bellesini M, Robert-Ebadi H, Combescure C, et al. D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2454-2467. doi: 10.1111/jth.15432. Epub 2021 Jul 20.
	34161655	0	Caiano L, Carrier M, Marshall A, et al. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2468-2479. doi: 10.1111/jth.15435. Epub 2021 Jul 12.
	34152080	0	Michels A, Swystun LL, Dwyer CN, et al. Stabilin-2 deficiency increases thrombotic burden and alters the composition of venous thrombi in a mouse model. J Thromb Haemost. 2021 Oct;19(10):2440-2453. doi: 10.1111/jth.15429. Epub 2021 Jul 19.
	34130496	0	Cooper C, Antle O, Lowerison J, et al. Impact of Weight-Band Dosing of Tinzaparin for Venous Thromboembolism Prophylaxis on Persistent Wound Drainage in Adult Patients Undergoing Hip and Knee Arthroplasty. Ann Pharmacother. 2021 Jun 16:10600280211024294. doi: 10.1177/10600280211024294.
	34129893	0	Lavi A, Breau RH, Mallick R, et al. Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. Urology. 2021 Nov;157:168-173. doi: 10.1016/j.urology.2021.05.053. Epub 2021 Jun 12.
	34126147	0	Jourdi G, Abdoul J, Siguret V, et al. Induced forms of alpha2-macroglobulin neutralize heparin and direct oral anticoagulant effects. Int J Biol Macromol. 2021 Aug 1;184:209-217. doi: 10.1016/j.ijbiomac.2021.06.058. Epub 2021 Jun 11.
	34119655	0	Vedantham S, Salter A, Lancia S, et al. Clinical Outcomes of a Pharmacomechanical Catheter-Directed Venous Thrombolysis Strategy that Included Rheolytic Thrombectomy in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2021 Sep;32(9):1296-1309.e7. doi: 10.1016/j.jvir.2021.06.001. Epub 2021 Jun 11.
	34117006	0	Wan T, Rahmani A, Hanakova M, et al. Reducing emergency department visits in patients with deep vein thrombosis: introducing a standardised outpatient treatment pathway. BMJ Open Qual. 2021 Jun;10(2). pii: bmjoq-2020-001123. doi: 10.1136/bmjoq-2020-001123.
	34116580	0	Cohen O, Caiano LM, Tufano A, et al. Cancer-Associated Splanchnic Vein Thrombosis. Semin Thromb Hemost. 2021 Jun 11. doi: 10.1055/s-0040-1722607.
	34114153	0	McCurdy JD, Ellen Kuenzig M, Spruin S, et al. Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge. Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064-5. doi: 10.1007/s10620-021-07064-5.
	34108229	0	Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
	34107198	0	Bourguignon A, Arnold DM, Warkentin TE, et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 19;385(8):720-728. doi: 10.1056/NEJMoa2107051. Epub 2021 Jun 9.
	34105140	0	Louzada ML. Thrombosis and myeloma: it is time to get the elephant out of the room. Br J Haematol. 2021 Jun;193(6):1027-1029. doi: 10.1111/bjh.17507. Epub 2021 Jun 9.
	34102656	0	Ting J, Yeung K, Paes B, et al. How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2021 Jun 7. pii: 00001721-900000000-98373. doi: 10.1097/MBC.0000000000001052.
	34097772	0	Martens KL, Amos CI, Hernandez CR, et al. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 Sep 1;96(9):1137-1146. doi: 10.1002/ajh.26268. Epub 2021 Jun 24.
	34087481	0	Mai V, Tan BK, Mainbourg S, et al. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis. Vascul Pharmacol. 2021 Aug;139:106882. doi: 10.1016/j.vph.2021.106882. Epub 2021 Jun 2.
	34086880	0	Lorentz CU, Tucker EI, Verbout NG, et al. The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood. 2021 Dec 2;138(22):2173-2184. doi: 10.1182/blood.2021011725.
	34085509	0	You D, Skeith L, Korley R, et al. Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis. Can J Surg. 2021 Jun 4;64(3):E324-E329. doi: 10.1503/cjs.021019.
	34083615	0	Li BX, Dai X, Xu XR, et al. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbalpha. Sci Rep. 2021 Jun 3;11(1):11663. doi: 10.1038/s41598-021-91165-8.
	34039677	0	Porres-Aguilar M, Tapson VF, Rivera-Lebron BN, et al. Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19. J Investig Med. 2021 Aug;69(6):1153-1155. doi: 10.1136/jim-2021-001856. Epub 2021 May 26.
	34027293	0	Li KX, Diendere G, Galanaud JP, et al. Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review. Res Pract Thromb Haemost. 2021 May 8;5(4):e12527. doi: 10.1002/rth2.12527. eCollection 2021 May.
	34027291	0	Ikesaka R, Siegal D, Mallick R, et al. Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): A two-center open-label pilot randomized controlled trial. Res Pract Thromb Haemost. 2021 May 5;5(4):e12517. doi: 10.1002/rth2.12517. eCollection 2021 May.
	34023735	0	Goto S, Turpie AGG, Farjat AE, et al. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. Thromb Res. 2021 Jul;203:155-162. doi: 10.1016/j.thromres.2021.05.007. Epub 2021 May 15.
	34018298	0	Nazy I, Sachs UJ, Arnold DM, et al. Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021 Jun;19(6):1585-1588. doi: 10.1111/jth.15341. Epub 2021 May 20.
	34000493	0	Rahme E, Godin R, Nedjar H, et al. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Thromb Res. 2021 Jul;203:121-130. doi: 10.1016/j.thromres.2021.05.005. Epub 2021 May 11.
	33992716	0	Wiercioch W, Nieuwlaat R, Dahm P, et al. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 May 13;138:115-127. doi: 10.1016/j.jclinepi.2021.04.016.
	33990338	0	Sholzberg M, Arnold DM, Laupacis A. Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia. CMAJ. 2021 Jun 14;193(24):E913-E915. doi: 10.1503/cmaj.210882. Epub 2021 May 14.
	33984481	0	Nykanen AI, Selby R, McRae KM, et al. Pseudo Heparin Resistance After Pulmonary Endarterectomy: Role of Thrombus Production of Factor VIII. Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):315-323. doi: 10.1053/j.semtcvs.2021.03.042. Epub 2021 May 10.
	33984268	0	Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10.
	33971682	0	Schellong S, Ageno W, Casella IB, et al. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2021 May 10. doi: 10.1055/s-0041-1729169.
	33971678	0	Aibar J, Schulman S. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost. 2021 Sep;47(6):709-723. doi: 10.1055/s-0041-1725057. Epub 2021 May 10.
	33959927	0	Niaz S, Kirwan C, Clayton N, et al. Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding. CJEM. 2021 May;23(3):325-329. doi: 10.1007/s43678-020-00054-y. Epub 2021 Jan 20.
	33949182	0	Raslan OM, Lazo-Langner A. Treatment of retinal vein thrombosis: what about anticoagulants? Minerva Med. 2021 May 5. pii: S0026-4806.21.07474-7. doi: 10.23736/S0026-4806.21.07474-7.
	33940219	0	Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30.
	33930198	0	Avila L, Amiri N, Pullenayegum E, et al. Diagnostic value of D-dimers for limb deep vein thrombosis in children: A prospective study. Am J Hematol. 2021 Aug 1;96(8):954-960. doi: 10.1002/ajh.26212. Epub 2021 May 15.
	33906965	0	Jevtic SD, Morris AM, Warkentin TE, et al. Heparin-induced thrombocytopenia. CMAJ. 2021 May 17;193(20):E736. doi: 10.1503/cmaj.210637. Epub 2021 Apr 27.
	33900385	0	Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism. Blood Adv. 2021 Apr 27;5(8):2237-2244. doi: 10.1182/bloodadvances.2020002398.
	33881229	0	Gendron N, Dragon-Durey MA, Chocron R, et al. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 Nov;73(11):1976-1985. doi: 10.1002/art.41777. Epub 2021 Sep 22.
	33872825	0	Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15.
	33872452	0	Tardy-Poncet B, de Maistre E, Pouplard C, et al. Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation. J Thromb Haemost. 2021 Aug;19(8):1959-1972. doi: 10.1111/jth.15344. Epub 2021 Jun 14.
	33866561	0	Krzyzaniak H, You DZ, Mosca G, et al. Venous thromboembolism rates in patients with bone and soft tissue sarcoma of the extremities following surgical resection: A systematic review. J Surg Oncol. 2021 Sep;124(3):390-399. doi: 10.1002/jso.26499. Epub 2021 Apr 18.
	33863794	0	Holbrook A, Benipal H, Paterson JM, et al. Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study. CMAJ Open. 2021 Apr 16;9(2):E364-E375. doi: 10.9778/cmajo.20200138. Print 2021 Apr-Jun.
	33862470	0	Baumann Kreuziger L, Gaddh M, Onadeko O, et al. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study. Thromb Res. 2021 Jun;202:155-161. doi: 10.1016/j.thromres.2021.03.021. Epub 2021 Apr 6.
	33860518	0	Fredenburgh JC, Weitz JI. Factor XI as a Target for New Anticoagulants. Hamostaseologie. 2021 Apr;41(2):104-110. doi: 10.1055/a-1384-3715. Epub 2021 Apr 15.
	33857789	0	Ladha D, Mallick R, Wang TF, et al. Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial. Thromb Res. 2021 Jun;202:151-154. doi: 10.1016/j.thromres.2021.03.013. Epub 2021 Mar 21.
	33856269	0	Clifford CR, Jung RG, Hibbert B, et al. Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison. Platelets. 2021 Apr 15:1-6. doi: 10.1080/09537104.2021.1904134.
	33848369	0	Pelland-Marcotte MC, Kulkarni K, Athale UH, et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2021 Jul 1;96(7):796-804. doi: 10.1002/ajh.26193. Epub 2021 May 10.
	33836493	0	Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism? Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25.
	33836492	0	Douros A, Filliter C, Azoulay L, et al. Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism. Thromb Res. 2021 Jun;202:128-133. doi: 10.1016/j.thromres.2021.03.026. Epub 2021 Mar 29.
	33835334	0	Porres-Aguilar M, Hoeper MM, Rivera-Lebron BN, et al. Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis. 2021 Oct;52(3):791-796. doi: 10.1007/s11239-021-02445-z. Epub 2021 Apr 9.
	33834620	0	Xu K, de Wit K, Geersing GJ, et al. A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer. J Thromb Haemost. 2021 Jul;19(7):1752-1758. doi: 10.1111/jth.15337. Epub 2021 May 4.
	33834605	0	Allain Wouterlood M, Malhame I, Levesque K, et al. Pregnancy-associated pelvic vein thrombosis: Insights from a multicenter case series. J Thromb Haemost. 2021 Aug;19(8):1926-1931. doi: 10.1111/jth.15333. Epub 2021 May 5.
	33832217	0	Caiano LM, Riva N, Carrier M, et al. Treatment of portal vein thrombosis: an updated narrative review. Minerva Med. 2021 Apr 9. pii: S0026-4806.21.07526-1. doi: 10.23736/S0026-4806.21.07526-1.
	33831962	0	Mai V, Mainbourg S, Tan BK, et al. Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis. Thromb Haemost. 2021 Dec;121(12):1670-1673. doi: 10.1055/a-1477-4027. Epub 2021 Apr 8.
	33830628	0	Kapopara PR, Safikhan NS, Huang JL, et al. CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models. J Thromb Haemost. 2021 Aug;19(8):1932-1947. doi: 10.1111/jth.15338. Epub 2021 May 7.
	33827287	0	Ray JG, Vermeulen MJ, Schull MJ, et al. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211008986. doi: 10.1177/10760296211008986.
	33826233	0	Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1.
	33823560	0	Goldin M, Giannis D, Diab W, et al. Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2351.
	33818240	0	Agbani EO, Poole AW. Aquaporins in platelet function. Platelets. 2021 Oct 3;32(7):895-901. doi: 10.1080/09537104.2021.1904133. Epub 2021 Apr 4.
	33812338	0	Becattini C, Di Nisio M, Franco L, et al. Treatment of venous thromboembolism in cancer patients: The dark side of the moon. Cancer Treat Rev. 2021 May;96:102190. doi: 10.1016/j.ctrv.2021.102190. Epub 2021 Mar 23.
	33806140	0	Tardy-Poncet B, Montmartin A, Piot M, et al. Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice. Biomedicines. 2021 Mar 25;9(4). pii: biomedicines9040332. doi: 10.3390/biomedicines9040332.
	33798804	0	Kawata E, Siew DA, Payne JG, et al. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thromb Res. 2021 Jun;202:90-95. doi: 10.1016/j.thromres.2021.03.018. Epub 2021 Mar 21.
	33794913	0	Roberge G, Wells PS. Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report. Thromb J. 2021 Apr 1;19(1):23. doi: 10.1186/s12959-021-00277-8.
	33792176	0	van Ommen CH, Albisetti M, Bhatt M, et al. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost. 2021 Apr;19(4):1123-1129. doi: 10.1111/jth.15260.
	33792175	0	Khorsand N, Beyer-Westendorf J, Sarode R, et al. Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021 Apr;19(4):1112-1115. doi: 10.1111/jth.15222.
	33781626	0	Li Z, Chen C, Liu P, et al. Comparison of oncological outcomes and major complications between laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IB1 cervical cancer with a tumour size less than 2 cm. Eur J Surg Oncol. 2021 Aug;47(8):2125-2133. doi: 10.1016/j.ejso.2021.03.238. Epub 2021 Mar 22.
	33779472	0	D'Astous J, Liederman Z, Douketis JD. Venous thromboembolism prophylaxis in high-risk orthopedic and cancer surgery. Postgrad Med. 2021 Aug;133(sup1):20-26. doi: 10.1080/00325481.2021.1891751. Epub 2021 Mar 28.
	33769581	0	Wang M, Zeraatkar D, Obeda M, et al. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Nov;87(11):4051-4100. doi: 10.1111/bcp.14833. Epub 2021 May 16.
	33753445	0	Humphries B, Leon-Garcia M, Bates S, et al. Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 2021 Mar 22;11(3):e046021. doi: 10.1136/bmjopen-2020-046021.
	33742436	0	Douxfils J, Adcock DM, Bates SM, et al. 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2021 Aug;121(8):1008-1020. doi: 10.1055/a-1450-8178. Epub 2021 Mar 19.
	33741176	0	Talasaz AH, Sadeghipour P, Kakavand H, et al. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Apr 20;77(15):1903-1921. doi: 10.1016/j.jacc.2021.02.035. Epub 2021 Mar 16.
	33736865	0	Griffiths CD, Simunovic M, Gafni A, et al. Posthospital discharge venous thromboembolism prophylaxis among colorectal and hepatobiliary surgeons: A practice survey. Surgery. 2021 Jul;170(1):173-179. doi: 10.1016/j.surg.2021.02.015. Epub 2021 Mar 15.
	33733032	0	Ageno W, Farjat A, Haas S, et al. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb.
	33733030	0	Boonyawat K, Lensing AWA, Prins MH, et al. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin. Res Pract Thromb Haemost. 2021 Feb 17;5(2):308-313. doi: 10.1002/rth2.12474. eCollection 2021 Feb.
	33733029	0	Tran A, Redley M, de Wit K. The psychological impact of pulmonary embolism: A mixed-methods study. Res Pract Thromb Haemost. 2021 Jan 28;5(2):301-307. doi: 10.1002/rth2.12484. eCollection 2021 Feb.
	33733023	0	Othman M, Cormier M, Barnes GD, et al. Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience. Res Pract Thromb Haemost. 2021 Mar 8;5(2):253-260. doi: 10.1002/rth2.12478. eCollection 2021 Feb.
	33725410	0	Thachil J, Khorana A, Carrier M. Similarities and perspectives on the two C's-Cancer and COVID-19. J Thromb Haemost. 2021 May;19(5):1161-1167. doi: 10.1111/jth.15294. Epub 2021 Mar 31.
	33724705	0	Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21.
	33719953	0	Rodriguez JJ, Munoz OC, Porres-Aguilar M, et al. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives. Cardiovasc Hematol Disord Drug Targets. 2021;21(1):23-29. doi: 10.2174/1871529X21666210315123347.
	33718937	0	Bhatt MD, Chan AK. Venous thrombosis in neonates. Fac Rev. 2021 Feb 25;10:20. doi: 10.12703/r/10-20. eCollection 2021.
	33713826	0	Shargall Y, Schneider L, Linkins LA, et al. Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer. Semin Thorac Cardiovasc Surg. 2021 Mar 11. pii: S1043-0679(21)00112-X. doi: 10.1053/j.semtcvs.2021.02.032.
	33706398	0	Smith J, Thornhill D, Goldenberg NA, et al. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct;121(10):1367-1375. doi: 10.1055/s-0041-1725199. Epub 2021 Mar 11.
	33691765	0	Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
	33658062	0	Al Raizah A, Al Askar A, Shaheen N, et al. High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study. Thromb J. 2021 Mar 3;19(1):13. doi: 10.1186/s12959-021-00265-y.
	33652328	0	Angchaisuksiri P, Goto S, Farjat AE, et al. Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. Thromb Res. 2021 May;201:63-72. doi: 10.1016/j.thromres.2021.02.024. Epub 2021 Feb 24.
	33651481	0	Avila L, Cullinan N, White M, et al. Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis. J Thromb Haemost. 2021 May;19(5):1283-1293. doi: 10.1111/jth.15284. Epub 2021 Apr 1.
	33650243	0	Malhame I, Othman M, Casais P, et al. Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis: A Survey on Anticoagulation for Mechanical Heart Valves in Pregnancy. J Thromb Haemost. 2021 Mar;19(3):859-864. doi: 10.1111/jth.15213.
	33649169	0	Little DHW, Sutradhar R, Cerasuolo JO, et al. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CMAJ. 2021 Mar 1;193(9):E304-E309. doi: 10.1503/cmaj.201433.
	33639297	0	Healey JS, Roberts JD, Field TS. Who is at risk of atrial fibrillation? Heart Rhythm. 2021 Jun;18(6):853-854. doi: 10.1016/j.hrthm.2021.02.019. Epub 2021 Feb 24.
	33639037	0	Nazy I, Jevtic SD, Moore JC, et al. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thromb Haemost. 2021 May;19(5):1342-1347. doi: 10.1111/jth.15283. Epub 2021 Mar 14.
	33634446	0	Milling TJ Jr, King B, Yue P, et al. Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients. Thromb Haemost. 2021 Aug;121(8):1097-1106. doi: 10.1055/a-1400-6159. Epub 2021 Feb 25.
	33618841	0	Bates SM, Klok FA. Special series on challenging anticoagulation cases: Experience counts when guidelines fall short. Thromb Res. 2021 Feb 18. pii: S0049-3848(21)00057-8. doi: 10.1016/j.thromres.2021.02.009.
	33593766	0	Bose G, Graveline J, Yogendrakumar V, et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ Open. 2021 Feb 16;11(2):e040212. doi: 10.1136/bmjopen-2020-040212.
	33586478	0	Raskob GE, Spyropoulos AC, Cohen AT, et al. Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients. J Am Heart Assoc. 2021 Feb;10(5):e019459. doi: 10.1161/JAHA.120.019459. Epub 2021 Feb 15.
	33585495	0	Gross PL, Chan NC. Thromboembolism in Older Adults. Front Med (Lausanne). 2021 Jan 27;7:470016. doi: 10.3389/fmed.2020.470016. eCollection 2020.
	33582956	0	Lai CMB, Smith T, Lee AYY. Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series. J Thromb Thrombolysis. 2021 Apr;51(3):725-733. doi: 10.1007/s11239-020-02320-3. Epub 2021 Feb 13.
	33570602	0	Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
	33560401	0	Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763.
	33558201	0	Khalife R, Aw A, Duffett L, et al. To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report. Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):e493-e496. doi: 10.1016/j.clml.2021.01.007. Epub 2021 Jan 13.
	33555020	0	Fabritz L, Crijns HJGM, Guasch E, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace. 2021 Mar 8;23(3):329-344. doi: 10.1093/europace/euaa279.
	33548928	0	Bates SM. Pulmonary Embolism in Pregnancy. Semin Respir Crit Care Med. 2021 Apr;42(2):284-298. doi: 10.1055/s-0041-1722867. Epub 2021 Feb 6.
	33548557	0	Lee A, Gu CS, Vedantham S, et al. Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1257-1265.e2. doi: 10.1016/j.jvsv.2021.01.017. Epub 2021 Feb 4.
	33546624	0	Servante J, Swallow G, Thornton JG, et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021 Feb 5;21(1):108. doi: 10.1186/s12884-021-03568-0.
	33544284	0	Schaefer JK, Li M, Wu Z, et al. Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism. J Thromb Thrombolysis. 2021 Jul;52(1):214-223. doi: 10.1007/s11239-021-02392-9. Epub 2021 Feb 5.
	33537540	0	Douketis JD, Syed S, Li N, et al. A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant. Res Pract Thromb Haemost. 2020 Dec 16;5(1):159-167. doi: 10.1002/rth2.12430. eCollection 2021 Jan.
	33537525	0	Baumgartner C, Tritschler T. Clinical significance of subsegmental pulmonary embolism: An ongoing controversy. Res Pract Thromb Haemost. 2020 Dec 9;5(1):14-16. doi: 10.1002/rth2.12464. eCollection 2021 Jan.
	33532693	0	Jerjes-Sanchez C, Rodriguez D, Farjat AE, et al. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan.
	33529872	0	Becattini C, Cimini LA, Carrier M. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding. Thromb Res. 2021 Apr;200:41-47. doi: 10.1016/j.thromres.2021.01.016. Epub 2021 Jan 26.
	33506480	0	Blanchette VS, Zunino L, Grassmann V, et al. A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A Subjects. Thromb Haemost. 2021 Oct;121(10):1326-1336. doi: 10.1055/a-1376-0970. Epub 2021 Jan 27.
	33492016	0	Sivasundaram L, Raji Y, Mengers SRP, et al. Investigating the International Normalized Ratio Thresholds for Complication in Shoulder Arthroplasty. J Am Acad Orthop Surg. 2021 Feb 1;29(3):131-137. doi: 10.5435/JAAOS-D-20-00280.
	33487649	0	Hache J, Bonsu KO, Chitsike R, et al. Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic. Can J Hosp Pharm. 2021 Winter;74(1):7-14. Epub 2021 Jan 1.
	33486321	0	Ayele HT, Brunetti VC, Renoux C, et al. Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021 Mar;199:123-131. doi: 10.1016/j.thromres.2020.12.029. Epub 2021 Jan 6.
	33476900	0	Fitzpatrick T, Wong C, Shen C, et al. Quality of anticoagulation using intravenous unfractionated heparin for cerebrovascular indications. Thromb Res. 2021 Mar;199:79-81. doi: 10.1016/j.thromres.2020.12.027. Epub 2021 Jan 7.
	33475238	0	Fu RJ, Wang WX, Tao HJ, et al. Quantitative evaluation of Danqi tablet by ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry integrated with bioassay. J Sep Sci. 2021 Apr;44(7):1552-1563. doi: 10.1002/jssc.202000932. Epub 2021 Feb 2.
	33472256	0	Skeith L, Rodger MA, Bates SM, et al. "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. Thromb Haemost. 2021 Oct;121(10):1353-1360. doi: 10.1055/a-1366-9261. Epub 2021 Jan 20.
	33470781	0	Kasapgil E, Badv M, Cantu CA, et al. Polysiloxane Nanofilaments Infused with Silicone Oil Prevent Bacterial Adhesion and Suppress Thrombosis on Intranasal Splints. ACS Biomater Sci Eng. 2021 Feb 8;7(2):541-552. doi: 10.1021/acsbiomaterials.0c01487. Epub 2021 Jan 20.
	33470571	0	Barrelet I, Mavrakanas T, Carballo S. [Oral anticoagulation in chronic kidney disease]. Rev Med Suisse. 2021 Jan 20;17(722):142-145.
	33463024	0	Konkle B, Pierce G, Coffin D, et al. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Nov;18(11):3074-3077. doi: 10.1111/jth.15023.
	33459726	0	Guillermo-Esposito C, Casais P, Cesarman-Maus G, et al. Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT) Arch Cardiol Mex. 2021 Dec 20;91(Suplemento COVID):047-054. doi: 10.24875/ACM.20000291.
	33449299	0	Philippe A, Chocron R, Gendron N, et al. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15.
	33448602	0	Tse B, Lim G, Sholzberg M, et al. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Nov;18(11):2870-2877. doi: 10.1111/jth.15027. Epub 2020 Aug 27.
	33448547	0	Leblanc K, Bell AD, Ezekowitz JA, et al. Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme. Int J Clin Pract. 2020 Dec;74(12):e13625. doi: 10.1111/ijcp.13625. Epub 2020 Aug 27.
	33444584	0	Poirier-Blanchette L, Koolian M, Schwartz BC. Testosterone Replacement Therapy Causing Extensive Portal and Mesenteric Vein Thrombosis. Am J Med. 2021 Jul;134(7):e426-e427. doi: 10.1016/j.amjmed.2020.12.018. Epub 2021 Jan 11.
	33444199	0	Baumgartner C, Klok FA, Carrier M, et al. Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE). BMJ Open. 2020 Nov 19;10(11):e040151. doi: 10.1136/bmjopen-2020-040151.
	33443455	0	Kaliel H, Mior M, Quan S, et al. Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620975489. doi: 10.1177/1076029620975489.
	33432589	0	Bendayan M, Mardigyan V, Williamson D, et al. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation. J Am Geriatr Soc. 2021 Apr;69(4):1012-1018. doi: 10.1111/jgs.16992. Epub 2021 Jan 11.
	33429125	0	Alam AU, Karkhaneh M, Sun HL, et al. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015. Thromb Res. 2021 Mar;199:59-66. doi: 10.1016/j.thromres.2020.12.021. Epub 2020 Dec 28.
	33417801	0	Badv M, Alonso-Cantu C, Shakeri A, et al. Biofunctional Lubricant-Infused Vascular Grafts Functionalized with Silanized Bio-Inks Suppress Thrombin Generation and Promote Endothelialization. ACS Biomater Sci Eng. 2019 Dec 9;5(12):6485-6496. doi: 10.1021/acsbiomaterials.9b01062. Epub 2019 Nov 8.
	33412596	0	Di Castelnuovo A, Costanzo S, Antinori A, et al. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug;121(8):1054-1065. doi: 10.1055/a-1347-6070. Epub 2021 Jan 7.
	33410894	0	Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021 Jan 7;137(1):103-114. doi: 10.1182/blood.2019002973.
	33405381	0	Le Gal G, Carrier M, Castellucci LA, et al. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Jan;19(1):297-303. doi: 10.1111/jth.15138.
	33403619	0	Demir KK, Simard C, Lipes J, et al. Life and Limb: a Case of COVID-19-Associated Multisystem Thrombosis and Review of the Literature. J Gen Intern Med. 2021 Mar;36(3):802-806. doi: 10.1007/s11606-020-06496-5. Epub 2021 Jan 5.
	33387395	0	Rubino JG, Arnold DM, Warkentin TE, et al. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2021 Apr;19(4):1096-1102. doi: 10.1111/jth.15233. Epub 2021 Feb 19.
	33378786	0	Le Mao R, Jimenez D, Bikdeli B, et al. Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism. Thromb Haemost. 2021 Jun;121(6):808-815. doi: 10.1055/s-0040-1721506. Epub 2020 Dec 30.
	33376944	0	Weitz JI, Prandoni P, Verhamme P. Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required? TH Open. 2020 Dec 23;4(4):e446-e456. doi: 10.1055/s-0040-1721735. eCollection 2020 Oct.
	33369212	0	Foulon-Pinto G, Jourdi G, Perrin J, et al. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months. Int J Lab Hematol. 2021 Aug;43(4):821-830. doi: 10.1111/ijlh.13443. Epub 2020 Dec 28.
	33368114	0	Kearon C, Carrier M, Gu CS, et al. Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial. Semin Thromb Hemost. 2020 Nov;46(8):977-985. doi: 10.1055/s-0040-1718891. Epub 2020 Dec 23.
	33368109	0	Schulman S. Recent Advances in Thrombosis and Hemostasis: Part VI. Semin Thromb Hemost. 2020 Nov;46(8):863-864. doi: 10.1055/s-0040-1715794. Epub 2020 Dec 23.
	33351119	0	Siegal DM, Barnes GD, Langlois NJ, et al. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Adv. 2020 Dec 22;4(24):6259-6273. doi: 10.1182/bloodadvances.2020003269.
	33331924	0	Melki I, Allaeys I, Tessandier N, et al. FcgammaRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood. 2020 Dec 17;136(25):2933-2945. doi: 10.1182/blood.2020004974.
	33326124	0	Warkentin TE, Smythe MA, Ali MA, et al. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Am J Hematol. 2021 Mar 1;96(3):320-329. doi: 10.1002/ajh.26075. Epub 2020 Dec 29.
	33317427	0	Endres K, St Bernard R, Chin-Yee I, et al. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Hematology. 2020 Dec;25(1):489-493. doi: 10.1080/16078454.2020.1855745.
	33316246	0	Schmedt N, Enders D, Walker J, et al. Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study. Am J Med. 2021 May;134(5):606-613.e6. doi: 10.1016/j.amjmed.2020.10.046. Epub 2020 Dec 11.
	33313465	0	den Exter PL, Kroft LJM, Gonsalves C, et al. Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts. Res Pract Thromb Haemost. 2020 Oct 1;4(8):1251-1261. doi: 10.1002/rth2.12422. eCollection 2020 Nov.
	33313464	0	Galanaud JP, Genty-Vermorel C, Rolland C, et al. Compression stockings to prevent postthrombotic syndrome: Literature overview and presentation of the CELEST trial. Res Pract Thromb Haemost. 2020 Oct 30;4(8):1239-1250. doi: 10.1002/rth2.12445. eCollection 2020 Nov.
	33306241	0	Valeriani E, Di Nisio M, Riva N, et al. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost. 2021 Apr;19(4):983-991. doi: 10.1111/jth.15214. Epub 2021 Feb 24.
	33302211	0	de Wit K, Linkins LA. Challenging anticoagulation cases: A case of acute pulmonary embolism in a patient with chronic thrombocytopenia. Thromb Res. 2021 Feb;198:83-85. doi: 10.1016/j.thromres.2020.11.035. Epub 2020 Dec 3.
	33293309	0	Tritschler T, Langlois N, Hutton B, et al. Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults. BMJ Open. 2020 Dec 7;10(12):e040122. doi: 10.1136/bmjopen-2020-040122.
	33292258	0	Boonyawat K, Chantrathammachart P, Numthavaj P, et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thromb J. 2020 Nov 23;18(1):34. doi: 10.1186/s12959-020-00248-5.
	33289557	0	Bao HL, Ishizuka T, Yamashita A, et al. Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2'-deoxyguanosine. J Med Chem. 2021 Jan 14;64(1):711-718. doi: 10.1021/acs.jmedchem.0c01711. Epub 2020 Dec 8.
	33280553	0	Hussein HM, Anderson DC. Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation? Stroke. 2021 Jan;52(1):100-102. doi: 10.1161/STROKEAHA.120.032536. Epub 2020 Dec 7.
	33278785	0	Elias A, Schmidt J, Bellou A, et al. Opinion and practice survey about the use of prognostic models in acute pulmonary embolism. Thromb Res. 2021 Feb;198:40-48. doi: 10.1016/j.thromres.2020.10.027. Epub 2020 Nov 1.
	33275705	0	Selby R. "TEG talk": expanding clinical roles for thromboelastography and rotational thromboelastometry. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):67-75. doi: 10.1182/hematology.2020000090.
	33275323	0	Wang TF, Billett HH, Connors JM, et al. Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. Oncologist. 2021 Jan;26(1):e17-e23. doi: 10.1002/onco.13570. Epub 2020 Dec 4.
	33269616	0	Wells PS, Theberge I, Bowdridge J, et al. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases. J Am Heart Assoc. 2020 Dec 15;9(24):e016600. doi: 10.1161/JAHA.120.016600. Epub 2020 Dec 3.
	33254037	0	Riess H, Verhamme P, Weitz JI, et al. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Crit Rev Oncol Hematol. 2021 Jan;157:103125. doi: 10.1016/j.critrevonc.2020.103125. Epub 2020 Oct 20.
	33253514	0	McAlpine K, Breau R, Carrier M, et al. Thromboprophylaxis practice patterns and beliefs among physicians treating patients with abdominopelvic cancers at a Canadian centre. Can J Surg. 2020 Nov 30;63(6):E562-E568. doi: 10.1503/cjs.015219.
	33249076	0	Atsou S, Furlan F, Duchemin J, et al. Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study. Eur J Pharmacol. 2021 Jan 15;891:173764. doi: 10.1016/j.ejphar.2020.173764. Epub 2020 Nov 27.
	33247808	0	Galanaud JP, Trujillo-Santos J, Bikdeli B, et al. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry. J Thromb Thrombolysis. 2021 Aug;52(2):532-541. doi: 10.1007/s11239-020-02347-6. Epub 2020 Nov 28.
	33232187	0	Cohen AJ, Boggio L, Billett HH, et al. North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy. J Womens Health (Larchmt). 2021 Jun;30(6):829-836. doi: 10.1089/jwh.2020.8385. Epub 2020 Nov 24.
	33231123	0	Lemieux-Sarrasin D, Pelland-Marcotte MC, Simonyan D, et al. Distance to the pediatric oncology center does not affect survival in children with acute lymphoblastic leukemia: a report from CYP-C. Leuk Lymphoma. 2021 Apr;62(4):960-966. doi: 10.1080/10428194.2020.1849673. Epub 2020 Nov 24.
	33229505	0	Khorana AA, Cohen AT, Carrier M, et al. Prevention of venous thromboembolism in ambulatory patients with cancer. ESMO Open. 2020 Nov;5(6):e000948. doi: 10.1136/esmoopen-2020-000948.
	33216354	0	Patel SH, George TL, Wang TF, et al. Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin. Cancer. 2021 Mar 15;127(6):938-945. doi: 10.1002/cncr.33337. Epub 2020 Nov 20.
	33208779	0	Chan KYT, Yong ASM, Wang X, et al. The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII. Sci Rep. 2020 Nov 18;10(1):20116. doi: 10.1038/s41598-020-76782-z.
	33196511	0	Wang TF, Waller AP, Lin E, et al. A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):16-22. doi: 10.1097/MBC.0000000000000968.
	33191198	0	Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22.
	33190023	0	Roberge G, Delluc A. Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer. Thromb Res. 2021 Jan;197:77-83. doi: 10.1016/j.thromres.2020.10.033. Epub 2020 Nov 6.
	33174815	0	Shoamanesh A, Patrice Lindsay M, Castellucci LA, et al. Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020. Int J Stroke. 2021 Apr;16(3):321-341. doi: 10.1177/1747493020968424. Epub 2020 Nov 11.
	33174368	0	Chiasakul T, Patell R, Maraveyas A, et al. Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials. J Thromb Haemost. 2021 Feb;19(2):489-501. doi: 10.1111/jth.15175. Epub 2020 Dec 3.
	33170819	0	Lillicrap D. Evaluating the potential benefits of the extravascular pool of factor IX. Blood Coagul Fibrinolysis. 2021 Jan 1;32(1):68-69. doi: 10.1097/MBC.0000000000000969.
	33160117	0	Payne JG, Tagalakis V, Wu C, et al. Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis. Thromb Res. 2021 Jan;197:8-12. doi: 10.1016/j.thromres.2020.10.030. Epub 2020 Nov 1.
	33160115	0	Knoll W, Mallick R, Wells PS, et al. Safety and efficacy of apixaban thromboprophylaxis in cancer patients with metastatic disease: A post-hoc analysis of the AVERT trial. Thromb Res. 2021 Jan;197:13-15. doi: 10.1016/j.thromres.2020.10.026. Epub 2020 Nov 1.
	33138326	0	Liederman Z, Chan N, Bhagirath V. Current Challenges in Diagnosis of Venous Thromboembolism. J Clin Med. 2020 Oct 29;9(11). pii: jcm9113509. doi: 10.3390/jcm9113509.
	33134787	0	Galanaud JP, Sevestre MA, Pernod G, et al. Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis. Res Pract Thromb Haemost. 2020 Sep 15;4(7):1216-1223. doi: 10.1002/rth2.12409. eCollection 2020 Oct.
	33134784	0	Riva N, Carrier M, Gatt A, et al. Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey. Res Pract Thromb Haemost. 2020 Sep 11;4(7):1192-1202. doi: 10.1002/rth2.12424. eCollection 2020 Oct.
	33119197	0	Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J Thromb Haemost. 2021 Jan;19(1):46-50. doi: 10.1111/jth.15156. Epub 2020 Nov 18.
	33112399	0	Goto S, Haas S, Ageno W, et al. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. JAMA Netw Open. 2020 Oct 1;3(10):e2022886. doi: 10.1001/jamanetworkopen.2020.22886.
	33104289	0	Schaefer JK, Li M, Wu Z, et al. Anticoagulant medication adherence for cancer-associated thrombosis: A comparison of LMWH to DOACs. J Thromb Haemost. 2021 Jan;19(1):212-220. doi: 10.1111/jth.15153. Epub 2020 Nov 21.
	33099284	0	Schulman S, Hu Y, Konstantinides S. Venous Thromboembolism in COVID-19. Thromb Haemost. 2020 Dec;120(12):1642-1653. doi: 10.1055/s-0040-1718532. Epub 2020 Oct 24.
	33082930	0	Chan NC, Weitz JI. Recent advances in understanding, diagnosing and treating venous thrombosis. F1000Res. 2020 Oct 6;9. doi: 10.12688/f1000research.27115.1. eCollection 2020.
	33079379	0	Zhang J, Atalla M, Mallick R, et al. Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial. J Thromb Thrombolysis. 2021 Apr;51(3):720-724. doi: 10.1007/s11239-020-02317-y. Epub 2020 Oct 20.
	33078911	0	Xu Y, Siegal DM, Anand SS. Ethnoracial variations in venous thrombosis: Implications for management, and a call to action. J Thromb Haemost. 2021 Jan;19(1):30-40. doi: 10.1111/jth.15140. Epub 2020 Nov 20.
	33075181	0	O'Brien HER, Zhang XF, Sanz-Hernandez M, et al. Blocking von Willebrand factor free thiols inhibits binding to collagen under high and pathological shear stress. J Thromb Haemost. 2021 Feb;19(2):358-369. doi: 10.1111/jth.15142. Epub 2020 Nov 18.
	33074284	0	Shoamanesh A, Hart RG, Connolly SJ, et al. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2021 Jan 1;78(1):11-20. doi: 10.1001/jamaneurol.2020.3836.
	33065408	0	Shaw JR, Kumar V, Mallick R, et al. Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thromb Res. 2020 Dec;196:437-443. doi: 10.1016/j.thromres.2020.09.035. Epub 2020 Oct 8.
	33064698	0	Carrillo-Esper R, Melgar-Bieberach RE, Tapia-Salazar M, et al. Manifestaciones extrapulmonares de la infeccion por SARS-CoV-2. Cir Cir. 2020;88(5):654-663. doi: 10.24875/CIRU.20000363.
	33064561	0	Mian O, Matino D, Roberts R, et al. Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962226. doi: 10.1177/1076029620962226.
	33049056	0	Darzi AJ, Repp AB, Spencer FA, et al. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
	33048811	0	Porres-Aguilar M, Heresi GA, Anaya-Ayala JE, et al. [Pulmonary embolism or pulmonary thrombosis in situ in severe pneumonic COVID-19 associated coagulopathy: does systemic thrombolysis have a role?] Medicina (B Aires). 2020;80(5):581-582.
	33048461	0	Germini F, Zarabi S, Eventov M, et al. Pulmonary embolism prevalence among emergency department cohorts: A systematic review and meta-analysis by country of study. J Thromb Haemost. 2021 Jan;19(1):173-185. doi: 10.1111/jth.15124. Epub 2020 Nov 18.
	33047462	0	Fredenburgh JC, Weitz JI. New anticoagulants: Moving beyond the direct oral anticoagulants. J Thromb Haemost. 2021 Jan;19(1):20-29. doi: 10.1111/jth.15126. Epub 2020 Nov 3.
	33032809	0	Favaloro EJ, Mohammed S, Donikian D, et al. A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Pathology. 2021 Feb;53(2):247-256. doi: 10.1016/j.pathol.2020.07.012. Epub 2020 Oct 5.
	33027169	0	MacDonald DRW, Neilly D, Schneider PS, et al. Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials. J Orthop Trauma. 2020 Nov;34 Suppl 3:S70-S75. doi: 10.1097/BOT.0000000000001939.
	33014332	0	Underwood B, Zhao Q, Walker AR, et al. Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia. Int J Hematol Oncol. 2020 Sep 4;9(3):IJH28. doi: 10.2217/ijh-2020-0009.
	33007077	0	Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
	33002131	0	Thom K, Lensing AWA, Nurmeev I, et al. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE). Blood Adv. 2020 Oct 13;4(19):4632-4639. doi: 10.1182/bloodadvances.2020002637.
	33000892	0	Little DHW, Robertson T, Douketis J, et al. Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health-care providers. J Thromb Haemost. 2021 Jan;19(1):153-160. doi: 10.1111/jth.15111. Epub 2020 Oct 21.
	32976752	0	Schunemann HJ, Ventresca M, Crowther M, et al. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. Lancet Haematol. 2020 Oct;7(10):e746-e755. doi: 10.1016/S2352-3026(20)30293-3.
	32969580	0	Kumar V, Shaw JR, Key NS, et al. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer. Oncologist. 2020 Dec;25(12):1075-1083. doi: 10.1002/onco.13540. Epub 2020 Oct 12.
	32969288	0	Tafur AJ, Clark NP, Spyropoulos AC, et al. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. J Am Heart Assoc. 2020 Oct 20;9(19):e017316. doi: 10.1161/JAHA.120.017316. Epub 2020 Sep 24.
	32968991	0	Aibar J, Schulman S. New-Onset Atrial Fibrillation in Sepsis: A Narrative Review. Semin Thromb Hemost. 2021 Feb;47(1):18-25. doi: 10.1055/s-0040-1714400. Epub 2020 Sep 23.
	32967458	0	Michels A, Dwyer CN, Mewburn J, et al. von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. doi: 10.1161/ATVBAHA.120.314690. Epub 2020 Sep 24.
	32951663	0	Sun LR, Linds A, Sharma M, et al. Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. Pediatr Neurol. 2020 Oct;111:59-65. doi: 10.1016/j.pediatrneurol.2020.06.002. Epub 2020 Jun 10.
	32948386	0	Razavi MK, Salter A, Goldhaber SZ, et al. Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2020 Oct;31(10):1517-1528.e2. doi: 10.1016/j.jvir.2020.07.010. Epub 2020 Sep 15.
	32938299	0	Zaid Y, Puhm F, Allaeys I, et al. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res. 2020 Sep 17. doi: 10.1161/CIRCRESAHA.120.317703.
	32932543	0	Jourdi G, Lobies S, Kosmider O, et al. Coagulation Characterization of Prothrombin 20209C > T Variant: About 27 New Cases. Thromb Haemost. 2021 Feb;121(2):246-249. doi: 10.1055/s-0040-1716541. Epub 2020 Sep 15.
	32914582	0	Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11.
	32911392	0	Pizzi R, Gini G, Caiano L, et al. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Thromb Res. 2020 Dec;196:209-212. doi: 10.1016/j.thromres.2020.09.004. Epub 2020 Sep 3.
	32898930	0	Galanaud JP, Ducruet T, Kahn SR. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis. J Thromb Haemost. 2020 Dec;18(12):3309-3315. doi: 10.1111/jth.15091. Epub 2020 Oct 15.
	32888372	0	Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
	32881339	0	Favaloro EJ, Amgalan A, Allen T, et al. "Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendation from the women's SSC of the ISTH": Response to comment from Kitchen et al. J Thromb Haemost. 2020 Sep;18(9):2420-2422. doi: 10.1111/jth.15007.
	32881337	0	Zuily S, Cohen H, Isenberg D, et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2020 Sep;18(9):2126-2137. doi: 10.1111/jth.14935.
	32881334	0	Lillicrap D, Morrissey JH. 2020 - Year of COVID-19. J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.
	32881272	0	Thachil J, Longstaff C, Favaloro EJ, et al. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost. 2020 Sep;18(9):2408-2411. doi: 10.1111/jth.14956.
	32877956	0	Picker N, Lee AY, Cohen AT, et al. Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study). Thromb Haemost. 2021 Feb;121(2):206-215. doi: 10.1055/s-0040-1714739. Epub 2020 Sep 2.
	32869501	0	Eddy M, Robert-Ebadi H, Richardson L, et al. External validation of the YEARS diagnostic algorithm for suspected pulmonary embolism. J Thromb Haemost. 2020 Dec;18(12):3289-3295. doi: 10.1111/jth.15083. Epub 2020 Oct 23.
	32866823	0	Peterson W, Liederman Z, Baker J, et al. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thromb Res. 2020 Dec;196:127-129. doi: 10.1016/j.thromres.2020.08.028. Epub 2020 Aug 19.
	32864557	0	Koster A, Nazy I, Birschmann IE, et al. High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodies. Res Pract Thromb Haemost. 2020 Jul 23;4(6):1060-1064. doi: 10.1002/rth2.12348. eCollection 2020 Aug.
	32853584	0	Arnold DM, Heddle NM, Cook RJ, et al. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1.
	32851572	0	Ageno W, Casella IB, Chee KH, et al. Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Apr;51(3):561-570. doi: 10.1007/s11239-020-02239-9.
	32846051	0	Kadir RA, Kobayashi T, Iba T, et al. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry-Communication from the ISTH SSC for Women's Health. J Thromb Haemost. 2020 Nov;18(11):3086-3098. doi: 10.1111/jth.15072. Epub 2020 Oct 14.
	32838111	0	Rosovsky RP, Sanfilippo KM, Wang TF, et al. Anticoagulation Practice Patterns in COVID-19: A Global Survey. Res Pract Thromb Haemost. 2020 Jul 9. pii: RTH212414. doi: 10.1002/rth2.12414.
	32816822	0	Godoy LC, Goligher EC, Lawler PR, et al. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.
	32815416	0	Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.
	32815198	0	Biswas M, Ryan PM, Nakrani R, et al. Central venous catheters are an important factor in paediatric thrombosis. Acta Paediatr. 2021 Mar;110(3):1001-1008. doi: 10.1111/apa.15543. Epub 2020 Sep 16.
	32799129	0	Kovacs MR, Lazo-Langner A, Louzada ML, et al. Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism. Thromb Res. 2020 Nov;195:231-232. doi: 10.1016/j.thromres.2020.07.052. Epub 2020 Jul 30.
	32798962	0	Patterson S, Al Nabhani I, Linkins LA. Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill. Thromb Res. 2020 Sep;193:218-220. doi: 10.1016/j.thromres.2020.08.011. Epub 2020 Aug 6.
	32788108	0	Robin P, van Es N, Le Roux PY, et al. Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. Thromb Res. 2020 Oct;194:153-157. doi: 10.1016/j.thromres.2020.06.034. Epub 2020 Jun 23.
	32788105	0	Huynh A, Arnold DM, Smith JW, et al. The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thromb Res. 2020 Oct;194:135-141. doi: 10.1016/j.thromres.2020.06.012. Epub 2020 Jun 6.
	32788103	0	Kovacs MR, Lazo-Langner A, Kovacs MJ. Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive? Thromb Res. 2020 Oct;194:119-120. doi: 10.1016/j.thromres.2020.06.031. Epub 2020 Jun 19.
	32762455	0	Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):1958-1960. doi: 10.1161/ATVBAHA.120.314977. Epub 2020 Jul 30.
	32762081	0	Conway EM, Pryzdial ELG. Is the COVID-19 thrombotic catastrophe complement-connected? J Thromb Haemost. 2020 Nov;18(11):2812-2822. doi: 10.1111/jth.15050. Epub 2020 Sep 18.
	32759284	0	Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020 Aug 5;370:m2177. doi: 10.1136/bmj.m2177.
	32757722	0	Barrett TJ, Lee AH, Xia Y, et al. Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ Res. 2020 Sep 11;127(7):945-947. doi: 10.1161/CIRCRESAHA.120.317803. Epub 2020 Aug 6.
	32756938	0	Shaw JR, Li N, Vanassche T, et al. Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Adv. 2020 Aug 11;4(15):3520-3527. doi: 10.1182/bloodadvances.2020002335.
	32740218	0	Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):489-496. doi: 10.1097/MNH.0000000000000634.
	32738644	0	Andrew L, Ni Ainle F, Blondon M, et al. Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality. Thromb Res. 2020 Sep;193:190-197. doi: 10.1016/j.thromres.2020.07.007. Epub 2020 Jul 7.
	32736776	0	Ilich A, Kumar V, Henderson M, et al. Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study. Thromb Res. 2020 Jul;191 Suppl 1:S31-S36. doi: 10.1016/S0049-3848(20)30394-7.
	32736774	0	Selby R, Duffy ER, Berny-Lang MA, et al. Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis. Thromb Res. 2020 Jul;191 Suppl 1:S26-S30. doi: 10.1016/S0049-3848(20)30393-5.
	32735828	0	Schulman S. Is venous thromboembolism a preventable cause of death? Lancet Haematol. 2020 Aug;7(8):e555-e556. doi: 10.1016/S2352-3026(20)30219-2.
	32732928	0	Ma Y, Chen F, Liu C, et al. A novel predictive score for citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation. Sci Rep. 2020 Jul 30;10(1):12861. doi: 10.1038/s41598-020-69902-2.
	32726911	0	D'Astous J, Carrier M. Screening for Occult Cancer in Patients with Venous Thromboembolism. J Clin Med. 2020 Jul 27;9(8). pii: jcm9082389. doi: 10.3390/jcm9082389.
	32726824	0	Giustozzi M, Castellucci LA, Barnes GD. Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians. Hamostaseologie. 2020 Aug;40(3):292-300. doi: 10.1055/a-1174-1290. Epub 2020 Jul 29.
	32723607	0	Malhame I, Tagalakis V, Dayan N. Diagnosing Pulmonary Embolism in Pregnancy: Synthesis of Current Guidelines and New Evidence. J Obstet Gynaecol Can. 2020 Dec;42(12):1546-1549. doi: 10.1016/j.jogc.2020.03.025. Epub 2020 Apr 28.
	32702124	0	Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. 2020 Jul 23;136(4):381-383. doi: 10.1182/blood.2020007335.
	32692888	0	Rudzinski JK, Govindasamy NP, Lewis JD, et al. The role of the androgen receptor in prostate cancer-induced platelet aggregation and platelet-induced invasion. J Thromb Haemost. 2020 Nov;18(11):2976-2986. doi: 10.1111/jth.15020. Epub 2020 Aug 24.
	32685899	0	van Ommen CH, Albisetti M, Chan AK, et al. The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease. Res Pract Thromb Haemost. 2020 May 25;4(5):886-892. doi: 10.1002/rth2.12352. eCollection 2020 Jul.
	32685890	0	Mazinani N, Strilchuk AW, Baylis JR, et al. Bleeding is increased in amyloid precursor protein knockout mouse. Res Pract Thromb Haemost. 2020 Jun 14;4(5):823-828. doi: 10.1002/rth2.12375. eCollection 2020 Jul.
	32685885	0	Elbaz C, Sholzberg M. An illustrated review of bleeding assessment tools and common coagulation tests. Res Pract Thromb Haemost. 2020 Jul 6;4(5):761-773. doi: 10.1002/rth2.12339. eCollection 2020 Jul.
	32685588	0	Peacock WF, Coleman CI, Wells P, et al. Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care. J Health Econ Outcomes Res. 2019 Oct 2;6(3):160-173. doi: 10.36469/9936. eCollection 2019.
	32683148	0	Ripsman D, Fergusson DA, Montroy J, et al. A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models. Thromb Res. 2020 Nov;195:103-113. doi: 10.1016/j.thromres.2020.07.008. Epub 2020 Jul 8.
	32680646	0	Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 Aug 4;76(5):594-622. doi: 10.1016/j.jacc.2020.04.053. Epub 2020 Jul 14.
	32678949	0	D'Souza R, Malhame I, Teshler L, et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020 Sep;99(9):1110-1120. doi: 10.1111/aogs.13962. Epub 2020 Aug 5.
	32676543	0	Wang YP, Kehar R, Iansavitchene A, et al. Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies. TH Open. 2020 Jul 13;4(3):e145-e152. doi: 10.1055/s-0040-1714918. eCollection 2020 Jul.
	32658609	0	Spyropoulos AC, Weitz JI. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm. Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
	32654348	0	Mulder FI, Carrier M, van Doormaal F, et al. Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2622-2628. doi: 10.1111/jth.15001. Epub 2020 Aug 4.
	32654308	0	AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28.
	32645667	0	Shaw JR, Carrier M, Dowlatshahi D, et al. Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes. Thromb Res. 2020 Nov;195:21-28. doi: 10.1016/j.thromres.2020.06.044. Epub 2020 Jul 1.
	32640269	0	Avila L, Amiri N, Yenson P, et al. Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing. J Pediatr. 2020 Jul 5. pii: S0022-3476(20)30835-0. doi: 10.1016/j.jpeds.2020.06.081.
	32619348	0	Rabinovich A, Abdul-Kadir R, Thachil J, et al. Reply to "Errors in the diagnosis for DIC due to a statistical misunderstanding". J Thromb Haemost. 2020 Jul;18(7):1792-1793. doi: 10.1111/jth.14831.
	32619346	0	Di Nisio M, Valeriani E, Riva N, et al. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost. 2020 Jul;18(7):1562-1568. doi: 10.1111/jth.14836.
	32594508	0	Weitz JI, Angiolillo DJ, Geisler T, et al. Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence. Thromb Haemost. 2020 Aug;120(8):1147-1158. doi: 10.1055/s-0040-1713376. Epub 2020 Jun 28.
	32586587	0	Spyropoulos AC, Ageno W, Albers GW, et al. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020 Jun 30;75(25):3140-3147. doi: 10.1016/j.jacc.2020.04.071.
	32583306	0	Weitz JI, Haas S, Ageno W, et al. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x.
	32579570	0	Yogendrakumar V, Lun R, Khan F, et al. Venous thromboembolism prevention in intracerebral hemorrhage: A systematic review and network meta-analysis. PLoS One. 2020 Jun 24;15(6):e0234957. doi: 10.1371/journal.pone.0234957. eCollection 2020.
	32578414	0	Hwang HG, Kim YK, Kim MS, et al. Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease. Tuberc Respir Dis (Seoul). 2020 Jul;83(3):255-256. doi: 10.4046/trd.2020.0029. Epub 2020 Apr 29.
	32576089	0	Lu N, Smith JMC, Andrade JG, et al. Considerations in Adult Congenital Heart Disease and Stroke: A Case Report. Stroke. 2020 Aug;51(8):e148-e150. doi: 10.1161/STROKEAHA.119.028605. Epub 2020 Jun 24.
	32575112	0	Carrier M, Wang TF. Direct oral anticoagulants and cancer-associated VTE: good for all, or just some? Blood. 2020 Aug 6;136(6):669-673. doi: 10.1182/blood.2019004177.
	32574420	0	Xu Y, You D, Krzyzaniak H, et al. Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2566-2581. doi: 10.1111/jth.14977. Epub 2020 Jul 23.
	32574367	0	Yepes-Nunez JJ, Rajasekhar A, Rahman M, et al. Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism. Blood Adv. 2020 Jun 23;4(12):2798-2809. doi: 10.1182/bloodadvances.2020002195.
	32573898	0	Jackson Chornenki NL, Dwivedi DJ, Kwong AC, et al. Identification of hemostatic markers that define the pre-DIC state: A multi-center observational study. J Thromb Haemost. 2020 Oct;18(10):2524-2531. doi: 10.1111/jth.14973. Epub 2020 Jul 23.
	32569377	0	Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected deep vein thrombosis. Blood Adv. 2020 Jun 23;4(12):2779-2788. doi: 10.1182/bloodadvances.2020001558.
	32563061	0	Murthy SK, Robertson McCurdy AB, Carrier M, et al. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting. Thromb Res. 2020 Oct;194:26-32. doi: 10.1016/j.thromres.2020.06.005. Epub 2020 Jun 3.
	32561453	0	Violette PD, Vernooij RWM, Aoki Y, et al. An International Survey on the Use of Thromboprophylaxis in Urological Surgery. Eur Urol Focus. 2021 May;7(3):653-658. doi: 10.1016/j.euf.2020.05.015. Epub 2020 Jun 16.
	32557627	0	Pelland-Marcotte MC, Amiri N, Avila ML, et al. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev. 2020 Jun 18;6:CD005982. doi: 10.1002/14651858.CD005982.pub3.
	32548552	0	Bauersachs R, Khorana AA, Lee AYY, et al. Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban. Res Pract Thromb Haemost. 2020 Apr 4;4(4):532-549. doi: 10.1002/rth2.12327. eCollection 2020 May.
	32542391	0	Darzi AJ, Karam SG, Spencer FA, et al. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 Jun 23;4(12):2557-2566. doi: 10.1182/bloodadvances.2020001937.
	32539500	0	Kimpton M, Rodger MA. Web Exclusive. Annals for Hospitalists Inpatient Notes - Can I Withdraw Anticoagulants in This Patient With Prior Venous Thromboembolism? Ann Intern Med. 2020 Jun 16;172(12):HO2-HO3. doi: 10.7326/M20-1253.
	32526791	0	Schulman S, Konstantinides S, Hu Y, et al. Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158]. Thromb Haemost. 2020 Aug;120(8):1143-1146. doi: 10.1055/s-0040-1712913. Epub 2020 Jun 11.
	32511715	0	Patel P, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Jun 9;4(11):2516-2522. doi: 10.1182/bloodadvances.2019001409.
	32511684	0	Hill K, Sucha E, Rhodes E, et al. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants. JAMA Intern Med. 2020 Aug 1;180(8):1052-1060. doi: 10.1001/jamainternmed.2020.1835.
	32506822	0	Ni R, Neves MAD, Wu C, et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets. J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950.
	32506364	0	Chibane S, Gibeau G, Poulin F, et al. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report. J Thromb Thrombolysis. 2021 Jan;51(1):25-28. doi: 10.1007/s11239-020-02173-w.
	32505262	0	Shaw JR, Kaplovitch E, Douketis J. Periprocedural Management of Oral Anticoagulation. Med Clin North Am. 2020 Jul;104(4):709-726. doi: 10.1016/j.mcna.2020.02.005. Epub 2020 May 12.
	32502594	0	Moores LK, Tritschler T, Brosnahan S, et al. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2.
	32497628	0	Porres-Aguilar M, Anaya-Ayala JE, Mukherjee D, et al. Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19. J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):898-899. doi: 10.1016/j.jvsv.2020.04.032. Epub 2020 Jun 1.
	32497167	0	Mirza R, Nieuwlaat R, Lopez-Nunez JJ, et al. Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry). Blood Adv. 2020 Jun 9;4(11):2460-2467. doi: 10.1182/bloodadvances.2019001373.
	32496023	0	Tritschler T, Kraaijpoel N, Girard P, et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Jun;18(6):1495-1500. doi: 10.1111/jth.14769.
	32485418	0	Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27.
	32473692	0	Kaplovitch E, Shaw JR, Douketis J. Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli. Crit Care Clin. 2020 Jul;36(3):465-480. doi: 10.1016/j.ccc.2020.02.004.
	32473596	0	Bikdeli B, Madhavan MV, Gupta A, et al. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30.
	32467044	0	Leighton JL, You D, Schneider P. Limiting Blood Loss in Orthopaedic Trauma: Strategies and Effects. Injury. 2020 May;51 Suppl 2:S123-S127. doi: 10.1016/j.injury.2020.04.040. Epub 2020 May 11.
	32456506	0	Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020 Aug 17;31(6):740-745. doi: 10.1080/09537104.2020.1768523. Epub 2020 May 26.
	32454394	0	Nassabein R, Routy B, Blais N, et al. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer. Eur J Cancer. 2020 Jul;134:1-2. doi: 10.1016/j.ejca.2020.05.002. Epub 2020 May 18.
	32453843	0	Wiercioch W, Nieuwlaat R, Akl EA, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 May 26;4(10):2351-2365. doi: 10.1182/bloodadvances.2020001768.
	32444398	0	Mavrakanas TA, Garlo K, Charytan DM. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1146-1154. doi: 10.2215/CJN.11650919. Epub 2020 May 22.
	32433797	0	Takada T, van Doorn S, Parpia S, et al. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis. J Thromb Haemost. 2020 Sep;18(9):2245-2252. doi: 10.1111/jth.14900. Epub 2020 Jul 8.
	32430965	0	Lefler DS, Cuker A, Linkins LA, et al. Maximum 24-hour platelet count fall: Metric for improving the diagnosis of heparin-induced thrombocytopenia among patients with intermediate probability 4Ts scores. J Thromb Haemost. 2020 Aug;18(8):2018-2024. doi: 10.1111/jth.14897. Epub 2020 Jun 25.
	32428195	0	Paquette M, Mbuagbaw L, Iorio A, et al. Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):251-260. doi: 10.1093/ehjcvp/pvaa052.
	32422442	0	Bounameaux H, Haas S, Farjat AE, et al. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thromb Res. 2020 Jul;191:103-112. doi: 10.1016/j.thromres.2020.04.036. Epub 2020 Apr 28.
	32416310	0	Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: What's the link? A narrative review. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27.
	32414520	0	Amgalan A, Othman M. TEG in pregnancy: Current challenges and future potential applications. Thromb Res. 2020 Jul;191:140-141. doi: 10.1016/j.thromres.2020.03.017. Epub 2020 Mar 24.
	32396939	0	Mulder FI, Bosch FTM, Young AM, et al. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis. Blood. 2020 Sep 17;136(12):1433-1441. doi: 10.1182/blood.2020005819.
	32396622	0	Izcovich A, Cuker A, Kunkle R, et al. A user guide to the American Society of Hematology clinical practice guidelines. Blood Adv. 2020 May 12;4(9):2095-2110. doi: 10.1182/bloodadvances.2020001755.
	32395827	0	Wang TF, Delluc A. Thromboprophylaxis in patients with multiple myeloma. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12.
	32392613	0	Schulman S. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism. Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
	32375490	0	Henke PK, Kahn SR, Pannucci CJ, et al. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation. 2020 Jun 16;141(24):e914-e931. doi: 10.1161/CIR.0000000000000769. Epub 2020 May 7.
	32369855	0	Giustozzi M, Curcio A, Weijs B, et al. Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. 2020 May;120(5):847-856. doi: 10.1055/s-0040-1709527. Epub 2020 May 5.
	32369854	0	Montroy J, Lalu MM, Auer RC, et al. The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis. Thromb Haemost. 2020 May;120(5):832-846. doi: 10.1055/s-0040-1709712. Epub 2020 May 5.
	32356929	0	Amgalan A, Allen T, Othman M, et al. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH. J Thromb Haemost. 2020 Aug;18(8):1813-1838. doi: 10.1111/jth.14882.
	32346486	0	Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1. eCollection 2020.
	32339233	0	Juang LJ, Mazinani N, Novakowski SK, et al. Coagulation factor XII contributes to hemostasis when activated by soil in wounds. Blood Adv. 2020 Apr 28;4(8):1737-1745. doi: 10.1182/bloodadvances.2019000425.
	32336010	0	van Es N, Ventresca M, Di Nisio M, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis. J Thromb Haemost. 2020 Aug;18(8):1940-1951. doi: 10.1111/jth.14824. Epub 2020 Jul 8.
	32334825	0	McAlpine K, Lavallee LT. Reply to: Re: Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2020 Jun;167(6):1026. doi: 10.1016/j.surg.2020.02.030. Epub 2020 Apr 22.
	32333946	0	Ashley J, McArthur E, Bota S, et al. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22.
	32325043	0	Goldhaber SZ, Ageno W, Casella IB, et al. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE Study. Am J Med. 2020 Aug;133(8):936-945. doi: 10.1016/j.amjmed.2020.03.036. Epub 2020 Apr 20.
	32323192	0	Zhang L, Yan X, Fox KAA, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2020 Jul;50(1):20-29. doi: 10.1007/s11239-020-02077-9.
	32323191	0	Solms A, Willmann S, Reinecke I, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul;50(1):1-11. doi: 10.1007/s11239-020-02073-z.
	32323190	0	Reinecke I, Solms A, Willmann S, et al. Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism. J Thromb Thrombolysis. 2020 Jul;50(1):12-19. doi: 10.1007/s11239-020-02078-8.
	32320170	0	Holbrook A, Morrow R, Lee AYY, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. J Popul Ther Clin Pharmacol. 2020 Apr 13;27(2):e28-e44. doi: 10.15586/jptcp.v27i2.662.
	32311448	0	Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
	32299756	0	Gruel Y, De Maistre E, Pouplard C, et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020 Apr;39(2):291-310. doi: 10.1016/j.accpm.2020.03.012. Epub 2020 Apr 13.
	32289865	0	Abdulla A, Davis WM, Ratnaweera N, et al. A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer. Thromb Haemost. 2020 Apr;120(4):702-713. doi: 10.1055/s-0040-1708481. Epub 2020 Apr 14.
	32289164	0	Izcovich A, Criniti JM, Popoff F, et al. Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis. Blood Adv. 2020 Apr 14;4(7):1539-1553. doi: 10.1182/bloodadvances.2020001513.
	32289163	0	Neumann I, Izcovich A, Zhang Y, et al. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020 Apr 14;4(7):1512-1517. doi: 10.1182/bloodadvances.2019000840.
	32284189	0	Bungard TJ, Ritchie B, Bolt J, et al. Use of Direct Oral Anticoagulants Versus Traditional Therapies for Acute Venous Thromboembolism After Direct Discharge From the Emergency Department or After Hospitalization: An Audit of 16 Canadian Hospitals. Clin Ther. 2020 May;42(5):873-881. doi: 10.1016/j.clinthera.2020.03.001. Epub 2020 Apr 10.
	32262660	0	Leung JM, Berry LR, Atkinson HM, et al. Surface modification of poly(dimethylsiloxane) with a covalent antithrombin-heparin complex for the prevention of thrombosis: use of polydopamine as bonding agent. J Mater Chem B. 2015 Aug 7;3(29):6032-6036. doi: 10.1039/c5tb00808e. Epub 2015 Jun 29.
	32246743	0	Young G, Lensing AWA, Monagle P, et al. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation. J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4.
	32237599	0	Le Collen L, Quere I, Galanaud JP. [Deep-vein thrombosis and pulmonary embolism]. Rev Prat. 2019 Dec;69(10):e327-e336.
	32230912	0	Makedonov I, Kahn SR, Galanaud JP. Prevention and Management of the Post-Thrombotic Syndrome. J Clin Med. 2020 Mar 27;9(4). pii: jcm9040923. doi: 10.3390/jcm9040923.
	32227213	0	Bhatt M, Braun C, Patel P, et al. Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy. Blood Adv. 2020 Apr 14;4(7):1250-1264. doi: 10.1182/bloodadvances.2019000960.
	32223115	0	Lee AYY. Anticoagulant Therapy for Venous Thromboembolism in Cancer. N Engl J Med. 2020 Apr 23;382(17):1650-1652. doi: 10.1056/NEJMe2004220. Epub 2020 Mar 29.
	32219982	0	Mithoowani S, Cervi A, Shah N, et al. Management of major bleeds in patients with immune thrombocytopenia. J Thromb Haemost. 2020 Jul;18(7):1783-1790. doi: 10.1111/jth.14809. Epub 2020 May 6.
	32211571	0	Kahn SR, Shivakumar S. What's new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost. 2020 Mar 9;4(3):366-376. doi: 10.1002/rth2.12323. eCollection 2020 Mar.
	32205598	0	Fernando SM, Mok G, Castellucci LA, et al. Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding. Crit Care Med. 2020 Apr;48(4):515-524. doi: 10.1097/CCM.0000000000004206.
	32205131	0	Chen Y, Chen H, Yang J, et al. Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):919-929. doi: 10.1016/j.jvsv.2020.01.010. Epub 2020 Mar 21.
	32202042	0	Valeriani E, Porreca E, Weitz JI, et al. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis. J Thromb Haemost. 2020 Jul;18(7):1661-1671. doi: 10.1111/jth.14807. Epub 2020 Apr 16.
	32171947	0	Schmidt RA, Al Zaki A, Desilet N, et al. Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism. Thromb Res. 2020 Apr;188:106-114. doi: 10.1016/j.thromres.2020.02.005. Epub 2020 Feb 13.
	32168402	0	Moumneh T, Riou J, Douillet D, et al. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study. J Thromb Haemost. 2020 Jun;18(6):1398-1407. doi: 10.1111/jth.14796. Epub 2020 Apr 16.
	32167669	0	Warkentin TE, Sheppard JI, Smith JW, et al. Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2020 Jun;18(6):1435-1446. doi: 10.1111/jth.14794. Epub 2020 Apr 27.
	32150614	0	Lee AYY. The changing landscape of anticoagulation in cancer-associated thrombosis. Blood Adv. 2020 Mar 10;4(5):969. doi: 10.1182/bloodadvances.2019000842.
	32146068	0	Siegal DM, Healey JS. Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen? Can J Cardiol. 2020 Apr;36(4):459-461. doi: 10.1016/j.cjca.2019.11.008. Epub 2019 Nov 15.
	32145144	0	Rabinovich A, Gu CS, Vedantham S, et al. External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost. 2020 Jun;18(6):1381-1389. doi: 10.1111/jth.14791. Epub 2020 Apr 9.
	32142099	0	Siegal DM, Eikelboom JW, Lee SF, et al. Variations in incidence of venous thromboembolism in low-, middle-, and high-income countries. Cardiovasc Res. 2021 Jan 21;117(2):576-584. doi: 10.1093/cvr/cvaa044.
	32133581	0	Fitzgerald J, McMonnies R, Sharkey A, et al. Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. Can J Anaesth. 2020 Jun;67(6):746-753. doi: 10.1007/s12630-020-01609-4. Epub 2020 Mar 4.
	32132678	0	Mackman N, Bergmeier W, Stouffer GA, et al. Therapeutic strategies for thrombosis: new targets and approaches. Nat Rev Drug Discov. 2020 May;19(5):333-352. doi: 10.1038/s41573-020-0061-0. Epub 2020 Mar 4.
	32130721	0	Nazy I, Elliott TD, Arnold DM. Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor. Br J Haematol. 2020 Aug;190(4):594-598. doi: 10.1111/bjh.16553. Epub 2020 Mar 4.
	32125293	0	Tritschler T, Castellucci LA, Van Es N, et al. Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants. Pol Arch Intern Med. 2020 Jun 6;130(6):529-538. doi: 10.20452/pamw.15225. Epub 2020 Mar 3.
	32112537	0	Porres-Aguilar M, Kahn SR, Hirsch AM. Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020 Mar;18(3):755-756. doi: 10.1111/jth.14705.
	32112441	0	Avram AT, Blostein MD, Hirsch AM, et al. Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery. Am J Hematol. 2020 Jun;95(6):712-717. doi: 10.1002/ajh.25768. Epub 2020 Mar 20.
	32110758	0	Dawson AJ, Akaberi A, Galanaud JP, et al. Patient-reported reasons for and predictors of noncompliance with compression stockings in a randomized trial of stockings to prevent postthrombotic syndrome. Res Pract Thromb Haemost. 2019 Dec 29;4(2):269-277. doi: 10.1002/rth2.12296. eCollection 2020 Feb.
	32098609	0	Butcher KS, Ng K, Sheridan P, et al. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. Stroke. 2020 Apr;51(4):1190-1198. doi: 10.1161/STROKEAHA.119.027569. Epub 2020 Feb 26.
	32097460	0	Skeith L, Baumann Kreuziger L, Crowther MA, et al. A practical approach to evaluating postoperative thrombocytopenia. Blood Adv. 2020 Feb 25;4(4):776-783. doi: 10.1182/bloodadvances.2019001414.
	32092132	0	Darzi AJ, Karam SG, Charide R, et al. Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
	32091505	0	Roberge G, Carrier M. How to manage patients with symptomatic subsegmental pulmonary embolism? Pol Arch Intern Med. 2020 Apr 30;130(4):310-316. doi: 10.20452/pamw.15211. Epub 2020 Feb 24.
	32073218	0	Tritschler T, Kraaijpoel N, Langlois N, et al. Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts. J Thromb Haemost. 2020 Jun;18(6):1415-1420. doi: 10.1111/jth.14775. Epub 2020 Mar 30.
	32056070	0	Roberge G, Tritschler T, MacGillivray C, et al. Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report. J Thromb Thrombolysis. 2020 Oct;50(3):674-677. doi: 10.1007/s11239-020-02062-2.
	32045437	0	Kraaijpoel N, Carrier M, Le Gal G, et al. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis. PLoS One. 2020 Feb 11;15(2):e0228788. doi: 10.1371/journal.pone.0228788. eCollection 2020.
	32040553	0	Khatib R, Ross S, Kennedy SA, et al. Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis. Blood Adv. 2020 Feb 11;4(3):500-513. doi: 10.1182/bloodadvances.2019001223.
	32037570	0	Lee A, Mendoza J, Brubaker AL, et al. Eliminating international normalized ratio threshold for transfusion in pediatric patients with acute liver failure. Clin Transplant. 2020 Apr;34(4):e13819. doi: 10.1111/ctr.13819. Epub 2020 Feb 28.
	32036158	0	Robin P, Grewal RK, Le Roux PY, et al. Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism. Thromb Res. 2020 Apr;188:25-27. doi: 10.1016/j.thromres.2020.01.028. Epub 2020 Jan 30.
	32028109	0	Calais C, Mercier G, Meusy A, et al. Pulmonary embolism home treatment: What GP want? Thromb Res. 2020 Mar;187:180-185. doi: 10.1016/j.thromres.2020.01.015. Epub 2020 Jan 16.
	32011635	0	Spyropoulos AC, Schulman S, Douketis JD. Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-Reply. JAMA Intern Med. 2020 Feb 1;180(2):333-334. doi: 10.1001/jamainternmed.2019.5851.
	32008258	0	Olesen KKW, Wheeler M, Eikelboom JW. Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer. Thromb Haemost. 2020 Feb;120(2):194-196. doi: 10.1055/s-0039-3402809. Epub 2020 Feb 2.
	31999844	0	Li A, Carlson JJ, Kuderer NM, et al. Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States. Cancer. 2020 Apr 15;126(8):1736-1748. doi: 10.1002/cncr.32724. Epub 2020 Jan 30.
	31999063	0	Zwicker JI, Wang TF, DeAngelo DJ, et al. The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. J Thromb Haemost. 2020 Feb;18(2):278-284. doi: 10.1111/jth.14671.
	31999061	0	Lillicrap D, Morrissey JH. Hemostasis and thrombosis 101-A challenge to energize. J Thromb Haemost. 2020 Feb;18(2):269. doi: 10.1111/jth.14731.
	31999058	0	Horner D, Stevens JW, Pandor A, et al. Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care. J Thromb Haemost. 2020 Feb;18(2):519-520. doi: 10.1111/jth.14708.
	31995204	0	McCurdy JD, Kuenzig ME, Smith G, et al. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis. 2020 Oct 23;26(11):1761-1768. doi: 10.1093/ibd/izaa002.
	31989097	0	Noble S, Nelson A, Scott J, et al. Patient Experience of Living With Cancer-Associated Thrombosis in Canada (PELICANADA). Res Pract Thromb Haemost. 2019 Oct 21;4(1):154-160. doi: 10.1002/rth2.12274. eCollection 2020 Jan.
	31989095	0	Shaw JR, Zhang T, Le Gal G, et al. Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis. Res Pract Thromb Haemost. 2020 Jan 20;4(1):131-140. doi: 10.1002/rth2.12285. eCollection 2020 Jan.
	31989071	0	Gossack-Keenan K, De Wit K, Gardiner E, et al. Showing Your Thinking: Using Mind Maps to Understand the Gaps Between Experienced Emergency Physicians and Their Students. AEM Educ Train. 2019 Sep 1;4(1):54-63. doi: 10.1002/aet2.10379. eCollection 2020 Jan.
	31986474	0	Zhang J, Toupin D, Lebel MC, et al. Development of an INR for rivaroxaban monitoring using plasma samples from patients. Thromb Res. 2020 Mar;187:122-124. doi: 10.1016/j.thromres.2020.01.009. Epub 2020 Jan 10.
	31983322	0	Garcia MJ, Sterling KM, Kahn SR, et al. Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study. J Am Heart Assoc. 2020 Feb 4;9(3):e013398. doi: 10.1161/JAHA.119.013398. Epub 2020 Jan 25.
	31982293	0	Houston BL, Uminski K, Mutter T, et al. Efficacy and Safety of Tranexamic Acid in Major Non-Cardiac Surgeries at High Risk for Transfusion: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2020 Jan;34(1):51-62. doi: 10.1016/j.tmrv.2019.10.001. Epub 2019 Oct 23.
	31978224	0	Wang TF, Carrier M. How I treat obese patients with oral anticoagulants. Blood. 2020 Mar 19;135(12):904-911. doi: 10.1182/blood.2019003528.
	31975354	0	Weitz JI, Raskob GE, Spyropoulos AC, et al. Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials. Thromb Haemost. 2020 Mar;120(3):515-524. doi: 10.1055/s-0039-1701009. Epub 2020 Jan 23.
	31955061	0	Quan S, Smith J, Wu C, et al. Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism. Thromb Res. 2020 Mar;187:56-62. doi: 10.1016/j.thromres.2020.01.011. Epub 2020 Jan 11.
	31953535	0	Capodanno D, Bhatt DL, Eikelboom JW, et al. Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nat Rev Cardiol. 2020 Apr;17(4):242-257. doi: 10.1038/s41569-019-0314-y. Epub 2020 Jan 17.
	31935028	0	Weitz JI, Bauersachs R, Becker B, et al. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. doi: 10.1001/jama.2019.20687.
	31925875	0	Blondon M, Le Gal G, Meyer G, et al. Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: A cost-effectiveness analysis. J Thromb Haemost. 2020 Apr;18(4):865-875. doi: 10.1111/jth.14733. Epub 2020 Feb 28.
	31917402	0	Kearon C, Kahn SR. Long-term treatment of venous thromboembolism. Blood. 2020 Jan 30;135(5):317-325. doi: 10.1182/blood.2019002364.
	31917385	0	Weitz JI, Chan NC. Novel antithrombotic strategies for treatment of venous thromboembolism. Blood. 2020 Jan 30;135(5):351-359. doi: 10.1182/blood.2019000919.
	31904611	0	Khandelwal A, Phua CW, Chaudhry HR, et al. Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing. Blood Coagul Fibrinolysis. 2020 Jan;31(1):60-64. doi: 10.1097/MBC.0000000000000882.
	31899848	0	Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11.
	31893963	0	Agbani EO, Zhao X, Williams CM, et al. Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis. Platelets. 2020 Oct 2;31(7):853-859. doi: 10.1080/09537104.2019.1709632. Epub 2020 Jan 1.
	31893562	0	Al-Ani F, Wang YP, Lazo-Langner A. Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia. Thromb Haemost. 2020 Feb;120(2):322-328. doi: 10.1055/s-0039-3400303. Epub 2020 Jan 1.
	31881626	0	Janhofer DE, Lakhiani C, Kim PJ, et al. The Utility of Preoperative Venous Testing for Lower Extremity Flap Planning in Patients with Lower Extremity Wounds. Plast Reconstr Surg. 2020 Jan;145(1):164e-171e. doi: 10.1097/PRS.0000000000006384.
	31877292	0	Jaffer IH, Fredenburgh JC, Stafford A, et al. Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin Generation. Ann Thorac Surg. 2020 Aug;110(2):582-590. doi: 10.1016/j.athoracsur.2019.10.091. Epub 2019 Dec 24.
	31876366	0	Tieu P, Paes B, Ahmed A, et al. Inferior vena cava syndrome in neonates: An evidence-based systematic review of the literature. Pediatr Blood Cancer. 2020 Apr;67(4):e28114. doi: 10.1002/pbc.28114. Epub 2019 Dec 26.
	31872492	0	Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020 Apr;18(4):926-930. doi: 10.1111/jth.14720. Epub 2020 Feb 17.
	31869505	0	Parpia S, Takach Lapner S, Schutgens R, et al. Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta-analysis. J Thromb Haemost. 2020 Mar;18(3):669-675. doi: 10.1111/jth.14718. Epub 2020 Jan 14.
	31858522	0	Schindewolf M, Weitz JI. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment. Thromb Haemost. 2020 Jan;120(1):14-26. doi: 10.1055/s-0039-3400302. Epub 2019 Dec 13.
	31851608	0	Pandor A, Horner D, Davis S, et al. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation. Health Technol Assess. 2019 Dec;23(63):1-190. doi: 10.3310/hta23630.
	31843251	0	Kahn SR, Julian JA, Kearon C, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):8-23.e18. doi: 10.1016/j.jvsv.2019.03.023.
	31838139	0	Medeiros SK, Emery B, Bhagirath V, et al. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism? Thromb Res. 2020 Feb;186:13-19. doi: 10.1016/j.thromres.2019.11.030. Epub 2019 Nov 30.
	31821779	0	Lin C, Martin KA, Wang M, et al. Long-term antithrombotic therapy after venous stent placement. Phlebology. 2020 Jul;35(6):402-408. doi: 10.1177/0268355519893819. Epub 2019 Dec 10.
	31812027	0	Cantor N, Carrier M, Rodger MA, et al. Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study. Thromb Res. 2020 Jan;185:132-134. doi: 10.1016/j.thromres.2019.11.021. Epub 2019 Nov 22.
	31809335	0	Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol. 2020 Feb;33(1):17-23. doi: 10.1097/WCO.0000000000000780.
	31808866	0	Peterson EA, Lee AYY. Update from the clinic: what's new in the diagnosis of cancer-associated thrombosis? Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):167-174. doi: 10.1182/hematology.2019000024.
	31808858	0	Kimpton M, Carrier M. What's new in the prevention and treatment of cancer-associated thrombosis? Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):158-166. doi: 10.1182/hematology.2019000023.
	31808849	0	Kimpton M, Siegal DM. Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor-associated major bleeding. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):204-208. doi: 10.1182/hematology.2019000074.
	31808835	0	Siegal DM. What we have learned about direct oral anticoagulant reversal. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):198-203. doi: 10.1182/hematology.2019000072.
	31806700	0	Verbrugge FH, Martin AC, Siegal D, et al. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk. Heart. 2020 Jun;106(11):845-851. doi: 10.1136/heartjnl-2019-315873. Epub 2019 Dec 5.
	31796490	0	Tang GH, Norris E, Petrucci J, et al. Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study. BMJ Open. 2019 Dec 2;9(12):e032891. doi: 10.1136/bmjopen-2019-032891.
	31794602	0	Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
	31791152	0	Choi M, Butler E, Clarke A, et al. Managing pregnancy-associated clinical emergencies in systemic lupus erythematosus: a case-based approach. Expert Rev Clin Immunol. 2020 Jan;16(1):5-22. doi: 10.1080/1744666X.2019.1699057. Epub 2020 Jan 8.
	31789846	0	Chan TM, Mercuri M, Turcotte M, et al. Making Decisions in the Era of the Clinical Decision Rule: How Emergency Physicians Use Clinical Decision Rules. Acad Med. 2020 Aug;95(8):1230-1237. doi: 10.1097/ACM.0000000000003098.
	31781397	0	Prudhomme N, Kwok ESH, Olejnik L, et al. A Health Records Review of Outpatient Referrals from the Emergency Department. Emerg Med Int. 2019 Oct 31;2019:5179081. doi: 10.1155/2019/5179081. eCollection 2019.
	31777160	0	Inciardi RM, Giugliano RP, Claggett B, et al. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation. Eur J Heart Fail. 2019 Dec;21(12):1571-1579. doi: 10.1002/ejhf.1606. Epub 2019 Nov 27.
	31776584	0	Karsanji DJ, Bates SM, Skeith L. The risk and prevention of venous thromboembolism in the pregnant traveller. J Travel Med. 2020 Mar 13;27(2). pii: 5644628. doi: 10.1093/jtm/taz091.
	31774957	0	Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-2134. doi: 10.1056/NEJMoa1909159.
	31770030	0	Agbani EO, Hers I, Poole AW. Letter by Agbani et al Regarding Article, "Clot Contraction Drives the Translocation of Procoagulant Platelets to Thrombus Surface". Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):e287-e289. doi: 10.1161/ATVBAHA.119.313468. Epub 2019 Nov 26.
	31769796	0	Agzarian J, Litle V, Linkins LA, et al. International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis. Eur J Cardiothorac Surg. 2020 May 1;57(5):854-859. doi: 10.1093/ejcts/ezz319.
	31761399	0	Quezada A, Jimenez D, Bikdeli B, et al. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism. Int J Cardiol. 2020 Mar 1;302:157-163. doi: 10.1016/j.ijcard.2019.11.102. Epub 2019 Nov 14.
	31748926	0	Sanfilippo KM, Wang TF. Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review. Curr Treat Options Cardiovasc Med. 2019 Nov 20;21(11):70. doi: 10.1007/s11936-019-0764-x.
	31742836	0	Li S, Fang Y, Li L, et al. Bleeding assessment in haemophilia carriers-High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China. Haemophilia. 2020 Jan;26(1):122-128. doi: 10.1111/hae.13889. Epub 2019 Nov 19.
	31728509	0	Vethanayagam B, Kahn SR. Flying while pregnant: what is the thrombosis risk? J Travel Med. 2020 Mar 13;27(2). pii: 5625777. doi: 10.1093/jtm/taz084.
	31727694	0	Mulder FI, Di Nisio M, Ay C, et al. Clinical implications of incidental venous thromboembolism in cancer patients. Eur Respir J. 2020 Feb 6;55(2). pii: 13993003.01697-2019. doi: 10.1183/13993003.01697-2019. Print 2020 Feb.
	31724642	0	Byrne J, Greco E, Yeo E, et al. Tibial bypass salvage with eptifibatide in a patient with thrombocythemia. J Vasc Surg Cases. 2015 Nov 1;1(4):246-248. doi: 10.1016/j.jvsc.2015.08.004. eCollection 2015 Dec.
	31710863	0	Jourdi G, Delrue M, Stepanian A, et al. Potential usefulness of activated charcoal (DOAC remove(R)) for dRVVT testing in patients receiving Direct Oral AntiCoagulants. Thromb Res. 2019 Dec;184:86-91. doi: 10.1016/j.thromres.2019.11.001. Epub 2019 Nov 5.
	31699660	0	Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
	31683107	0	Stoller N, Limacher A, Mean M, et al. Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism. Thromb Res. 2019 Dec;184:24-30. doi: 10.1016/j.thromres.2019.10.008. Epub 2019 Oct 22.
	31678748	0	Yu J, Li A, Laureano M, et al. Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thromb Res. 2019 Dec;184:16-23. doi: 10.1016/j.thromres.2019.10.004. Epub 2019 Oct 21.
	31675758	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part V. Semin Thromb Hemost. 2019 Nov;45(8):757-759. doi: 10.1055/s-0039-1700490. Epub 2019 Nov 1.
	31668083	0	Abdulrehman J, Eikelboom JW, Siegal DM. Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence. Future Cardiol. 2019 Nov;15(6):395-404. doi: 10.2217/fca-2019-0038. Epub 2019 Oct 31.
	31661033	0	Khan F, Kimpton M, Tritschler T, et al. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol. Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5.
	31654551	0	Horner D, Stevens JW, Pandor A, et al. Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta-analysis. J Thromb Haemost. 2020 Feb;18(2):422-438. doi: 10.1111/jth.14666. Epub 2019 Dec 1.
	31648712	0	Weitz JI, Chan NC. Are Ticks the Answer to Medical Device-Associated Clotting? J Am Coll Cardiol. 2019 Oct 29;74(17):2190-2192. doi: 10.1016/j.jacc.2019.08.1027.
	31624782	0	Murray S, McLintock C, Lazure P, et al. Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international study. Res Pract Thromb Haemost. 2019 Jun 28;3(4):626-638. doi: 10.1002/rth2.12237. eCollection 2019 Oct.
	31624780	0	Othman M, Santamaria Ortiz A, Cerda M, et al. Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis. Res Pract Thromb Haemost. 2019 Aug 1;3(4):607-614. doi: 10.1002/rth2.12243. eCollection 2019 Oct.
	31621093	0	Warkentin TE, Nazy I, Sheppard JI, et al. Serotonin-release assay-negative heparin-induced thrombocytopenia. Am J Hematol. 2020 Jan;95(1):38-47. doi: 10.1002/ajh.25660. Epub 2019 Nov 6.
	31614388	0	Bikdeli B, Jimenez D, Garcia-Tsao G, et al. Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. Semin Thromb Hemost. 2019 Nov;45(8):793-801. doi: 10.1055/s-0039-1697682. Epub 2019 Oct 15.
	31600808	0	Pelland-Marcotte MC, Tole S, Pechlivanoglou P, et al. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis. Thromb Haemost. 2019 Dec;119(12):2034-2042. doi: 10.1055/s-0039-1697027. Epub 2019 Oct 10.
	31600806	0	Miranda S, Benhamou Y, Wells P, et al. Safety of Primary Thromboprophylaxis Using Apixaban in Ambulatory Cancer Patients with Intracranial Metastatic Disease or Primary Brain Tumors. Thromb Haemost. 2019 Nov;119(11):1886-1887. doi: 10.1055/s-0039-1695769. Epub 2019 Oct 10.
	31599808	0	Levy JH, van Ryn J, Sellke FW, et al. Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study. Ann Surg. 2021 Sep 1;274(3):e204-e211. doi: 10.1097/SLA.0000000000003638.
	31593849	0	Porres-Aguilar M, Anaya-Ayala JE, Jimenez D, et al. Pulmonary Embolism Response Teams: Pursuing Excellence in the Care for Venous Thromboembolism. Arch Med Res. 2019 Jul;50(5):257-258. doi: 10.1016/j.arcmed.2019.08.011. Epub 2019 Oct 5.
	31592728	0	Magnuson EA, Chinnakondepalli K, Vilain K, et al. Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005659. doi: 10.1161/CIRCOUTCOMES.119.005659. Epub 2019 Oct 8.
	31587337	0	Orzel LA, Abel EE, Blais DM, et al. Risk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study. Pharmacotherapy. 2019 Dec;39(12):1157-1166. doi: 10.1002/phar.2335. Epub 2019 Oct 29.
	31586388	0	Kulkarni S, Piraino D, Strauss R, et al. The Cost of Pre-Analytical Errors in INR Testing at a Tertiary-Care Hospital Laboratory: Potential for Significant Cost Savings. Lab Med. 2020 May 6;51(3):320-324. doi: 10.1093/labmed/lmz062.
	31582557	0	Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3.
	31582135	0	Eikelboom JW, van Ryn J, Reilly P, et al. Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment. J Am Coll Cardiol. 2019 Oct 8;74(14):1760-1768. doi: 10.1016/j.jacc.2019.07.070.
	31574560	0	Rabbolini DJ, Othman M. Molecular and Genetic Testing in Thrombosis and Hemostasis. Semin Thromb Hemost. 2019 Oct;45(7):657-660. doi: 10.1055/s-0039-1694993. Epub 2019 Oct 1.
	31572733	0	Lesyk G, Jurasz P. Advances in Platelet Subpopulation Research. Front Cardiovasc Med. 2019 Sep 13;6:138. doi: 10.3389/fcvm.2019.00138. eCollection 2019.
	31558677	0	Paciullo F, Bury L, Noris P, et al. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica. 2020 Jul;105(7):1948-1956. doi: 10.3324/haematol.2019.227876. Epub 2019 Sep 26.
	31557394	0	Al Lawati K, Aljazeeri J, Bates SM, et al. Ability of a single negative ultrasound to rule out deep vein thrombosis in pregnant women: A systematic review and meta-analysis. J Thromb Haemost. 2020 Feb;18(2):373-380. doi: 10.1111/jth.14650. Epub 2019 Oct 16.
	31555668	0	Kim H, Conway EM. Platelets and Complement Cross-Talk in Early Atherogenesis. Front Cardiovasc Med. 2019 Sep 6;6:131. doi: 10.3389/fcvm.2019.00131. eCollection 2019.
	31551368	0	Boffa MB, Marar TT, Yeang C, et al. Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. J Lipid Res. 2019 Dec;60(12):2082-2089. doi: 10.1194/jlr.P094763. Epub 2019 Sep 24.
	31536873	0	Boonyawat K, Kunakorntham P, Angchaisuksiri P. Oral anticoagulant-associated bleeding requiring hospitalization in Thai patients: Incidences, risk factors, and outcomes. Thromb Res. 2019 Nov;183:33-35. doi: 10.1016/j.thromres.2019.09.004. Epub 2019 Sep 5.
	31531846	0	Kander EM, Zhao Q, Bhat SA, et al. Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib. Br J Haematol. 2019 Nov;187(3):399-402. doi: 10.1111/bjh.16209. Epub 2019 Sep 18.
	31530593	0	Alaifan T, Alenazy A, Xiang Wang D, et al. Tranexamic acid in cardiac surgery: a systematic review and meta-analysis (protocol). BMJ Open. 2019 Sep 17;9(9):e028585. doi: 10.1136/bmjopen-2018-028585.
	31529984	0	Lamb DA, Bungard TJ, Lowerison J, et al. Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs. Ann Pharmacother. 2020 Mar;54(3):277-282. doi: 10.1177/1060028019877215. Epub 2019 Sep 17.
	31529590	0	Weitz JI, Segers A, Raskob G, et al. Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis. J Thromb Haemost. 2019 Dec;17(12):2081-2088. doi: 10.1111/jth.14639. Epub 2019 Oct 13.
	31506556	0	Eltringham-Smith LJ, Yu R, Qadri SM, et al. Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy. Sci Rep. 2019 Sep 10;9(1):13029. doi: 10.1038/s41598-019-49552-9.
	31494438	0	Spencer NH, Sardo LA, Cordell JP, et al. Structure and function of a perioperative anticoagulation management clinic. Thromb Res. 2019 Oct;182:167-174. doi: 10.1016/j.thromres.2019.08.007. Epub 2019 Aug 23.
	31492632	0	Farge D, Frere C, Connors JM, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3.
	31489277	0	Hashmi A, Kim P, Ahmad SW, et al. Superior Sagittal Venous Sinus Thrombosis in a Patient with Illicit Testosterone Use. Cureus. 2019 Aug 26;11(8):e5491. doi: 10.7759/cureus.5491.
	31487115	0	Gay J, Duchemin J, Imarazene M, et al. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study. Int J Lab Hematol. 2019 Dec;41(6):738-744. doi: 10.1111/ijlh.13101. Epub 2019 Sep 5.
	31479183	0	Lillicrap D, Morrissey JH. Genomic momentum for hemostasis and thrombosis. J Thromb Haemost. 2019 Sep;17(9):1411. doi: 10.1111/jth.14582.
	31448291	0	Le Blanc J, Lordkipanidze M. Platelet Function in Aging. Front Cardiovasc Med. 2019 Aug 7;6:109. doi: 10.3389/fcvm.2019.00109. eCollection 2019.
	31436045	0	Spyropoulos AC, Brohi K, Caprini J, et al. Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019 Nov;17(11):1966-1972. doi: 10.1111/jth.14598. Epub 2019 Aug 22.
	31434018	0	Xu Y, Schulman S, Dowlatshahi D, et al. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thromb Res. 2019 Oct;182:12-19. doi: 10.1016/j.thromres.2019.07.026. Epub 2019 Aug 2.
	31429203	0	Conway EM. Thrombin: Coagulation's master regulator of innate immunity. J Thromb Haemost. 2019 Nov;17(11):1785-1789. doi: 10.1111/jth.14586. Epub 2019 Aug 20.
	31420937	0	Li A, Kuderer NM, Garcia DA, et al. Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis. J Thromb Haemost. 2019 Dec;17(12):2141-2151. doi: 10.1111/jth.14613. Epub 2019 Sep 17.
	31420903	0	Liederman Z, Van Cott EM, Smock K, et al. Heparin-induced thrombocytopenia: An international assessment of the quality of laboratory testing. J Thromb Haemost. 2019 Dec;17(12):2123-2130. doi: 10.1111/jth.14611. Epub 2019 Sep 25.
	31415251	0	Grottke O, Schulman S. Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors. Anesthesiology. 2019 Nov;131(5):1153-1165. doi: 10.1097/ALN.0000000000002910.
	31407544	0	Deshet Meirovich D, Winder A. [MANAGEMENT OF VENOUS THROMBOEMBOLISM: WHICH DRUG, WHAT DOSE AND FOR HOW LONG]. Harefuah. 2019 Aug;158(8):534-539.
	31404933	0	Ghorbanpour E, Lillicrap D. Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and Thrombosis. Semin Thromb Hemost. 2019 Oct;45(7):751-756. doi: 10.1055/s-0039-1692977. Epub 2019 Aug 12.
	31402557	0	Tardy B, Chalayer E, Kamphuisen PW, et al. Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC. J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12.
	31397594	0	Manji F, Warkentin TE, Sheppard JI, et al. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban. Platelets. 2020;31(1):124-127. doi: 10.1080/09537104.2019.1652263. Epub 2019 Aug 9.
	31382307	0	Suryanarayan D, Lee AYY, Wu C. Direct Oral Anticoagulants in Cancer Patients. Semin Thromb Hemost. 2019 Sep;45(6):638-647. doi: 10.1055/s-0039-1693479. Epub 2019 Aug 5.
	31381464	0	Key NS, Khorana AA, Kuderer NM, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5.
	31380891	0	Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.
	31379000	0	Sanfilippo KM, Luo S, Wang TF, et al. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.
	31377000	0	McAlpine K, Breau RH, Knee C, et al. Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2019 Dec;166(6):1084-1091. doi: 10.1016/j.surg.2019.05.050. Epub 2019 Jul 31.
	31370075	0	Schellong SM, Goldhaber SZ, Weitz JI, et al. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost. 2019 Oct;119(10):1675-1685. doi: 10.1055/s-0039-1693461. Epub 2019 Aug 1.
	31368220	0	Makris M, Iorio A, Lenting PJ. Emicizumab and thrombosis: The story so far. J Thromb Haemost. 2019 Aug;17(8):1269-1272. doi: 10.1111/jth.14556.
	31364490	0	Zhang L, Yan X, Nandy P, et al. Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719863641. doi: 10.1177/1753944719863641.
	31363740	0	Shargall Y, Brunelli A, Murthy S, et al. Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey. Eur J Cardiothorac Surg. 2020 Feb 1;57(2):331-337. doi: 10.1093/ejcts/ezz191.
	31360033	0	Bhatt P, Gupta DK, Agrawal D, et al. Budd-Chiari Syndrome With Spontaneous Intrahepatic Portosystemic Shunts: A Case Series. J Clin Exp Hepatol. 2019 May-Jun;9(3):412-415. doi: 10.1016/j.jceh.2018.08.003. Epub 2018 Aug 25.
	31354089	0	Weinberg I, Vedantham S, Salter A, et al. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019 Oct;24(5):442-451. doi: 10.1177/1358863X19862043. Epub 2019 Jul 27.
	31353841	0	Wang TF, Zwicker JI, Ay C, et al. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28.
	31350267	0	Swystun LL, Ogiwara K, Rawley O, et al. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients. Blood. 2019 Sep 12;134(11):880-891. doi: 10.1182/blood.2019000190. Epub 2019 Jul 26.
	31340984	0	Khan F, Rahman A, Carrier M, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
	31318718	0	Kaur H, Fisher K, Othman M. Thromboelastography testing in mice following blood collection from facial vein and cardiac puncture. Blood Coagul Fibrinolysis. 2019 Oct;30(7):366-369. doi: 10.1097/MBC.0000000000000836.
	31317483	0	Carrier M, Soff G, Le Gal G. Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants. Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7.
	31309685	0	Medeiros SK, Zafar N, Liaw PC, et al. Purification of silica-free DNA and characterization of its role in coagulation. J Thromb Haemost. 2019 Nov;17(11):1860-1865. doi: 10.1111/jth.14565. Epub 2019 Jul 30.
	31301689	0	Kraaijpoel N, Tritschler T, Guillo E, et al. Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: A systematic review. J Thromb Haemost. 2019 Oct;17(10):1590-1607. doi: 10.1111/jth.14570. Epub 2019 Jul 31.
	31294317	0	Lazo-Langner A. Studies in upper extremity deep vein thrombosis: Addressing the knowledge gaps. Res Pract Thromb Haemost. 2019 May 15;3(3):312-314. doi: 10.1002/rth2.12210. eCollection 2019 Jul.
	31282771	0	Escobar M, Santagostino E, Mancuso ME, et al. Switching patients in the age of long-acting recombinant products? Expert Rev Hematol. 2019;12(sup1):1-13. doi: 10.1080/17474086.2018.1564032.
	31279158	0	Rodger MA, Miranda S, Delluc A, et al. Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next? Thromb Res. 2019 Aug;180:105-109. doi: 10.1016/j.thromres.2019.06.017. Epub 2019 Jun 26.
	31273089	0	Delluc A, Miranda S, Exter PD, et al. Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis. Haematologica. 2020 May;105(5):1436-1442. doi: 10.3324/haematol.2019.222828. Epub 2019 Jul 4.
	31271705	0	Di Nisio M, van Es N, Carrier M, et al. Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study. J Thromb Haemost. 2019 Nov;17(11):1866-1874. doi: 10.1111/jth.14561. Epub 2019 Jul 25.
	31252313	0	Little D, Siegal DM. Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding. Thromb Res. 2019 Aug;180:86. doi: 10.1016/j.thromres.2019.06.003. Epub 2019 Jun 13.
	31249922	0	Brekelmans MPA, Buller HR, Mercuri MF, et al. Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent. TH Open. 2018 Jan 8;2(1):e1-e7. doi: 10.1055/s-0037-1615251. eCollection 2018 Jan.
	31243691	0	Montalescot G, Brotons C, Cosyns B, et al. Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial. Am J Cardiovasc Drugs. 2020 Feb;20(1):61-71. doi: 10.1007/s40256-019-00356-2.
	31226664	0	Tritschler T, Castellucci LA. It's time for head-to-head trials with direct oral anticoagulants. Thromb Res. 2019 Aug;180:64-69. doi: 10.1016/j.thromres.2019.05.019. Epub 2019 May 31.
	31226480	0	Jaffer IH, Weitz JI. The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem. Acta Biomater. 2019 Aug;94:2-10. doi: 10.1016/j.actbio.2019.06.021. Epub 2019 Jun 18.
	31220403	0	Haas S, Ageno W, Weitz JI, et al. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. J Thromb Haemost. 2019 Oct;17(10):1694-1706. doi: 10.1111/jth.14548. Epub 2019 Jul 23.
	31218838	0	Rabinovich A, Abdul-Kadir R, Thachil J, et al. DIC in obstetrics: Diagnostic score, highlights in management, and international registry-communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis. J Thromb Haemost. 2019 Sep;17(9):1562-1566. doi: 10.1111/jth.14523. Epub 2019 Jun 20.
	31216551	0	Ma Y, Chen F, Xu Y, et al. Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption Plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study. Blood Purif. 2019;48(3):223-232. doi: 10.1159/000500408. Epub 2019 Jun 19.
	31210407	0	Serrano PE, Parpia S, Valencia M, et al. Incidence of delayed venous thromboembolic events in patients undergoing abdominal and pelvic surgery for cancer: a systematic review and meta-analysis. ANZ J Surg. 2019 Oct;89(10):1217-1223. doi: 10.1111/ans.15290. Epub 2019 Jun 18.
	31207027	0	Delluc A, Wang TF, Yap ES, et al. Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17.
	31200828	0	Melosky B, Bradbury P, Tu D, et al. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. Lung Cancer. 2019 Jul;133:48-55. doi: 10.1016/j.lungcan.2019.04.027. Epub 2019 May 1.
	31186132	0	Field TS. Recurrent venous thromboembolism after cerebral venous thrombosis: which lower-risk survivors are at risk for recurrence? Thromb Res. 2019 Oct;182:182-183. doi: 10.1016/j.thromres.2019.05.015. Epub 2019 May 31.
	31183844	0	Ageno W, Haas S, Weitz JI, et al. Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost. 2019 Aug;119(8):1365-1372. doi: 10.1055/s-0039-1688828. Epub 2019 Jun 10.
	31176033	0	Al Rawahi B, Almegren M, Carrier M. The efficacy and safety of anticoagulation in cerebral vein thrombosis: A Systematic review and meta-analysis: Re-Abdulaziz Almulhim, Saad Fallatah, Ivo Abraham. Comparing incomparable with the wrong analytics: anticoagulation, disability, intracranial hemorrhage, and mortality in acute cerebral vein thrombosis. Thrombosis Research Volume 178, June 2019, Pages 110-111. Thromb Res. 2019 Aug;180:28. doi: 10.1016/j.thromres.2019.05.020. Epub 2019 May 30.
	31175610	0	Douros A, Durand M, Doyle CM, et al. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies. Drug Saf. 2019 Oct;42(10):1135-1148. doi: 10.1007/s40264-019-00842-1.
	31174635	0	Mai V, Guay CA, Perreault L, et al. Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis. Chest. 2019 Jun;155(6):1199-1216. doi: 10.1016/j.chest.2019.02.402.
	31170773	0	Mithoowani S, Arnold DM. First-Line Therapy for Immune Thrombocytopenia. Hamostaseologie. 2019 Aug;39(3):259-265. doi: 10.1055/s-0039-1684031. Epub 2019 Jun 6.
	31152504	0	Lillicrap D, Morrissey JH. 27th ISTH Congress - July in Melbourne. J Thromb Haemost. 2019 Jun;17(6):847. doi: 10.1111/jth.14463.
	31145837	0	Baylis JR, Lee MM, St John AE, et al. Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self-propelling particles. J Thromb Haemost. 2019 Oct;17(10):1645-1654. doi: 10.1111/jth.14526. Epub 2019 Jun 26.
	31141645	0	Carrier M, Le Gal G, Wells PS. Preventing Venous Thromboembolism in Patients with Cancer. Reply. N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003.
	31138592	0	Paquette M, Witt DM, Holbrook A, et al. A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation. Blood Adv. 2019 May 28;3(10):1638-1646. doi: 10.1182/bloodadvances.2019000067.
	31129575	0	Kahn SR, Diendere G, Morrison DR, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019 May 24;9(5):e024444. doi: 10.1136/bmjopen-2018-024444.
	31127695	0	Othman M, Han K, Elbatarny M, et al. The use of viscoelastic hemostatic tests in pregnancy and puerperium: review of the current evidence - communication from the Women's Health SSC of the ISTH. J Thromb Haemost. 2019 Jul;17(7):1184-1189. doi: 10.1111/jth.14461. Epub 2019 May 24.
	31109636	0	Kaplovitch E, Dounaevskaia V. Treatment in the dental practice of the patient receiving anticoagulation therapy. J Am Dent Assoc. 2019 Jul;150(7):602-608. doi: 10.1016/j.adaj.2019.02.011. Epub 2019 May 17.
	31108013	0	Langlois E, Cusson-Dufour C, Moumneh T, et al. Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT-PE-pregnancy study. J Thromb Haemost. 2019 Aug;17(8):1329-1334. doi: 10.1111/jth.14483. Epub 2019 Jun 5.
	31106406	0	Senini V, Amara U, Paul M, et al. Porphyromonas gingivalis lipopolysaccharide activates platelet Cdc42 and promotes platelet spreading and thrombosis. J Periodontol. 2019 Nov;90(11):1336-1345. doi: 10.1002/JPER.18-0596. Epub 2019 Jul 1.
	31100632	0	Chornenki NLJ, Um KJ, Mendoza PA, et al. Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis. Thromb Res. 2019 Jul;179:81-86. doi: 10.1016/j.thromres.2019.05.003. Epub 2019 May 5.
	31092489	0	Goldhar HA, O'Meara P, Castellucci LA. A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis. BMJ Case Rep. 2019 May 14;12(5). pii: 12/5/e227450. doi: 10.1136/bcr-2018-227450.
	31092159	0	Field TS, Hill MD. Cerebral Venous Thrombosis. Stroke. 2019 Jun;50(6):1598-1604. doi: 10.1161/STROKEAHA.119.025334. Epub 2019 May 16.
	31088940	0	Christiansen SD, Liu J, Boffa MB, et al. Simultaneous R2(*) and quantitative susceptibility mapping measurement enables differentiation of thrombus hematocrit and age: an in vitro study at 3 T. J Neurointerv Surg. 2019 Nov;11(11):1155-1161. doi: 10.1136/neurintsurg-2019-014802. Epub 2019 May 14.
	31084649	0	Ho ML, Carrier M. Just the facts: Management of life-threatening bleeding with oral anticoagulant use in the emergency department. CJEM. 2019 Jul;21(4):460-463. doi: 10.1017/cem.2019.345. Epub 2019 May 14.
	31073853	0	Dubinsky S, Thawer A, McLeod AG, et al. Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone. Support Care Cancer. 2019 Sep;27(9):3209-3217. doi: 10.1007/s00520-019-04816-y. Epub 2019 May 10.
	31066471	0	McCurdy JD, Israel A, Hasan M, et al. A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019 Jun;49(12):1493-1501. doi: 10.1111/apt.15286. Epub 2019 May 8.
	31060047	0	Le Moigne E, Timsit S, Ben Salem D, et al. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study. Ann Intern Med. 2019 Jun 4;170(11):756-763. doi: 10.7326/M18-3485. Epub 2019 May 7.
	31050876	0	Warkentin TE, Sheppard JI, Smith JW, et al. Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay. Int J Lab Hematol. 2019 Aug;41(4):493-502. doi: 10.1111/ijlh.13031. Epub 2019 May 3.
	31038838	0	Shaw JR, Douketis J, Le Gal G, et al. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. J Thromb Haemost. 2019 Jul;17(7):1171-1178. doi: 10.1111/jth.14468. Epub 2019 May 29.
	31034291	0	Gurbel PA, Fox KAA, Tantry US, et al. Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease. Circulation. 2019 Apr 30;139(18):2170-2185. doi: 10.1161/CIRCULATIONAHA.118.033580.
	31033194	0	Kearon C, Parpia S, Spencer FA, et al. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study. J Thromb Haemost. 2019 Jul;17(7):1144-1152. doi: 10.1111/jth.14458. Epub 2019 May 20.
	31030810	0	Pelland-Marcotte MC, Carcao MD. Hemophilia in a Changing Treatment Landscape. Hematol Oncol Clin North Am. 2019 Jun;33(3):409-423. doi: 10.1016/j.hoc.2019.01.007. Epub 2019 Mar 29.
	31019911	0	Conway EM. Polyphosphates and Complement Activation. Front Med (Lausanne). 2019 Apr 4;6:67. doi: 10.3389/fmed.2019.00067. eCollection 2019.
	31011709	0	Shida Y, Swystun LL, Brown C, et al. Shear stress and platelet-induced tensile forces regulate ADAMTS13-localization within the platelet thrombus. Res Pract Thromb Haemost. 2019 Mar 23;3(2):254-260. doi: 10.1002/rth2.12196. eCollection 2019 Apr.
	31008430	0	Tseng EK, Jo D, Shih AW, et al. Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment. AEM Educ Train. 2019 Jan 6;3(2):179-187. doi: 10.1002/aet2.10315. eCollection 2019 Apr.
	31005064	0	Shaya SA, Gani DM, Weitz JI, et al. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Thromb Haemost. 2019 Jun;119(6):992-999. doi: 10.1055/s-0039-1685141. Epub 2019 Apr 20.
	31001438	0	Durivage A, Le Templier G, Cumyn A, et al. Pregnancy in a Woman with Latent Myeloproliferative Neoplasm Induced Chronic Portal Vein Thrombosis, Portal Cavernoma, and Gastric Varices. Case Rep Obstet Gynecol. 2019 Mar 14;2019:5702983. doi: 10.1155/2019/5702983. eCollection 2019.
	30999965	0	Bose G, Graveline J, Yogendrakumar V, et al. Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol. Syst Rev. 2019 Apr 18;8(1):99. doi: 10.1186/s13643-019-1022-8.
	30985986	0	Kim PY, Di Giuseppantonio LR, Wu C, et al. An assay to measure levels of factor Xa inhibitors in blood and plasma. J Thromb Haemost. 2019 Jul;17(7):1153-1159. doi: 10.1111/jth.14451. Epub 2019 May 10.
	30933993	0	Mai V, Bertoletti L, Cucherat M, et al. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis. PLoS One. 2019 Apr 1;14(4):e0214134. doi: 10.1371/journal.pone.0214134. eCollection 2019.
	30925842	0	Kimpton M, Carrier M. Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism. Expert Opin Drug Saf. 2019 Apr;18(4):313-320. doi: 10.1080/14740338.2019.1601699. Epub 2019 Apr 8.
	30923107	0	Weitz JI, Chan NC. MAA868 locks factor XIa in a zymogen-like state. Blood. 2019 Mar 28;133(13):1393-1394. doi: 10.1182/blood-2019-02-900480.
	30921533	0	Ahrari A, Al-Ani F, Wang YP, et al. Treatment of venous thromboembolism in acute leukemia: A systematic review. Thromb Res. 2019 Jun;178:1-6. doi: 10.1016/j.thromres.2019.03.014. Epub 2019 Mar 20.
	30919384	0	Field TS, Weijs B, Curcio A, et al. Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. 2019 Jun;119(6):981-991. doi: 10.1055/s-0039-1683429. Epub 2019 Mar 27.
	30917049	0	Chan NC, Weitz JI. AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIa. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):533-535. doi: 10.1161/ATVBAHA.119.312459.
	30890372	0	Reardon PM, Patrick S, Taljaard M, et al. Diagnostic Accuracy and Financial Implications of Age-Adjusted D-Dimer Strategies for the Diagnosis of Deep Venous Thrombosis in the Emergency Department. J Emerg Med. 2019 May;56(5):469-477. doi: 10.1016/j.jemermed.2019.01.027. Epub 2019 Mar 16.
	30875491	0	Suleman A, Jarvis V, Hadziomerovic A, et al. Implanted vascular access device related deep vein thrombosis in oncology patients: A prospective cohort study. Thromb Res. 2019 May;177:117-121. doi: 10.1016/j.thromres.2019.02.033. Epub 2019 Mar 6.
	30860557	0	Tritschler T, Kraaijpoel N, Wells PS. Inferior Vena Cava Filters in the Management of Venous Thromboembolism-Reply. JAMA. 2019 Mar 12;321(10):1007. doi: 10.1001/jama.2018.21127.
	30859370	0	Woodruff S, Lee AYY, Carrier M, et al. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study. J Thromb Thrombolysis. 2019 May;47(4):495-504. doi: 10.1007/s11239-019-01833-w.
	30858184	0	Hage A, Louzada M, Kiaii B. Sepsis-induced heparin resistance during extracorporeal membrane oxygenation. CMAJ. 2019 Mar 11;191(10):E283-E285. doi: 10.1503/cmaj.181061.
	30850385	0	Khatib R, Ludwikowska M, Witt DM, et al. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis. Blood Adv. 2019 Mar 12;3(5):789-796. doi: 10.1182/bloodadvances.2018025163.
	30846497	0	Cate VT, Lensing AWA, Weitz JI, et al. Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study. Haematologica. 2019 Oct;104(10):e474-e477. doi: 10.3324/haematol.2018.209924. Epub 2019 Mar 7.
	30840115	0	Klaassen Z, Wallis CJD, Lavallee LT, et al. Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World J Urol. 2020 Mar;38(3):593-600. doi: 10.1007/s00345-019-02705-x. Epub 2019 Mar 6.
	30826719	0	Lange N, Mean M, Stalder O, et al. Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism. Thromb Res. 2019 May;177:10-16. doi: 10.1016/j.thromres.2019.02.017. Epub 2019 Feb 15.
	30822795	0	Schulman S. Recent Advances in Thrombosis and Hemostasis-Part IV. Semin Thromb Hemost. 2019 Mar;45(2):130-131. doi: 10.1055/s-0039-1678721. Epub 2019 Mar 1.
	30808507	0	Teoh DA, Hutton MJH, Else S, et al. Epidural analgesia? A prospective analysis of perioperative coagulation in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Am J Surg. 2019 May;217(5):887-892. doi: 10.1016/j.amjsurg.2019.01.034. Epub 2019 Feb 1.
	30808045	0	Weitz JI, Chan NC. Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials. Thromb Haemost. 2019 May;119(5):689-694. doi: 10.1055/s-0039-1679906. Epub 2019 Feb 26.
	30783764	0	Hernandez MC, Traynor M, Bruce JL, et al. Surgical Considerations for Pediatric Snake Bites in Low- and Middle-Income Countries. World J Surg. 2019 Jul;43(7):1636-1643. doi: 10.1007/s00268-019-04953-9.
	30779598	0	Chan NC, Weitz JI. Rivaroxaban for prevention and treatment of venous thromboembolism. Future Cardiol. 2019 Mar;15(2):63-77. doi: 10.2217/fca-2018-0076. Epub 2019 Feb 19.
	30772417	0	Pelland-Marcotte MC, Tucker C, Klaassen A, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019 Mar;6(3):e144-e153. doi: 10.1016/S2352-3026(18)30224-2. Epub 2019 Feb 13.
	30762590	0	Hur WS, Warner H, Machan L, et al. Coagulation factor XIII-A and activated FXIII-A decrease in some deep vein thrombosis patients following catheter-directed thrombolysis. Blood Coagul Fibrinolysis. 2019 Jun;30(4):176-180. doi: 10.1097/MBC.0000000000000797.
	30760422	0	Lee H, Tan MK, Yan AT, et al. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. Can J Cardiol. 2019 Feb;35(2):160-168. doi: 10.1016/j.cjca.2018.11.023. Epub 2018 Dec 3.
	30755438	0	Tritschler T, Wells PS. Extended therapy for unprovoked venous thromboembolism: when is it indicated? Blood Adv. 2019 Feb 12;3(3):499. doi: 10.1182/bloodadvances.2018026518.
	30743281	0	Piran S, Schulman S. Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Narrative Review. Semin Thromb Hemost. 2019 Mar;45(2):150-156. doi: 10.1055/s-0039-1678720. Epub 2019 Feb 11.
	30731388	0	Chin-Yee N, Tanuseputro P, Carrier M, et al. Thromboembolic disease in palliative and end-of-life care: A narrative review. Thromb Res. 2019 Mar;175:84-89. doi: 10.1016/j.thromres.2018.12.028. Epub 2019 Jan 3.
	30730782	0	Connolly SJ, Crowther M, Eikelboom JW, et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. N Engl J Med. 2019 Apr 4;380(14):1326-1335. doi: 10.1056/NEJMoa1814051. Epub 2019 Feb 7.
	30729377	0	Wells P, Peacock WF, Fermann GJ, et al. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul;48(1):149-157. doi: 10.1007/s11239-019-01814-z.
	30716777	0	Duffett L, Kearon C, Rodger M, et al. Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis. Thromb Haemost. 2019 Mar;119(3):479-489. doi: 10.1055/s-0039-1677793. Epub 2019 Feb 4.
	30709542	0	Versteeg HH, Rodger M. Bugs in the system. Thromb Res. 2019 Feb;174:166. doi: 10.1016/j.thromres.2019.01.004.
	30702997	0	Coppens M, Weitz JI, Eikelboom JWA. Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease. Circ Res. 2019 Feb;124(3):416-425. doi: 10.1161/CIRCRESAHA.118.313141.
	30702992	0	Weitz JI, Fazio S. Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis. Circ Res. 2019 Feb;124(3):351-353. doi: 10.1161/CIRCRESAHA.118.314576.
	30702990	0	Chan NC, Weitz JI. Antithrombotic Agents. Circ Res. 2019 Feb;124(3):426-436. doi: 10.1161/CIRCRESAHA.118.313155.
	30699965	0	Singha SK, Muhammad I, Ibrahim MA, et al. 4-O-Methylhonokiol Influences Normal Cardiovascular Development in Medaka Embryo. Molecules. 2019 Jan 29;24(3). pii: molecules24030475. doi: 10.3390/molecules24030475.
	30699446	0	Kearon C, Gu CS, Julian JA, et al. Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial. Thromb Haemost. 2019 Apr;119(4):633-644. doi: 10.1055/s-0039-1677795. Epub 2019 Jan 30.
	30697707	0	Davis S, Goodacre S, Pandor A, et al. Decision-analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury. Br J Haematol. 2019 Jul;186(1):166-168. doi: 10.1111/bjh.15748. Epub 2019 Jan 29.
	30693813	0	Ivetic N, Arnold DM, Smith JW, et al. A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia. Platelets. 2019;30(8):1017-1021. doi: 10.1080/09537104.2018.1562169. Epub 2019 Jan 29.
	30691551	0	Douros A, Renoux C, Yin H, et al. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation. Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25.
	30685874	0	Arnold DM, Jamula E, Heddle NM, et al. Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27.
	30685873	0	Rezig S, Mao RL, Couturaud F, et al. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event. Thromb Haemost. 2019 Mar;119(3):490-495. doi: 10.1055/s-0039-1677745. Epub 2019 Jan 27.
	30658963	0	Piran S, Khatib R, Schulman S, et al. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Adv. 2019 Jan 22;3(2):158-167. doi: 10.1182/bloodadvances.2018024133.
	30657628	0	Abdoellakhan RA, Beyer-Westendorf J, Schulman S, et al. Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding. J Thromb Haemost. 2019 Mar;17(3):499-506. doi: 10.1111/jth.14388. Epub 2019 Feb 13.
	30656824	0	Righini M, Robert-Ebadi H, Glauser F, et al. Effect of anticoagulant treatment on pain in distal deep vein thrombosis: an ancillary analysis from the cactus trial. J Thromb Haemost. 2019 Mar;17(3):507-510. doi: 10.1111/jth.14387. Epub 2019 Feb 3.
	30650446	0	Cohen AT, Agnelli G, Buller HR, et al. Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial. Thromb Haemost. 2019 Mar;119(3):461-466. doi: 10.1055/s-0038-1676983. Epub 2019 Jan 16.
	30640980	0	Eekels JJM, Althaus K, Bakchoul T, et al. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2019 Mar;17(3):525-531. doi: 10.1111/jth.14383. Epub 2019 Feb 20.
	30598642	0	Lensing AWA, Male C, Young G, et al. Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018.
	30597497	0	De Caterina R, Ageno W, Agnelli G, et al. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thromb Haemost. 2019 Jan;119(1):14-38. doi: 10.1055/s-0038-1675816. Epub 2018 Dec 31.
	30595331	0	Carrier M, Altman AD, Blais N, et al. Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery. Am J Surg. 2019 Sep;218(3):537-550. doi: 10.1016/j.amjsurg.2018.11.046. Epub 2018 Dec 16.
	30593086	0	Ageno W, Haas S, Weitz JI, et al. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28.
	30592396	0	Girard P, Le Gal G. Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Dec 6;379(23):2279. doi: 10.1056/NEJMc1813803.
	30591426	0	Jourdi G, Le Bonniec B, Gouin-Thibault I. Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. Ann Biol Clin (Paris). 2019 Feb 1;77(1):67-78. doi: 10.1684/abc.2018.1400.
	30586751	0	Comerota AJ, Kearon C, Gu CS, et al. Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 2019 Feb 26;139(9):1162-1173. doi: 10.1161/CIRCULATIONAHA.118.037425.
	30582672	0	Huynh A, Arnold DM, Kelton JG, et al. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. J Thromb Haemost. 2019 Feb;17(2):389-399. doi: 10.1111/jth.14369.
	30580558	0	Weitz JI, Chan NC. Advances in Antithrombotic Therapy. Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):7-12. doi: 10.1161/ATVBAHA.118.310960.
	30567722	0	Denis HL, Lamontagne-Proulx J, St-Amour I, et al. Platelet abnormalities in Huntington's disease. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):272-283. doi: 10.1136/jnnp-2018-318854. Epub 2018 Dec 19.
	30559261	0	Piran S, Schulman S. Treatment of bleeding complications in patients on anticoagulant therapy. Blood. 2019 Jan 31;133(5):425-435. doi: 10.1182/blood-2018-06-820746. Epub 2018 Dec 17.
	30553163	0	Thiyagarajah K, Ellingwood L, Endres K, et al. Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and meta-analysis. Thromb Res. 2019 Feb;174:34-39. doi: 10.1016/j.thromres.2018.12.012. Epub 2018 Dec 8.
	30545613	0	Tagalakis V. Sex may matter when it comes to the presenting location of deep vein thrombosis. Thromb Res. 2019 Jan;173:164-165. doi: 10.1016/j.thromres.2018.12.001. Epub 2018 Dec 6.
	30537547	0	Ravina K, Strickland BA, Buchanan IA, et al. Postoperative Antiplatelet Therapy in the Treatment of Complex Basilar Apex Aneurysms Implementing Hunterian Ligation and Extracranial-to-Intracranial Bypass: Review of the Literature with an Illustrative Case Report. World Neurosurg. 2019 Mar;123:113-122. doi: 10.1016/j.wneu.2018.11.237. Epub 2018 Dec 8.
	30534007	0	Kubitza D, Willmann S, Becka M, et al. Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study. Thromb J. 2018 Dec 4;16:31. doi: 10.1186/s12959-018-0186-0. eCollection 2018.
	30530771	0	Keulers A, Nikoubashman O, Mpotsaris A, et al. Preventing vessel perforations in endovascular thrombectomy: feasibility and safety of passing the clot with a microcatheter without microwire: the wireless microcatheter technique. J Neurointerv Surg. 2019 Jul;11(7):653-658. doi: 10.1136/neurintsurg-2018-014267. Epub 2018 Dec 7.
	30529390	0	Zumbrunn B, Stalder O, Mean M, et al. Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism. Thromb Res. 2019 Jan;173:124-130. doi: 10.1016/j.thromres.2018.11.011. Epub 2018 Nov 12.
	30528575	0	Manlhiot C, McCrindle BW, Williams S, et al. Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease. J Pediatr. 2019 Apr;207:42-48. doi: 10.1016/j.jpeds.2018.10.064. Epub 2018 Dec 7.
	30520242	0	Bhatt MD, Patel V, Butt ML, et al. Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy. Pediatr Blood Cancer. 2019 Apr;66(4):e27572. doi: 10.1002/pbc.27572. Epub 2018 Dec 5.
	30511879	0	Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
	30507843	0	Gkalea V, Khaterchi A, Levy P, et al. Prospective Evaluation of a Rapid Functional Assay for Heparin-Induced Thrombocytopenia Diagnosis in Critically Ill Patients. Crit Care Med. 2019 Mar;47(3):353-359. doi: 10.1097/CCM.0000000000003574.
	30506352	0	Mahamad S, Chaudhry H, Nisenbaum R, et al. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients. J Thromb Thrombolysis. 2019 Feb;47(2):272-279. doi: 10.1007/s11239-018-1785-0.
	30505737	0	McAlpine K, Lavallee LT. Decreasing rates of venous thromboembolism after radical cystectomy: an encouraging trend and more work is still needed. Transl Androl Urol. 2018 Dec;7(6):982-983. doi: 10.21037/tau.2018.07.15.
	30504344	0	Skeith L. Anticoagulating patients with high-risk acquired thrombophilias. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):439-449. doi: 10.1182/asheducation-2018.1.439.
	30504342	0	Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):426-431. doi: 10.1182/asheducation-2018.1.426.
	30498046	0	Robin P, Eddy M, Sikora L, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data. BMJ Open. 2018 Nov 28;8(11):e023939. doi: 10.1136/bmjopen-2018-023939.
	30487292	0	van der Wall SJ, van der Pol LM, Ende-Verhaar YM, et al. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev. 2018 Nov 28;27(150). pii: 27/150/180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31.
	30482767	0	Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.
	30482766	0	Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3292-3316. doi: 10.1182/bloodadvances.2018024786.
	30482765	0	Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893.
	30482764	0	Lim W, Le Gal G, Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3226-3256. doi: 10.1182/bloodadvances.2018024828.
	30482763	0	Schunemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
	30482762	0	Panepinto JA, Pai M. The value of clinical practice guidelines in hematology. Blood Adv. 2018 Nov 27;2(22):3196-3197. doi: 10.1182/bloodadvances.2018025395.
	30482761	0	Willmann S, Zhang L, Mayer H, et al. Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients. Blood Adv. 2018 Nov 27;2(22):3193-3195. doi: 10.1182/bloodadvances.2018027078.
	30478093	0	Kraaijpoel N, Carrier M. How I treat cancer-associated venous thromboembolism. Blood. 2019 Jan 24;133(4):291-298. doi: 10.1182/blood-2018-08-835595. Epub 2018 Nov 26.
	30467189	0	Solymoss S. Postthrombotic syndrome: simple prevention. Blood. 2018 Nov 22;132(21):2216-2217. doi: 10.1182/blood-2018-10-877076.
	30463994	0	Skeith L. Anticoagulating patients with high-risk acquired thrombophilias. Blood. 2018 Nov 22;132(21):2219-2229. doi: 10.1182/blood-2018-05-848697.
	30446212	0	Yan MTS, Rydz N, Goodyear D, et al. Acquired factor XIII deficiency: A review. Transfus Apher Sci. 2018 Dec;57(6):724-730. doi: 10.1016/j.transci.2018.10.013. Epub 2018 Oct 30.
	30442731	0	Streiff MB, Holmstrom B, Angelini D, et al. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018 Nov;16(11):1289-1303. doi: 10.6004/jnccn.2018.0084.
	30425073	0	Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Blood Adv. 2018 Nov 13;2(21):3081-3087. doi: 10.1182/bloodadvances.2018020230.
	30412622	0	Johnston A, Hsieh SC, Carrier M, et al. A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making. PLoS One. 2018 Nov 9;13(11):e0207410. doi: 10.1371/journal.pone.0207410. eCollection 2018.
	30410424	0	Chan A, Lensing AWA, Kubitza D, et al. Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis. Thromb J. 2018 Nov 1;16:29. doi: 10.1186/s12959-018-0182-4. eCollection 2018.
	30404743	0	Andrade JG, Verma A, Mitchell LB, et al. 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026.
	30397010	0	Yogendrakumar V, Lun R, Hutton B, et al. Comparing pharmacological venous thromboembolism prophylaxis to intermittent pneumatic compression in acute intracerebral haemorrhage: protocol for a systematic review and network meta-analysis. BMJ Open. 2018 Nov 5;8(11):e024405. doi: 10.1136/bmjopen-2018-024405.
	30385440	0	Bungard TJ, Ritchie B, Bolt J, et al. Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals. BMJ Open. 2018 Oct 31;8(10):e022065. doi: 10.1136/bmjopen-2018-022065.
	30385439	0	Bungard TJ, Ritchie B, Bolt J, et al. Management of acute venous thromboembolism among a cohort of patients discharged directly from the emergency department. BMJ Open. 2018 Oct 31;8(10):e022064. doi: 10.1136/bmjopen-2018-022064.
	30385438	0	Bungard TJ, Ritchie B, Bolt J, et al. Anticoagulant therapies for acute venous thromboembolism: a comparison between those discharged directly from the emergency department versus hospital in two Canadian cities. BMJ Open. 2018 Oct 31;8(10):e022063. doi: 10.1136/bmjopen-2018-022063.
	30384119	0	Hachem LD, Mansouri A, Scales DC, et al. Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: A prospective observational study and systematic review of the literature. Clin Neurol Neurosurg. 2018 Dec;175:68-73. doi: 10.1016/j.clineuro.2018.09.032. Epub 2018 Sep 26.
	30365345	0	Halford GM, Lordkipanidze M. An interview with Professor Gus Born. Platelets. 2018 Dec;29(8):744-748. doi: 10.1080/09537104.2018.1533756. Epub 2018 Oct 26.
	30362248	0	Bhatt MD, Parmar N, Fowler JA, et al. Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols. Pediatr Blood Cancer. 2019 Feb;66(2):e27483. doi: 10.1002/pbc.27483. Epub 2018 Oct 25.
	30357273	0	Righini M, Robert-Ebadi H, Elias A, et al. Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study. Ann Intern Med. 2018 Dec 4;169(11):766-773. doi: 10.7326/M18-1670. Epub 2018 Oct 23.
	30354213	0	Ni R, Vaezzadeh N, Zhou J, et al. Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model. Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2338-2344. doi: 10.1161/ATVBAHA.118.311404.
	30352507	0	Badv M, Imani SM, Weitz JI, et al. Lubricant-Infused Surfaces with Built-In Functional Biomolecules Exhibit Simultaneous Repellency and Tunable Cell Adhesion. ACS Nano. 2018 Nov 27;12(11):10890-10902. doi: 10.1021/acsnano.8b03938. Epub 2018 Oct 24.
	30349887	0	Piran S, Traquair H, Chan N, et al. Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study. Res Pract Thromb Haemost. 2018 Aug 29;2(4):684-688. doi: 10.1002/rth2.12146. eCollection 2018 Oct.
	30349886	0	Linkins LA, Hu G, Warkentin TE. Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials. Res Pract Thromb Haemost. 2018 Aug 9;2(4):678-683. doi: 10.1002/rth2.12145. eCollection 2018 Oct.
	30349885	0	Ma KA, Kahn SR, Akaberi A, et al. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study. Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.
	30349884	0	Samuelson Bannow BR, Lee AYY, Khorana AA, et al. Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review. Res Pract Thromb Haemost. 2018 Jun 19;2(4):664-669. doi: 10.1002/rth2.12111. eCollection 2018 Oct.
	30327391	0	Wang KL, van Es N, Cameron C, et al. Extended treatment of venous thromboembolism: a systematic review and network meta-analysis. Heart. 2019 Apr;105(7):545-552. doi: 10.1136/heartjnl-2018-313617. Epub 2018 Oct 16.
	30326130	0	Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous Thromboembolism: Advances in Diagnosis and Treatment. JAMA. 2018 Oct 16;320(15):1583-1594. doi: 10.1001/jama.2018.14346.
	30322987	0	Khan F, Ramirez FD, Hibbert B. Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation. CMAJ. 2018 Oct 15;190(41):E1227-E1230. doi: 10.1503/cmaj.180470.
	30317403	0	Peleg M, Michalowski W, Wilk S, et al. Ideating Mobile Health Behavioral Support for Compliance to Therapy for Patients with Chronic Disease: A Case Study of Atrial Fibrillation Management. J Med Syst. 2018 Oct 13;42(11):234. doi: 10.1007/s10916-018-1077-4.
	30316749	0	Boffa MB, Stranges S, Klar N, et al. Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal. J Clin Lipidol. 2018 Nov - Dec;12(6):1358-1366. doi: 10.1016/j.jacl.2018.08.012. Epub 2018 Sep 11.
	30308522	0	Pailleret C, Jourdi G, Siguret V, et al. Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study. Eur J Anaesthesiol. 2019 Jun;36(6):449-456. doi: 10.1097/EJA.0000000000000903.
	30295590	0	Rezazadeh S, Chew DS, Miller RJH, et al. Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation/atrial flutter discharged from the emergency department: REMINDER study. CJEM. 2018 Nov;20(6):841-849. doi: 10.1017/cem.2018.415. Epub 2018 Oct 8.
	30278776	0	Moyer GC, Bannow BS, Thornburg C, et al. Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):209S-216S. doi: 10.1177/1076029618804080. Epub 2018 Oct 2.
	30268859	0	Robin P, Kumar S, Salaun PY, et al. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thromb Res. 2018 Nov;171:97-102. doi: 10.1016/j.thromres.2018.09.050. Epub 2018 Sep 19.
	30268858	0	Robin P, Otten HM, Delluc A, et al. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thromb Res. 2018 Nov;171:92-96. doi: 10.1016/j.thromres.2018.09.055. Epub 2018 Sep 23.
	30262580	0	Laureano M, Crowther MA. Higher-risk APS: do we dare to DOAC? Blood. 2018 Sep 27;132(13):1357-1358. doi: 10.1182/blood-2018-08-867036.
	30262383	0	Laskov I, Kessous R, Abitbol J, et al. Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature. J Obstet Gynaecol Can. 2018 Dec;40(12):1571-1579. doi: 10.1016/j.jogc.2018.04.003. Epub 2018 Sep 24.
	30261356	0	Dube C, Douketis JD, Moffat KA, et al. Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time. Thromb Res. 2018 Nov;171:62-67. doi: 10.1016/j.thromres.2018.09.051. Epub 2018 Sep 19.
	30257890	0	Alcindor T, Al-Fakeeh A, Goulding K, et al. Venous Thromboembolism in Patients with Sarcoma: A Retrospective Study. Oncologist. 2019 Mar;24(3):e111-e114. doi: 10.1634/theoncologist.2018-0081. Epub 2018 Sep 26.
	30253868	0	Bekker W, Hernandez MC, Zielinski MD, et al. Defining an intra-operative blunt mesenteric injury grading system and its use as a tool for surgical-decision making. Injury. 2019 Jan;50(1):27-32. doi: 10.1016/j.injury.2018.08.014. Epub 2018 Aug 22.
	30242329	0	Sholzberg M, Xu Y. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy. JAMA. 2018 Oct 9;320(14):1485-1486. doi: 10.1001/jama.2018.13998.
	30201588	0	Schulman S. Splanchnic vein thrombosis: what are the long-term risks? Lancet Haematol. 2018 Oct;5(10):e431-e432. doi: 10.1016/S2352-3026(18)30137-6. Epub 2018 Sep 7.
	30194674	0	Lodewyks C, Heinrichs J, Grocott HP, et al. Point-of-care viscoelastic hemostatic testing in cardiac surgery patients: a systematic review and meta-analysis. Can J Anaesth. 2018 Dec;65(12):1333-1347. doi: 10.1007/s12630-018-1217-9. Epub 2018 Sep 7.
	30190113	0	Goyard C, Cote B, Looten V, et al. Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism. Thromb Res. 2018 Nov;171:190-198. doi: 10.1016/j.thromres.2018.08.015. Epub 2018 Aug 26.
	30186045	0	Cohen AT, Maraveyas A, Beyer-Westendorf J, et al. COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study. Thromb J. 2018 Sep 4;16:21. doi: 10.1186/s12959-018-0176-2. eCollection 2018.
	30170635	0	Versteeg HH, Rodger M. It's all in your genes. Thromb Res. 2018 Sep;169:157. doi: 10.1016/j.thromres.2018.08.009.
	30145946	0	Spyropoulos AC, Ageno W, Albers GW, et al. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness. N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.
	30141279	0	Pelland-Marcotte MC, Humpl T, James PD, et al. Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children. Br J Haematol. 2018 Oct;183(2):267-275. doi: 10.1111/bjh.15530. Epub 2018 Aug 23.
	30121419	0	Ten Cate H, Lensing AWA, Weitz JI, et al. The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15.
	30113416	0	Aguilar C, Sartori M, D'Angelo A, et al. Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study. Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566. doi: 10.1097/MBC.0000000000000750.
	30108204	0	Senzolo M, Riva N, Dentali F, et al. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis. Clin Transl Gastroenterol. 2018 Aug 15;9(8):176. doi: 10.1038/s41424-018-0043-2.
	30093297	0	Weitz JI, Earl KM, Leblanc K, et al. Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran. Can J Cardiol. 2018 Sep;34(9):1116-1119. doi: 10.1016/j.cjca.2018.05.023. Epub 2018 Jun 5.
	30093248	0	Teichman J, Chaudhry HR, Sholzberg M. Novel assays in the coagulation laboratory: a clinical and laboratory perspective. Transfus Apher Sci. 2018 Aug;57(4):480-484. doi: 10.1016/j.transci.2018.07.008. Epub 2018 Jul 20.
	30080513	0	Murad MH, Kahn SR. Response. Chest. 2018 Aug;154(2):460-461. doi: 10.1016/j.chest.2018.04.042.
	30077494	0	Sharif S, Eventov M, Kearon C, et al. Comparison of the age-adjusted and clinical probability-adjusted D-dimer to exclude pulmonary embolism in the ED. Am J Emerg Med. 2019 May;37(5):845-850. doi: 10.1016/j.ajem.2018.07.053. Epub 2018 Jul 30.
	30076179	0	Delluc A, Le Mao R, Tromeur C, et al. Incidence of upper-extremity deep vein thrombosis in western France: a community-based study. Haematologica. 2019 Jan;104(1):e29-e31. doi: 10.3324/haematol.2018.194951. Epub 2018 Aug 3.
	30071567	0	Jourdi G, Gouin-Thibault I, Siguret V, et al. FXa-alpha2-Macroglobulin Complex Neutralizes Direct Oral Anticoagulants Targeting FXa In Vitro and In Vivo. Thromb Haemost. 2018 Sep;118(9):1535-1544. doi: 10.1055/s-0038-1667014. Epub 2018 Aug 2.
	30064975	0	Warkentin TE, Sheppard JI, Linkins LA, et al. High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT. Blood. 2018 Sep 20;132(12):1345-1349. doi: 10.1182/blood-2018-04-847483. Epub 2018 Jul 31.
	30064683	0	Prandoni P, Lensing AWA, Prins MH, et al. Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Thromb Res. 2018 Aug;168:121-129. doi: 10.1016/j.thromres.2018.06.009. Epub 2018 Jul 10.
	30060256	0	Kraaijpoel N, Di Nisio M, Mulder FI, et al. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug;118(8):1439-1449. doi: 10.1055/s-0038-1667001. Epub 2018 Jul 30.
	30056293	0	Al Rawahi B, Almegren M, Carrier M. The efficacy and safety of anticoagulation in cerebral vein thrombosis: A systematic review and meta-analysis. Thromb Res. 2018 Sep;169:135-139. doi: 10.1016/j.thromres.2018.07.023. Epub 2018 Jul 25.
	30051364	0	Serrano PE, Parpia S, Linkins LA, et al. Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study. Ann Surg Oncol. 2018 Oct;25(11):3214-3221. doi: 10.1245/s10434-018-6671-7. Epub 2018 Jul 26.
	30049564	0	Pryzdial ELG, Lee FMH, Lin BH, et al. Blood coagulation dissected. Transfus Apher Sci. 2018 Aug;57(4):449-457. doi: 10.1016/j.transci.2018.07.003. Epub 2018 Jul 20.
	30046762	0	Ikesaka R, Langlois N, Carrier M, et al. Pilot trials in thrombosis: Purpose and pitfalls. Res Pract Thromb Haemost. 2018 Jun 13;2(3):572-579. doi: 10.1002/rth2.12117. eCollection 2018 Jul.
	30046758	0	Castellucci LA, de Wit K, Garcia D, et al. Extended anticoagulation for unprovoked venous thromboembolism. Res Pract Thromb Haemost. 2018 Jun 6;2(3):529-534. doi: 10.1002/rth2.12121. eCollection 2018 Jul.
	30046751	0	Lazo-Langner A, Liu K, Shariff S, et al. Immigration, region of origin, and the epidemiology of venous thromboembolism: A population-based study. Res Pract Thromb Haemost. 2018 May 27;2(3):469-480. doi: 10.1002/rth2.12113. eCollection 2018 Jul.
	30046747	0	Wang TF, Li A, Garcia D. Managing thrombosis in cancer patients. Res Pract Thromb Haemost. 2018 May 1;2(3):429-438. doi: 10.1002/rth2.12102. eCollection 2018 Jul.
	30046746	0	Bergmeier W, Antoniak S, Conway EM, et al. Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis. Res Pract Thromb Haemost. 2018 Apr 12;2(3):407-428. doi: 10.1002/rth2.12095. eCollection 2018 Jul.
	30046730	0	Shaw JR, Woodfine JD, Douketis J, et al. Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Res Pract Thromb Haemost. 2018 Feb 16;2(2):282-290. doi: 10.1002/rth2.12076. eCollection 2018 Apr.
	30046706	0	Wendelboe AM, Raskob GE, Angchaisuksiri P, et al. Global public awareness about atrial fibrillation. Res Pract Thromb Haemost. 2017 Oct 25;2(1):49-57. doi: 10.1002/rth2.12051. eCollection 2018 Jan.
	30046678	0	Arnold DM, Lauzier F, Albert M, et al. The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Res Pract Thromb Haemost. 2017 May 31;1(1):103-111. doi: 10.1002/rth2.12004. eCollection 2017 Jul.
	30046669	0	Khan F, Rahman A, Carrier M. Occult cancer detection in venous thromboembolism: the past, the present, and the future. Res Pract Thromb Haemost. 2017 Jun 16;1(1):9-13. doi: 10.1002/rth2.12007. eCollection 2017 Jul.
	30046668	0	Pabinger I, Reiser T, Weitz JI. Research and Practice in Thrombosis and Haemostasis - a new ISTH publishing platform for the global thrombosis and hemostasis community. Res Pract Thromb Haemost. 2017 May 30;1(1):6-8. doi: 10.1002/rth2.12005. eCollection 2017 Jul.
	30042148	0	Chan NC, Weitz JI. Antiplatelet therapy in the management of atherothrombosis: recent clinical advances. Blood Adv. 2018 Jul 24;2(14):1806. doi: 10.1182/bloodadvances.2018005074.
	30031290	0	Rodger MA, Le Gal G, Langlois NJ, et al. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer? Thromb Res. 2018 Sep;169:82-86. doi: 10.1016/j.thromres.2018.07.020. Epub 2018 Jul 17.
	30028001	0	Minhas H, Welsher A, Turcotte M, et al. Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies. Br J Haematol. 2018 Oct;183(1):119-126. doi: 10.1111/bjh.15509. Epub 2018 Jul 20.
	30014300	0	Htun KT, Ma MJY, Lee AYY. Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen. J Thromb Thrombolysis. 2018 Oct;46(3):386-392. doi: 10.1007/s11239-018-1711-5.
	30012319	0	Schulman S, Aisenberg J. Are NSAIDs Double Trouble? J Am Coll Cardiol. 2018 Jul 17;72(3):268-270. doi: 10.1016/j.jacc.2018.04.062. Epub 2018 Jul 9.
	29995656	0	Murray EKI, Murphy MSQ, Smith GN, et al. Thromboelastographic analysis of haemostasis in preeclamptic and normotensive pregnant women. Blood Coagul Fibrinolysis. 2018 Sep;29(6):567-572. doi: 10.1097/MBC.0000000000000759.
	29974358	0	Robinson A, Souied O, Bota AB, et al. Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat. 2018 Oct;171(3):607-620. doi: 10.1007/s10549-018-4868-x. Epub 2018 Jul 4.
	29971683	0	Shukla A, Bhatt P, Gupta DK, et al. Budd-Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int. 2018 Nov;12(6):560-566. doi: 10.1007/s12072-018-9880-z. Epub 2018 Jul 3.
	29967197	0	Yin OQP, Antman EM, Braunwald E, et al. Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial. Circulation. 2018 Oct 30;138(18):1963-1973. doi: 10.1161/CIRCULATIONAHA.118.033933.
	29965810	0	Gantioqui J, Stevic I, Atkinson H, et al. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography. Blood Coagul Fibrinolysis. 2018 Sep;29(6):521-527. doi: 10.1097/MBC.0000000000000751.
	29959155	0	Linkins LA MD, MSc, FRCPC. Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism. BMJ Evid Based Med. 2018 Dec;23(6):230. doi: 10.1136/bmjebm-2018-111007. Epub 2018 Jun 29.
	29948370	0	Li G, Lip GYH, Holbrook A, et al. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. Eur J Epidemiol. 2019 Feb;34(2):173-190. doi: 10.1007/s10654-018-0415-7. Epub 2018 Jun 8.
	29945822	0	Yoo T, Aggarwal R, Wang TF, et al. Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):575-583.e1. doi: 10.1016/j.jvsv.2017.12.059. Epub 2018 Jun 23.
	29891177	0	Liu N, Vigod SN, Farrugia MM, et al. Venous thromboembolism after induced abortion: a population-based, propensity-score-matched cohort study in Canada. Lancet Haematol. 2018 Jul;5(7):e279-e288. doi: 10.1016/S2352-3026(18)30069-3. Epub 2018 Jun 18.
	29880445	0	Delluc A, Clemons M. Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice. Thromb Res. 2018 Nov;171:177-178. doi: 10.1016/j.thromres.2018.06.003. Epub 2018 Jun 2.
	29866818	0	Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018 Jul 12;132(2):148-158. doi: 10.1182/blood-2017-12-768994. Epub 2018 Jun 4.
	29866211	0	Senior K, Burles K, Wang D, et al. Age-adjusted D-dimer thresholds in the investigation of suspected pulmonary embolism: A retrospective evaluation in patients ages 50 and older using administrative data. CJEM. 2018 Sep;20(5):725-731. doi: 10.1017/cem.2018.389. Epub 2018 Jun 5.
	29864787	0	Kraaijpoel N, van Es N, Raskob GE, et al. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study. Thromb Haemost. 2018 Jul;118(7):1270-1278. doi: 10.1055/s-0038-1649523. Epub 2018 Jun 4.
	29857347	0	Schulman S. Recent Advances in Thrombosis and Hemostasis - Part III. Semin Thromb Hemost. 2018 Jun;44(4):312-314. doi: 10.1055/s-0038-1654717. Epub 2018 Jun 1.
	29856817	0	Pai M, Adhikari NKJ, Ostermann M, et al. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLoS One. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285. eCollection 2018.
	29801744	0	Miller RJH, Chew DS, Rezazadeh S, et al. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter. Can J Cardiol. 2018 Jun;34(6):804-807. doi: 10.1016/j.cjca.2018.03.009. Epub 2018 Mar 24.
	29795666	0	Xu Y, Shoamanesh A, Schulman S, et al. Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. PLoS One. 2018 May 24;13(5):e0198031. doi: 10.1371/journal.pone.0198031. eCollection 2018.
	29790365	0	Andrade JG, Meseguer E, Didier R, et al. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with bioprosthetic valves. Expert Rev Cardiovasc Ther. 2018 May 23:1-6. doi: 10.1080/14779072.2018.1475229.
	29789147	0	Galanaud JP, Blaise S, Sevestre MA, et al. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer. Thromb Res. 2018 Nov;171:179-186. doi: 10.1016/j.thromres.2018.04.013. Epub 2018 Apr 20.
	29787944	0	Delluc A, Lacut K, Pan-Petesch B, et al. Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms. Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16.
	29781569	0	Nossair F, Schoettler P, Starr J, et al. Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature. Pediatr Blood Cancer. 2018 Sep;65(9):e27225. doi: 10.1002/pbc.27225. Epub 2018 May 21.
	29775482	0	Heraudeau A, Delluc A, Le Henaff M, et al. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. PLoS One. 2018 May 18;13(5):e0194973. doi: 10.1371/journal.pone.0194973. eCollection 2018.
	29772489	0	Lazo-Langner A, Al-Ani F, Weisz S, et al. Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study. Thromb Res. 2018 Jul;167:20-25. doi: 10.1016/j.thromres.2018.05.005. Epub 2018 May 5.
	29770793	0	Huisman MV, Barco S, Cannegieter SC, et al. Pulmonary embolism. Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28.
	29769447	0	Agbani EO, Williams CM, Li Y, et al. Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis. JCI Insight. 2018 May 17;3(10). pii: 99062. doi: 10.1172/jci.insight.99062. eCollection 2018 May 17.
	29766772	0	Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
	29748353	0	Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, et al. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction). Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e003998. doi: 10.1161/CIRCOUTCOMES.117.003998.
	29742368	0	Anderson DR, Doucette S, Kahn SR. Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 May 10;378(19):1848-1849. doi: 10.1056/NEJMc1803708.
	29731031	0	Mavrakanas TA, Sood MM. Direct Factor Xa Inhibitors for Long-term Stroke Prevention in Atrial Fibrillation: Could the Lower Dose Fit All? Can J Cardiol. 2018 May;34(5):690.e15. doi: 10.1016/j.cjca.2018.02.003. Epub 2018 Feb 7.
	29730328	0	Taniguchi Y, Brenot P, Jais X, et al. Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension. Chest. 2018 Sep;154(3):521-531. doi: 10.1016/j.chest.2018.03.059. Epub 2018 May 3.
	29724900	0	Avila ML, Amiri N, Stanojevic S, et al. Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children? Blood. 2018 Jun 14;131(24):2712-2719. doi: 10.1182/blood-2017-10-811216. Epub 2018 May 3.
	29723874	0	Douketis JD, Murphy SA, Antman EM, et al. Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial. Thromb Haemost. 2018 Jun;118(6):1001-1008. doi: 10.1055/s-0038-1645856. Epub 2018 May 3.
	29709455	0	Rohailla S, Malinowski AK, Gandhi S, et al. The Approach to Peripartum Management of Anticoagulation: A Multidisciplinary Survey. J Obstet Gynaecol Can. 2018 Jul;40(7):888-895.e6. doi: 10.1016/j.jogc.2017.10.010. Epub 2018 Apr 27.
	29708897	0	Khatri V, Chan AKC, Stein N, et al. Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia. Blood Coagul Fibrinolysis. 2018 Jun;29(4):399-403. doi: 10.1097/MBC.0000000000000731.
	29708541	0	Rys RN, Blostein MD, Lemarie CA. Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography. J Vis Exp. 2018 Apr 13;(134). doi: 10.3791/57392.
	29704767	0	ALKindi SY, Chai-Adisaksopha C, Cheah M, et al. Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center. Thromb Res. 2018 Jun;166:92-95. doi: 10.1016/j.thromres.2018.03.020. Epub 2018 Apr 3.
	29703487	0	Robin P, Carrier M. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism. Thromb Res. 2018 Apr;164 Suppl 1:S7-S11. doi: 10.1016/j.thromres.2017.12.024.
	29703478	0	Piran S, Schulman S. Management of recurrent venous thromboembolism in patients with cancer: A review. Thromb Res. 2018 Apr;164 Suppl 1:S172-S177. doi: 10.1016/j.thromres.2017.12.019.
	29703470	0	Kimpton M, Wells PS, Carrier M. Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial. Thromb Res. 2018 Apr;164 Suppl 1:S124-S129. doi: 10.1016/j.thromres.2018.01.018.
	29687454	0	Kahn SR, Morrison DR, Diendere G, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3.
	29680814	0	Le Roux PY, Robin P, Tromeur C, et al. SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcome. BMJ Open. 2018 Apr 21;8(4):e022024. doi: 10.1136/bmjopen-2018-022024.
	29680102	0	Lloyd AJ, Dewilde S, Noble S, et al. What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life? Value Health. 2018 Apr;21(4):449-455. doi: 10.1016/j.jval.2017.09.015. Epub 2017 Nov 10.
	29650271	0	Hong Y, Mansour S, Alotaibi G, et al. Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials. Crit Rev Oncol Hematol. 2018 May;125:12-18. doi: 10.1016/j.critrevonc.2018.02.010. Epub 2018 Mar 2.
	29632234	0	Prins MH, Lensing AWA, Prandoni P, et al. Risk of recurrent venous thromboembolism according to baseline risk factor profiles. Blood Adv. 2018 Apr 10;2(7):788-796. doi: 10.1182/bloodadvances.2018017160.
	29626988	0	Jourdi G, Lefebvre S, Le Bonniec B, et al. Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats. Pestic Biochem Physiol. 2018 Apr;146:19-24. doi: 10.1016/j.pestbp.2018.02.004. Epub 2018 Feb 15.
	29618162	0	Bauersachs R, Lee AYY, Kamphuisen PW, et al. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study. Thromb Haemost. 2018 May;118(5):914-921. doi: 10.1055/s-0038-1641150. Epub 2018 Apr 4.
	29607251	0	Grote CW, Cowan PC, Anderson DW, et al. Pseudotumor from Metal-on-Metal Total Hip Arthroplasty Causing Unilateral Leg Edema: Case Presentation and Literature Review. Biores Open Access. 2018 Mar 1;7(1):33-38. doi: 10.1089/biores.2017.0035. eCollection 2018.
	29605058	0	Le Gal G, Righini M. Preface to Diagnosis of venous thromboembolism. Thromb Res. 2018 Mar;163:200. doi: 10.1016/j.thromres.2018.02.139.
	29574430	0	Funnell C, Heran MKS, Teal P, et al. Rapidly expanding venous intracerebral haemorrhage with spot sign. BMJ Case Rep. 2018 Mar 23;2018. pii: bcr-2017-223055. doi: 10.1136/bcr-2017-223055.
	29567052	0	Montroy J, Hutton B, Moodley P, et al. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018 Feb 19. pii: S0887-7963(17)30151-7. doi: 10.1016/j.tmrv.2018.02.003.
	29566417	0	Khorana AA, Weitz JI. Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies. Thromb Haemost. 2018 May;118(S 01):S23-S33. doi: 10.1160/TH17-09-0681. Epub 2018 Mar 22.
	29564837	0	Schulman S, Gross PL, Ritchie B, et al. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21.
	29564687	0	Piran S, Gabriel C, Schulman S. Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study. J Thromb Thrombolysis. 2018 May;45(4):486-495. doi: 10.1007/s11239-018-1645-y.
	29545327	0	Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood. 2018 May 17;131(20):2215-2222. doi: 10.1182/blood-2018-01-785956. Epub 2018 Mar 15.
	29542828	0	Perreault S, Shahabi P, Cote R, et al. Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study. Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.
	29540105	0	Easaw JC, McCall S, Azim A. ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting. J Oncol Pharm Pract. 2019 Jun;25(4):818-823. doi: 10.1177/1078155218760704. Epub 2018 Mar 14.
	29528858	0	Boffa MB, Koschinsky ML. The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet? Curr Opin Lipidol. 2018 Jun;29(3):259-267. doi: 10.1097/MOL.0000000000000499.
	29525076	0	Kasner SE, Lavados P, Sharma M, et al. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1673-1682. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.027. Epub 2018 Mar 7.
	29522910	0	Delluc A, Ianotto JC, Tromeur C, et al. Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study. Thromb Res. 2018 Apr;164:79-84. doi: 10.1016/j.thromres.2018.02.151. Epub 2018 Mar 2.
	29521183	0	Alotaibi G, Wu C, Senthilselvan A, et al. Short- and long-term mortality after pulmonary embolism in patients with and without cancer. Vasc Med. 2018 Jun;23(3):261-266. doi: 10.1177/1358863X18754692. Epub 2018 Mar 9.
	29519352	0	Crowther MA, Lim W. Resolving Concerns With the Newer Oral Anticoagulant Medications: Is Hepatotoxicity a Real Concern? J Am Coll Cardiol. 2018 Mar 13;71(10):1114-1116. doi: 10.1016/j.jacc.2018.01.052.
	29519351	0	Douros A, Azoulay L, Yin H, et al. Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury. J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.
	29517503	0	Conway EM. Complement-coagulation connections. Blood Coagul Fibrinolysis. 2018 Apr;29(3):243-251. doi: 10.1097/MBC.0000000000000720.
	29506866	0	Li A, Garcia DA, Lyman GH, et al. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis. Thromb Res. 2019 Jan;173:158-163. doi: 10.1016/j.thromres.2018.02.144. Epub 2018 Mar 2.
	29490924	0	Kearon C, Parpia S, Spencer FA, et al. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 May 10;131(19):2151-2160. doi: 10.1182/blood-2017-09-805689. Epub 2018 Feb 28.
	29488097	0	Chan TM, Jo D, Shih AW, et al. The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series. Perspect Med Educ. 2018 Jun;7(3):219-223. doi: 10.1007/s40037-018-0406-0.
	29466159	0	Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
	29460705	0	Phelps MK, Wiczer TE, Erdeljac HP, et al. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience. J Oncol Pharm Pract. 2019 Jun;25(4):793-800. doi: 10.1177/1078155218757856. Epub 2018 Feb 20.
	29459016	0	Kahn SR, Pengo V. Special issue: Late consequences of venous thromboembolism. Thromb Res. 2018 Apr;164:99. doi: 10.1016/j.thromres.2018.02.005. Epub 2018 Feb 13.
	29440340	0	Khan F, Le Gal G, Rodger MA. The authors respond to "Thrombophilia testing in venous thromboembolism". CMAJ. 2018 Feb 12;190(6):E172. doi: 10.1503/cmaj.68991.
	29433730	0	Versteeg HH, Rodger M. HAPPY NEW CAREER!! Thromb Res. 2018 Feb;162:87. doi: 10.1016/j.thromres.2018.01.022.
	29433148	0	Gosselin RC, Adcock DM, Bates SM, et al. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2018 Mar;118(3):437-450. doi: 10.1055/s-0038-1627480. Epub 2018 Feb 12.
	29424601	0	Juhl RC, Roddy JVF, Wang TF, et al. Thromboembolic complications following aminocaproic acid use in patients with hematologic malignancies. Leuk Lymphoma. 2018 Oct;59(10):2377-2382. doi: 10.1080/10428194.2018.1434882. Epub 2018 Feb 9.
	29407624	0	Rodger M, Langlois N, Middeldorp S, et al. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism. Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.
	29406421	0	Fernando SM, Reardon PM, Dowlatshahi D, et al. Outcomes and Costs of Patients Admitted to the ICU Due to Spontaneous Intracranial Hemorrhage. Crit Care Med. 2018 May;46(5):e395-e403. doi: 10.1097/CCM.0000000000003013.
	29402471	0	Bertoletti L, Benhamou Y, Bejot Y, et al. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20.
	29397541	0	Piran S, Traquair H, Chan N, et al. Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study. J Thromb Thrombolysis. 2018 May;45(4):557-561. doi: 10.1007/s11239-018-1626-1.
	29392436	0	Younis M, Ray-Zack M, Haddad NN, et al. Prothrombin Complex Concentrate Reversal of Coagulopathy in Emergency General Surgery Patients. World J Surg. 2018 Aug;42(8):2383-2391. doi: 10.1007/s00268-018-4520-2.
	29384885	0	Wang L, Xu Y, Tuo M, et al. Recurrent stroke in a patient of lung cancer without pulmonary mass: A case report. Medicine (Baltimore). 2018 Feb;97(5):e9815. doi: 10.1097/MD.0000000000009815.
	29378357	0	Galanaud JP, Bertoletti L, Amitrano M, et al. Predictors of Post-Thrombotic Ulcer after Acute DVT: The RIETE Registry. Thromb Haemost. 2018 Feb;118(2):320-328. doi: 10.1160/TH17-08-0598. Epub 2018 Jan 29.
	29370183	0	Xu Y, Shoamanesh A, Schulman S, et al. Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. PLoS One. 2018 Jan 25;13(1):e0191137. doi: 10.1371/journal.pone.0191137. eCollection 2018.
	29368192	0	Shukla A, Bhatt P, Gupta DK, et al. Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver. Indian J Gastroenterol. 2017 Nov;36(6):474-480. doi: 10.1007/s12664-017-0811-z. Epub 2018 Jan 24.
	29355793	0	Roullet S, de Maistre E, Ickx B, et al. Position of the French Working Group on Perioperative Haemostasis (GIHP) on viscoelastic tests: What role for which indication in bleeding situations? Anaesth Crit Care Pain Med. 2019 Oct;38(5):539-548. doi: 10.1016/j.accpm.2017.12.014. Epub 2018 Feb 3.
	29353682	0	van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.
	29345686	0	Levy JH, Douketis J, Weitz JI. Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat Rev Cardiol. 2018 May;15(5):273-281. doi: 10.1038/nrcardio.2017.223. Epub 2018 Jan 18.
	29325985	0	Warkentin TE, Arnold DM, Kelton JG, et al. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay. Chest. 2018 Jun;153(6):1396-1404. doi: 10.1016/j.chest.2018.01.001. Epub 2018 Jan 8.
	29324333	0	Shaw JR, Castellucci L, Siegal D, et al. Management of direct oral anticoagulant associated bleeding: Results of a multinational survey. Thromb Res. 2018 Mar;163:19-21. doi: 10.1016/j.thromres.2018.01.008. Epub 2018 Jan 5.
	29320795	0	Klil-Drori AJ, Tagalakis V. Direct Oral Anticoagulants in End-Stage Renal Disease. Semin Thromb Hemost. 2018 Jun;44(4):353-363. doi: 10.1055/s-0037-1621715. Epub 2018 Jan 10.
	29310137	0	Wells PS, Ihaddadene R, Reilly A, et al. Diagnosis of Venous Thromboembolism: 20 Years of Progress. Ann Intern Med. 2018 Jan 16;168(2):131-140. doi: 10.7326/M17-0291. Epub 2018 Jan 9.
	29310057	0	Skeith L, Carrier M, Shivakumar S, et al. Guiding curriculum development of a national research training program in thrombosis medicine: A needs assessment involving faculty and trainees. Thromb Res. 2018 Feb;162:79-86. doi: 10.1016/j.thromres.2017.12.008. Epub 2017 Dec 13.
	29307536	0	Lauber S, Limacher A, Tritschler T, et al. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients. Am J Med. 2018 Jun;131(6):703.e7-703.e16. doi: 10.1016/j.amjmed.2017.12.015. Epub 2018 Jan 4.
	29307469	0	Lee AYY. Overview of VTE treatment in cancer according to clinical guidelines. Thromb Res. 2018 Apr;164 Suppl 1:S162-S167. doi: 10.1016/j.thromres.2018.01.002. Epub 2018 Jan 3.
	29296696	0	Cines DB, Yarovoi SV, Zaitsev SV, et al. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia. Blood Adv. 2016 Nov 22;1(1):62-74. doi: 10.1182/bloodadvances.2016000877. eCollection 2016 Nov 29.
	29289275	0	Versteeg HH, Rodger M. The misfits of blood coagulation. Thromb Res. 2018 Jan;161:119. doi: 10.1016/j.thromres.2017.12.010.
	29279816	0	Mojadidi MK, Mahmoud AN, Elgendy AY, et al. When Ablation Is Not the Answer: Acute Left Main Thrombosis Causing Incessant Ventricular Tachycardia Following Left Ventricular Assist Device Implant. Cureus. 2017 Oct 21;9(10):e1790. doi: 10.7759/cureus.1790.
	29277101	0	Agarwal A, Firdouse M, Brar N, et al. Incidence and Management of Thrombotic and Thromboembolic Complications Following the Superior Cavopulmonary Anastomosis Procedure: A Literature Review. Clin Appl Thromb Hemost. 2018 Apr;24(3):405-415. doi: 10.1177/1076029617739702. Epub 2017 Dec 25.
	29274307	0	Chai-Adisaksopha C, Iorio A, Crowther MA, et al. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Am J Med. 2018 Apr;131(4):430-437. doi: 10.1016/j.amjmed.2017.11.042. Epub 2017 Dec 20.
	29269514	0	Weitz JI, Fredenburgh JC. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants. Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):304-310. doi: 10.1161/ATVBAHA.117.309664. Epub 2017 Dec 21.
	29248859	0	Vanassche T, Verhamme P, Wells PS, et al. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Thromb Res. 2018 Feb;162:7-14. doi: 10.1016/j.thromres.2017.12.005. Epub 2017 Dec 13.
	29233324	0	Diamantouros A, Marchesano R, Geerts WH, et al. Development and evaluation of a continuing pharmacy education (CPE) program in thrombosis management. Curr Pharm Teach Learn. 2017 Sep;9(5):911-917. doi: 10.1016/j.cptl.2017.05.008. Epub 2017 Jul 14.
	29231094	0	Raskob GE, van Es N, Verhamme P, et al. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.